<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006580.pub5" GROUP_ID="AIRWAYS" ID="423207040113075606" MERGED_FROM="" MODIFIED="2017-08-14 09:31:57 +0100" MODIFIED_BY="Emma Dennett" NOTES="&lt;p&gt;&lt;b&gt;RN comments 10/1/17&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Although I appreciate word limit is tight, the abstract is quite vague, using words such as 'culture-specific' and 'certain asthma outcomes' without further explanation of what the authors are referring to. I think it could do with being tightened. I would also consider rephrasing &amp;quot;suffer from asthma&amp;quot;.&lt;/p&gt;&lt;p&gt;&amp;quot;A total of with a total of seven RCTs with 837 participants with asthma from ethnic minority groups seven studies (two in adults, four in children, one in both children and adults) were eligible for inclusion in this review. A total of 837 participants, aged from one to 63 years were included&amp;quot; - doesn't make sense&lt;/p&gt;&lt;p&gt;&amp;quot;in improving asthma quality of life scores in adults (MD 0.26, 95% CI 0.17 to 0.36)&amp;quot; - which QOL score? If this is the AQLQ, the MD and its CI fall within the MID so this may not be clinically important (same comment applies to where this is reported in the main text).&lt;/p&gt;&lt;p&gt;The main results section reads in a rather confusing way and I think the terminology needs to be revisited to make it clear whether you're reporting a rate or a dichotomous outcome. E.g &amp;quot;&lt;span&gt; such as the number of participants with one or more exacerbations during follow up (OR 0.80, 95% CI 0.50 to 1.26), the number of asthma exacerbations (OR 0.26, 95% CI 0.17 to 0.36)&amp;quot;: the first result is appropriately described as a dichotomous outcome, followed by an ORs (appropriate) but the second result sounds like a rate but then is followed by an OR. This is a problem throughout this section. In addition, I could not see where some of these statistical results had come from e.g. &amp;quot;t&lt;/span&gt;he number of asthma exacerbations (OR 0.26, 95% CI 0.17 to 0.36)&amp;quot; does not appear to be in a forest plot and also seems to be a significant result, but you are suggesting it is not?&lt;/p&gt;&lt;p&gt;There is no reference to risk of bias or the quality of the outcomes reported in the abstract, which is an important omission. You should also mention if you looked for harms or not.&lt;/p&gt;&lt;p&gt;Conclusions: &amp;quot;The available evidence showed that culture-specific education programmes for adults and children from minority groups are likely effective in improving asthma related outcomes.&amp;quot; I'm not sure this really follows the above results or the SOF tables which suggests most of the evidence is very low quality (i.e. the true effect estimates are likely to be different from those reported).&lt;/p&gt;&lt;p&gt;&lt;b&gt;PLS:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Positive results are highlighted and negative findings, plus the relative paucity of evidence and low confidence in the results, is not clearly described. This could be rather misleading.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The BTS 2014 guidelines have been updated to 2016 - please consider amending.&lt;/p&gt;&lt;p&gt;Poureslami 2011 isn't linked to a reference - please check.&lt;/p&gt;&lt;p&gt;I don't get a clear idea from the background about what the key components of a 'culture-specific' intervention are. IHWs are mentioned, but apart from that, what do these interventions look like? What makes it culture-specific as opposed to being delivered in a person's first language, for example?&lt;/p&gt;&lt;p&gt;&lt;b&gt;Search results:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Are Buist 2001 and Butz 2004 really still ongoing? If no information can be obtained on them, perhaps they should be moved to 'awaiting classification'? (i.e. it seems odd to have trials &amp;gt;10 years old as ongoing).&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results/description of studies:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;While the participants and outcomes are well-described, to me there is a lack of information about the interventions and what makes them 'culture-specific'. I appreciate that this information is in the characteristics table, but I think it needs to be summarised here as well. Also important is more detail about what the control group received in each case; to me, this is a crucial point, as it we need to understand if it is the cultural tailoring which is making a difference, or the asthma education generally. In my experience, 'usual care' can vary widely. For example, Valery 2010 provided children in the intervention group with AAPs - to what extent is this confounding any benefits seen from the culture-specific programme? This apparent lack of clarity about what the comparator is in each study for me is a major limitation of the utility of this review.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Risk of bias:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;I think, as CJC notes below, that risk of bias may need to be reconsidered for blinding in particular. I'm not convinced the quotes in the tables really justify the low risk judgement for &lt;a link_type=&quot;STUDY&quot; href=&quot;Blixen 2001&quot; protected=&quot;true&quot;&gt;Blixen 2001&lt;/a&gt;, &lt;a link_type=&quot;STUDY&quot; href=&quot;Canino 2008&quot; protected=&quot;true&quot;&gt;Canino 2008&lt;/a&gt; and &lt;a link_type=&quot;STUDY&quot; href=&quot;Poureslami 2012&quot; protected=&quot;true&quot;&gt;Poureslami 2012&lt;/a&gt;. If participants were aware of group allocation, it is possible this affected how they reported their QOL, knowledge etc, even if the person administering the questionnaire was blinded. Selective reporting may also need to be reconsidered; although describing whether you have used per protocol or ITT analysis is good practice, there is more to this domain than that. Did the studies have pre-published protocols or trial registrations, so you can compare the planned outcome measures to those reported? Do you suspect that only positive outcomes were reported? In fact, I think some of then things you have identified as 'other biases' are reporting biases (e.g.Moudgil 2000 &amp;quot;Objective measurement of airflow obstruction (e.g. peak flow) recorded for 12 months - nil data reported in paper&amp;quot;)&lt;/p&gt;&lt;p&gt;&lt;b&gt;Discussion: &lt;/b&gt;&lt;/p&gt;&lt;p&gt;The issues around what constitutes a culture-specific programme and what the control group received need to be explored further. As a clinician, I am not sure how I would apply the findings of this review.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Conclusions:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;I feel these are a little too strongly in favour of culture specific programmes, given the issues you have highlighted in the overall completeness section and the low GRADE ratings. The implications for research section also further confuses the issue about what the control groups received by recommending &amp;quot;Trials should include both adults and children/families, and &lt;span&gt;should compare the culture-specific programmes to generic education programmes (as opposed to culture specific vs routine care)&amp;quot;. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SOFs:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;As CJC notes, we need two SOFs; one for adults and one for children and the GRADE decisions need to be explained in the footnotes.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Other notes:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;I believe Puerto Rico is misspelt in several places.&lt;/p&gt;&lt;p&gt;An additional table would be very helpful, detailing the main points of each intervention (including why it was deemed to be culture specific), what the control group received, the setting and the total n. I think this would greatly help the reader to quickly understand the key similarities and differences between the included studies.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;CJC revisit December 2&lt;/b&gt;&lt;b&gt;3rd. Word document uploaded to workflow. The data entered from &lt;/b&gt;&lt;a link_type=&quot;STUDY&quot; href=&quot;Grover 2016&quot; protected=&quot;true&quot;&gt;Grover 2016&lt;/a&gt; is still worrying to me. Also the Risks of Bias do not look right at present and as there are two comparisons in this update it needs to have two SoF tables (when the Risks of Bias have been corrected).&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Please consider all points below raised by the Editorial team and the Contact Editor. Please respond to each comments briefly using bold text and note where you chose to make a change in the text, or, if you chose not to do so, why.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;CO feedback&lt;/b&gt;&lt;b&gt; 09/12/16:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The hyperlink for Poureslami 2011 appears broken in some parts - should be re-inserted.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Hyperlink re-inserted&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Some inconsistency between use of the terms 'culturally specific' vs 'culture specific' in the background.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Updated with culture-specific&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Is it possible to enhance the clarity of the definition of 'minority group' ('&lt;i&gt;The minority was defined as per the country definition&lt;/i&gt;')? This is quite an important aspect of the review. Is this your judgement or the authors and is it related to where they are currently living? e.g. if someone from the Indian sub-continent who lives in the UK is considered minority, does this mean they are not a minority group if the live in the Indian sub-continent? Is it related to population numbers?&lt;/p&gt;&lt;p&gt;&lt;b&gt;Amended to reflect that this was determined by the study authors at country level.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Section 'Data synthesis', sentence 2 seems incorrect. Consider reviewing.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Modified&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;I feel it would be useful to operationally define 'rural or non-rural' for the subgroup analysis? Perhaps, according to authors definition?&lt;/p&gt;&lt;p&gt;&lt;b&gt;I have modified as per suggestion&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Unless I missed it, there was no prior methods stating that all analyses were planned to be distinct between adults and paeds. While it makes sense, should be outlined in methods.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Good point - updated in the methods&lt;/b&gt;&lt;/p&gt;&lt;p&gt;I feel it could be useful to have a brief sentence added to the primary outcome results section that lists the GRADE rating achieved for that outcome. It is quite important but seldomly reported anywhere.&lt;/p&gt;&lt;p&gt;&lt;b&gt;The GRADE rating takes into account patient preferences and policy imperatives and not designed for primary outcomes (which are chosen by the reviewers!). As the CR primary outcome is not a recommendation statement we have not included this.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;I think it could be worth explaining how you handled the issue identified in 'Potential biases in the review process'. e.g. did you ensure other individuals entered the data from these studies (not the authors with the COI)? Is it wise to also openly acknowledge this in the 'declarations of interest' section?&lt;/p&gt;&lt;p&gt;&lt;b&gt;Thank you for the suggestion - have modified to include decision was made by review authors &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Emma Dennett notes 13/12/2016&lt;/b&gt;&lt;/p&gt;&lt;p&gt;There are a number of differences made since the last published version which have not been noted in 'differences between protocol and review'&lt;/p&gt;&lt;ul&gt;&lt;li&gt;background/methods/results/discussion have been redrafted&lt;/li&gt;&lt;li&gt;outcomes - primary a definition of exacerbations added. Secondary - number of outcomes has been reduced and some clarity added&lt;/li&gt;&lt;li&gt;new Risk of bias tool used&lt;/li&gt;&lt;li&gt;SOF table added&lt;/li&gt;&lt;li&gt;subgroups - adults v children and types of education have been removed. Adults and children now analysed separately.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;I have updated the differences with your suggestions. I wasn't sure if this needs to be done individually or under the same date, so have left this as single group&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Excluded studies &lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;there are 36 listed in the table, but there are reasons for 37 - please check.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Thank you - this was an error. There are n=36 studies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;only needs to include reason for exclusion and not a description of the studies&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;This was kept the same as the previous review, however I have updated to only reflect the reason why the study was excluded.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Risk of bias&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;We usually list the split domains separately as it's less confusing e.g. performance and detection bias - took me quite a while to check the accuracy of the section (which is not necessarily a problem, but indicates how easy it might be for the reader!).&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;blinding of participants - Valery incorrectly listed as low risk when it is high risk in the tables&lt;/li&gt;&lt;li&gt;attrition bias - needs correcting - text describes 4 at low risk, but figure tells a different story.&lt;/li&gt;&lt;li&gt;please check them all again carefully...&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;I've updated this as per your recommendations. Reviewed studies again&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Effects of interventions&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;I think this statement is wrong - there are more events in the control group, but a smaller proportion hence why the forest plot shows that the intervention favours the control group.&amp;quot; Numbers were small, however more children in the control group had exacerbations compared to the culture-specific group but this wasn't significant (OR 1.55; 95% CI 0.66 to 3.66).&amp;quot;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Actually, we are correct as we did not report events but number of children with exacerbations and the proportion of children in the intervention group was indeed higher than in the controls. Thus we have not changed but reworded for clarity. &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Discussion&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;I have softened this sentence &amp;quot;There was significant differences in several outcomes, however where outcomes did not reach statistical significance, the direction of results favoured the culture-specific programmes.&amp;quot; changing favoured to tended to favour as there were 4 outcomes which were not statistically significant but which 'favoured' control.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;OK and thanks&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;The discussion seems quite favourable to culture-specific programs despite there being few small studies and not overwhelming positive news from the analyses. I was wondering why the Tapp review was mentioned as from the title it didn't to my mind seem especially relevant, and so I started looking into the nature of the control groups in Tapp and this review. In Tapp, the control group is usual care. In this review it is either usual care or a culture specific version of the same intervention. There is only one study, La Roche, where they compare the same education but with a culture specific delivery/content. Therefore, this is the only study which really answers the review question. The others show that culture specific education is better than no education. This is alluded to in the last paragraph of the overall completeness of the evidence, but it would be clearer if it was upfront. i.e. the control groups described under 'included studies' and a subgroup analysis done and then the results clearly described and summarised in the discussion.&lt;/li&gt;&lt;li&gt;The editor commented: discussion, I would agree that it would seem fair to request the discussion of results be made more transparently related to the limited data that were available. Which would mean toning down statements like &amp;#8216;strengthening the supportive findings from the earlier review&amp;#8217; etc.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;We referenced the Tapp review in relation to generic asthma education where appropriate. The control group comparison between our review and that of Tapp does not come into play whatsoever. We respectfully disagree with you that there is only one paper that answers the question. Understanding the control group is essential; for example even in the Valry paper, the control group was not no education. Routine education is standard care and clinically based people would have recognised it, i.e. none of the papers used no education. &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;We were upfront in the last para referenced above wrt the type of cultural appropriateness and not what was misinterpreted by the first dot point comment above&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;We have toned down the discussion where we see fit.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Figures&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Not clear why some forest plots were chosen as figures. At forest I thought it was the FPs where culture-specific programs were favoured, but it seems to be the FPs with the nice diamonds? Have discussed with the editor who favours including the primary outcomes as figures and, if needed, maybe any other interesting ones. Perhaps FP 2.3 is clinically interesting (severe exacerbations), but perhaps only because there is more than one study data to pool...&lt;/p&gt;&lt;p&gt;&lt;b&gt;I have included forest plots for children for their primary outcomes (adults were already included).&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Summary of findings table&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;why are adults and children together in the SOF table when analysed separately throughout the review? I haven't gone into check where the data came from because of this and thus do not give specific comments on the content here.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;A decision was made to leave as one table. The table has been split by adult and paediatric with a footnote denoting each group&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;too many rows for exacerbations - choose the most important outcomes to decision makers instead. should really also include QoL and AEs (as patient important)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;As above&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;needs reasons for downgrading added to footnotes. Editor comment: one alternative way they might approach their conclusions is perhaps downgrading the strength of their findings due to indirectness (due to the lack of direct head to head comparisons of education vs cultural education studies)??&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Isn't this already discussed in the results??&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Check the column heading for the control group. Is this correct????&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Reworded&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;JRT Editorial notes 12th September 2016&lt;/b&gt;&lt;/p&gt;&lt;p&gt;- As at 12th September (still not done 11 December)- Ngaire Brown and Peter Morris still need to complete their conflict of interest forms, please ensure they do so before checking the review in for editorial approval.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Thank you for the heads up - Peter Morris has now completed his COI. I have phoned Ngaire and left a message for her to complete.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Please ensure that you specifically report all primary outcomes in your abstract, some are mentioned, but it would be good to ensure that the terminology used is similar also.&lt;/p&gt;&lt;p&gt;&lt;b&gt;We have amended to reflect changes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- In the abstract please report on adverse effects, even if there were none recorded - would be good to report on this elsewhere in the review, as it seems to be lacking.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Adverse effects are not relevant for this review.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- in Abstract/Main results, could be good to also include the number of additional number of studies and participants this update adds.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Abstracts/main results updated&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- A Cochrane review should attempt not to make any recommendations, so it could be good to re-phrase this sentence slightly in the abstract '...should be integrated into health policy to reduce ongoing disparities and poorer health outcomes faced by disadvantaged and minority groups.'&lt;/p&gt;&lt;p&gt;&lt;b&gt;Last sentence modified (track changed)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- PLS: This sentence could do with a re-write: ' Asthma education, recommended by all clinical guidelines, that are culturally-specific may improve asthma outcomes in minority groups.' particularly the 'recommended by all clinical guidelines' bit, it may read better with that section removed?&lt;/p&gt;&lt;p&gt;&lt;b&gt;Good point - sentence reworded&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Please check the consistency between the results expressed in the abstract, the plain language summary and the final conclusions. Currently it seems to me that more useful advice is shared in the plain language summary, but isn't expressed in the abstract at least in the same way? It seems that the data between adults and children varied and you only really express that in the plain language summary for example.&lt;/p&gt;&lt;p&gt;&lt;b&gt;This has been slightly modified &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- PLS/Abstract/Conclusions - it seems to me that you're uncertain of the evidence whilst at the same time recommending that this should be included in guidelines etc,&lt;/p&gt;&lt;p&gt;&lt;b&gt;I have modified this slightly&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- PLS/Quality of Evidence - you refer to 'Primary outcome' but you have four primary outcomes, please review and re-phrase&lt;/p&gt;&lt;p&gt;&lt;b&gt;The results are all part of primary outcomes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Background - please check for other relevant references for this sentence 'the effects on asthma related outcomes of many of these various forms of education have been addressed in other Cochrane reviews (&lt;a link_type=&quot;REFERENCE&quot; href=&quot;Powell 2002&quot; protected=&quot;true&quot;&gt;Powell 2002&lt;/a&gt;; &lt;a link_type=&quot;REFERENCE&quot; href=&quot;Wolf 2002&quot; protected=&quot;true&quot;&gt;Wolf 2002&lt;/a&gt;; &lt;a link_type=&quot;REFERENCE&quot; href=&quot;Gibson 2002a&quot; protected=&quot;true&quot;&gt;Gibson 2002a&lt;/a&gt;; &lt;a link_type=&quot;REFERENCE&quot; href=&quot;Gibson 2002b&quot; protected=&quot;true&quot;&gt;Gibson 2002b&lt;/a&gt;; &lt;a link_type=&quot;REFERENCE&quot; href=&quot;Tapp 2007&quot; protected=&quot;true&quot;&gt;Tapp 2007&lt;/a&gt;; &lt;a link_type=&quot;REFERENCE&quot; href=&quot;Toelle 2011&quot; protected=&quot;true&quot;&gt;Toelle 2011&lt;/a&gt;).'&lt;/p&gt;&lt;p&gt;&lt;b&gt;This was done in August&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Please check the full Background and bring any relevant references up-to-date&lt;/p&gt;&lt;p&gt;&lt;b&gt;As above&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Refresh this Background sentence to reflect that this is an update: 'The data will provide much needed evidence to guide asthma specific clinical practice guidelines and health policy.'&lt;/p&gt;&lt;p&gt;&lt;b&gt;As above (first reviewer)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Please record any changes to the original protocol in the 'Differences between the protocol and the review' for example it looks like the places you searched for studies has changed since the last update.&lt;/p&gt;&lt;p&gt;&lt;b&gt;As above in Emmas comments&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Under your 'Summary of Findings' heading I think it would also be good to describe in a little more detail how the table was created, that you used GRADE (please use a citation for this also) and so on.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Updated and cited&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Please double-check your 'Description of studies' section and the PRISMA diagram - the five studies reviewed are not mentioned in the Description of studies, perhaps needs adding in? I have re-written the text slightly, please check&lt;/p&gt;&lt;p&gt;&lt;b&gt;I don't understand what this means - the 5 studies are described. &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Under 'Other potential risk of bias' - I think a narrative explanation would be good to add here.&lt;/p&gt;&lt;p&gt;&lt;b&gt;See above - reviewer 1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- In 'Overall completeness and applicability.....' section under Discussion I have tried re-writing this sentence as it doesn't read well - please edit further if you wish to improve readability: 'This systematic review is substantially limited by containing only a few studies and by a lack of available data that is possible to include in a meta-analysis'&lt;/p&gt;&lt;p&gt;&lt;b&gt;We have reworded &lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- In 'Overall completeness and applicability... please check this sentence and re-write slightly: 'In the paediatric group, however, a reduction in participants with severe asthma exacerbations requiring hospitalisation was significantly reduced (&lt;a link_type=&quot;FIGURE&quot; href=&quot;05&quot; protected=&quot;true&quot;&gt;Figure 5&lt;/a&gt;).'&lt;/p&gt;&lt;p&gt;&lt;b&gt;I have modified this sentence.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- Under 'Potential biases' please state, assuming this was the case, that data extraction for this included study was performed by other authors i.e. not the author listed on the included study: 'One of the authors of this review is the senior author on the &lt;a link_type=&quot;STUDY&quot; href=&quot;Valery 2010&quot; protected=&quot;true&quot;&gt;Valery 2010&lt;/a&gt; paper. Additional data was obtained by direct contact with A/Prof Valery and from another Cochrane Review (&lt;a link_type=&quot;REFERENCE&quot; href=&quot;Chang 2010&quot; protected=&quot;true&quot;&gt;Chang 2010&lt;/a&gt;).'&lt;/p&gt;&lt;p&gt;&lt;b&gt;I have reworded as per suggestion&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- I am not sure that the conclusions should be recommending the inclusion within Guidelines&lt;/p&gt;&lt;p&gt;- Perhaps make it more clear that there are four ongoing studies within the Results of the text? - have efforts been made to contact the two earlier ones for this update?&lt;/p&gt;&lt;p&gt;&lt;b&gt;I've updated the results section - added 2 of the studies that were omitted. I have looked at clinical trial registries and no further updates. I have also searched for these authors/manuscripts and no data to update.&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;- For the Summary of Findings tables the Outcome headings look a little confusing, particularly with the additional information brackets, perhaps see if there is any way of making them more clear, particularly where there could be confusion between them.&lt;/p&gt;&lt;p&gt;&lt;b&gt;We have removed the brackets to make this a bit clearer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Emma J notes 18/8/16&lt;/b&gt;&lt;/p&gt;&lt;p&gt;1) Please make sure you run a validation report before submitting the review and address any warnings and errors that you can. The report is saying that there are: two study IDs for Press 2012 - ?delete from additional refs; and two for Poureslami 2011 - ?delete from additional refs.&lt;/p&gt;&lt;p&gt;&lt;b&gt;These are different studies, thus 2 references&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;CJC added Grover data for PACQL (which has tiny SDs and lots of weight). Email sent to Anne.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Finalised with CJC, ABC and GBM&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;CJC note July 26th: Please open up the data and have a look at the yellow notes for each study in each outcome! Happy to discuss when you have had a chance to go through with Anne.&lt;/p&gt;" NOTES_MODIFIED="2017-08-14 09:28:48 +0100" NOTES_MODIFIED_BY="Emma J Dennett" REVIEW_NO="CULT-AST" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2017-08-14 09:31:54 +0100" MODIFIED_BY="Emma Dennett">
<TITLE>Culture-specific programs for children and adults from minority groups who have asthma</TITLE>
<CONTACT MODIFIED="2017-08-14 09:31:54 +0100" MODIFIED_BY="Emma Dennett"><PERSON ID="52889469217817457803111101114109" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Gabrielle</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>McCallum</LAST_NAME><POSITION>Clinical Research Operations Manager</POSITION><EMAIL_1>gabrielle.mccallum@menzies.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Health Division</DEPARTMENT><ORGANISATION>Menzies School of Health Research, Charles Darwin University</ORGANISATION><CITY>Darwin</CITY><ZIP>0810</ZIP><REGION>Northern Territory</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>(08) 89228588</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-08-14 09:31:54 +0100" MODIFIED_BY="Emma Dennett"><PERSON ID="52889469217817457803111101114109" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Gabrielle</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>McCallum</LAST_NAME><POSITION>Clinical Research Operations Manager</POSITION><EMAIL_1>gabrielle.mccallum@menzies.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Health Division</DEPARTMENT><ORGANISATION>Menzies School of Health Research, Charles Darwin University</ORGANISATION><CITY>Darwin</CITY><ZIP>0810</ZIP><REGION>Northern Territory</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>(08) 89228588</PHONE_1></ADDRESS></PERSON><PERSON ID="4854" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>S</MIDDLE_INITIALS><LAST_NAME>Morris</LAST_NAME><POSITION>Paediatrician, Royal Darwin Hospital and Deputy Head</POSITION><EMAIL_1>Peter.Morris@menzies.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Health Division</DEPARTMENT><ORGANISATION>Menzies School of Health Research, Charles Darwin University</ORGANISATION><ADDRESS_1>PO Box 41096</ADDRESS_1><CITY>Darwin</CITY><ZIP>0811</ZIP><REGION>Northern Territory</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 8 8922 8196 ext: 28371</PHONE_1><PHONE_2>+61 8 8948 2291</PHONE_2><FAX_1>+61 8 8922 5187</FAX_1></ADDRESS></PERSON><PERSON ID="FA654A0182E26AA200C04FC137F32112" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Ngiare</FIRST_NAME><LAST_NAME>Brown</LAST_NAME><POSITION>Founding Director</POSITION><EMAIL_1>ngiare@ngaoara.org.au</EMAIL_1><EMAIL_2>ngiareb@gmail.com</EMAIL_2><ADDRESS><ORGANISATION>Ngaoara - Child and Adolescent Wellbeing</ORGANISATION><CITY>Austinmer</CITY><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></PERSON><PERSON ID="12396" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Anne</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Chang</LAST_NAME><POSITION>Senior Research Principal Fellow, NHMRC Practitioner Fellow</POSITION><EMAIL_1>Anne.Chang@menzies.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Health Division</DEPARTMENT><ORGANISATION>Menzies School of Health Research, Charles Darwin University</ORGANISATION><ADDRESS_1>PO Box 41096</ADDRESS_1><CITY>Darwin</CITY><ZIP>0811</ZIP><REGION>Northern Territories</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 411 699022</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-08-23 11:37:42 +0100" MODIFIED_BY="Elizabeth M Stovold">
<UP_TO_DATE>
<DATE DAY="10" MONTH="6" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="10" MONTH="6" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="9" MONTH="7" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="8" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-08-07 11:20:44 +0100" MODIFIED_BY="Emma J Dennett">
<DATE DAY="10" MONTH="6" YEAR="2016"/>
<DESCRIPTION>
<P>Author group changed and review updated to current Cochrane format.</P>
<P>Primary and secondary outcomes modified for clarification, and to reflect current asthma-related outcomes.</P>
<P>Subgroup analysis - adults versus children and types of education have been removed. Adults and children are now analysed separately.</P>
<P>New studies included (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) including an additional 220 participants.</P>
<P>New 'Risk of bias' tool used.</P>
<P>SoF table included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<DATE DAY="10" MONTH="6" YEAR="2016"/>
<DESCRIPTION>
<P>Literature search updated to June 2016. An update literature search in July 2017 was not fully incorporated and three studies were added to studies awaiting classification.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-06-01 09:47:21 +0100" MODIFIED_BY="Emma J Welsh">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-06-01 09:47:21 +0100" MODIFIED_BY="Emma J Welsh">
<DATE DAY="1" MONTH="12" YEAR="2008"/>
<DESCRIPTION>
<P>Author list changed </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-12-01 10:33:22 +0000" MODIFIED_BY="Toby J Lasserson">
<DATE DAY="17" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>One new author added to the byline of the review. The conclusions of the review have not been substantively amended by the addition of the study by Canino et al</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-12-01 10:33:20 +0000" MODIFIED_BY="Toby J Lasserson">
<DATE DAY="30" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Literature searches re-run; One new study added (Canino 2008). </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-12-01 10:33:19 +0000" MODIFIED_BY="Toby J Lasserson">
<DATE DAY="17" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="11" MONTH="12" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-04-14 03:46:08 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-04-14 03:46:08 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-04-14 03:46:08 +0100" MODIFIED_BY="[Empty name]">
<NAME>Australian Cochrane Airways Scholarship</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION>
<P>Gabrielle McCallum received a scholarship to complete review</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Australian Cochrane Airways Group Network Scholarship</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-08-07 12:16:08 +0100" MODIFIED_BY="Emma J Dennett">
<SUMMARY MODIFIED="2017-08-04 01:28:56 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Culture-specific programs for children and adults from minority groups who have asthma</TITLE>
<SUMMARY_BODY MODIFIED="2017-08-04 01:28:56 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>People with asthma who come from minority groups have poorer asthma outcomes. Asthma education that is culturally specific may improve asthma-related outcomes.</P>
<P>
<B>Review question</B>
</P>
<P>Do culture-specific asthma education programmes (compared to generic asthma education programmes or usual care) improve asthma-related outcomes in children and adults with asthma who belong to minority groups?</P>
<P>
<B>What evidence did we find?</B>
</P>
<P>Seven studies with 837 participants, aged from one to 63 years old were included in this review update. This review was limited by few studies and the quality of evidence was very low to low. In adults, we found that culture-specific programmes did not improve any of our primary outcomes, but were better in improving quality of life (although the mean difference was less that the minimum important difference for the score) (secondary outcome). In children however, when data were combined from studies, culture-specific programmes reduced severe exacerbations requiring hospitalisation (primary outcome), while single studies showed improved asthma control, asthma knowledge and adherence outcomes for our secondary outcomes.</P>
<P>
<B>Conclusion</B>
</P>
<P>The available evidence showed that culture-specific education programmes for adults and children from minority groups are likely effective in improving asthma-related outcomes. Although more robust evidence is required, asthma education programmes should be as culturally specific as possible in the context of chronic disease management and the complexity of health outcomes and culture, In the absence of any economic data, cost-effectiveness studies are also required</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The quality of the evidence was very low to low for all outcomes. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<ABS_BACKGROUND MODIFIED="2017-08-04 00:57:37 +0100" MODIFIED_BY="[Empty name]">
<P>People with asthma who come from minority groups often have poorer asthma outcomes, including more acute asthma-related doctor visits for flare-ups. Various programmes used to educate and empower people with asthma have previously been shown to improve certain asthma outcomes (e.g. adherence outcomes, asthma knowledge scores in children and parents, and cost-effectiveness). Models of care for chronic diseases in minority groups usually include a focus of the cultural context of the individual, and not just the symptoms of the disease. Therefore, questions about whether tailoring asthma education programmes that are culturally specific for people from minority groups are effective at improving asthma-related outcomes, that are feasible and cost-effective need to be answered.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-08-04 00:57:37 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether culture-specific asthma education programmes, in comparison to generic asthma education programmes or usual care, improve asthma-related outcomes in children and adults with asthma who belong to minority groups.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<P>We searched the Cochrane Register of Controlled Trials (CENTRAL), the Cochrane Airways Group Specialised Register, MEDLINE, Embase, review articles and reference lists of relevant articles. The latest search fully incorporated into the review was performed in June 2016.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-02-05 22:34:00 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) comparing the use of culture-specific asthma education programmes with generic asthma education programmes, or usual care, in adults or children from minority groups with asthma.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-09-12 10:51:03 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently selected, extracted and assessed the data for inclusion. We contacted study authors for further information if required.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-08-04 02:59:08 +0100" MODIFIED_BY="[Empty name]">
<P>In this review update, an additional three studies and 220 participants were added. A total of seven RCTs (two in adults, four in children, one in both children and adults) with 837 participants (aged from one to 63 years) with asthma from ethnic minority groups were eligible for inclusion in this review. The methodological quality of studies ranged from very low to low. For our primary outcome (asthma exacerbations during follow-up), the quality of evidence was low for all outcomes. In adults, use of a culture-specific programme, compared to generic programmes or usual care did not significantly reduce the number of participants from two studies with 294 participants for: exacerbations with one or more exacerbations during follow-up (odds ratio (OR) 0.80, 95% confidence interval (CI) 0.50 to 1.26), hospitalisations over 12 months (OR 0.83, 95% CI 0.31 to 2.22) and exacerbations requiring oral corticosteroids (OR 0.97, 95% CI 0.55 to 1.73). However, use of a culture-specific programme, improved asthma quality of life scores in 280 adults from two studies (mean difference (MD) 0.26, 95% CI 0.17 to 0.36) (although the MD was less then the minimal important difference for the score). In children, use of a culture-specific programme was superior to generic programmes or usual care in reducing severe asthma exacerbations requiring hospitalisation in two studies with 305 children (rate ratio 0.48, 95% CI 0.24 to 0.95), asthma control in one study with 62 children and QoL in three studies with 213 children, but not for the number of exacerbations during follow-up (OR 1.55, 95% CI 0.66 to 3.66) or the number of exacerbations (MD 0.18, 95% CI -0.25 to 0.62) among 100 children from two studies.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-08-04 02:49:26 +0100" MODIFIED_BY="[Empty name]">
<P>The available evidence showed that culture-specific education programmes for adults and children from minority groups are likely effective in improving asthma-related outcomes. This review was limited by few studies and evidence of very low to low quality. Not all asthma-related outcomes improved with culture-specific programs for both adults and children. Nevertheless, while modified culture-specific education programs are usually more time intensive, the findings of this review suggest using culture-specific asthma education programmes for children and adults from minority groups. However, more robust RCTs are needed to further strengthen the quality of evidence and determine the cost-effectiveness of culture-specific programs.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-08-07 12:16:08 +0100" MODIFIED_BY="Emma J Dennett">
<BACKGROUND MODIFIED="2017-08-04 01:01:08 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2017-08-04 01:01:02 +0100" MODIFIED_BY="[Empty name]">
<P>Asthma education is regarded as an important management step in national asthma guidelines (<LINK REF="REF-National-Asthma-Council-Australia-2015" TYPE="REFERENCE">National Asthma Council Australia 2015</LINK>; <LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>). Asthma education, defined as provision of information on asthma, encompasses various formats which include face-to-face encounters, group sessions, outreach, home visits, provision of asthma action plans, recognition of loss of asthma control and self-management skills (<LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>). The effects on asthma-related outcomes of many of these various forms of education have been addressed in other Cochrane reviews (<LINK REF="REF-Powell-2002" TYPE="REFERENCE">Powell 2002</LINK>; <LINK REF="REF-Wolf-2002" TYPE="REFERENCE">Wolf 2002</LINK>; <LINK REF="REF-Gibson-2002a" TYPE="REFERENCE">Gibson 2002a</LINK>; <LINK REF="REF-Gibson-2002b" TYPE="REFERENCE">Gibson 2002b</LINK>; <LINK REF="REF-Tapp-2007" TYPE="REFERENCE">Tapp 2007</LINK>; <LINK REF="REF-Toelle-2011" TYPE="REFERENCE">Toelle 2011</LINK>).</P>
<P>Racial and socio-economic factors can influence both asthma severity and rates of recurrent acute presentations to emergency health facilities (<LINK REF="REF-Coultas-1994" TYPE="REFERENCE">Coultas 1994</LINK>; <LINK REF="REF-de-Oliveira-1999" TYPE="REFERENCE">de Oliveira 1999</LINK>; <LINK REF="REF-Sin-2002" TYPE="REFERENCE">Sin 2002</LINK>; <LINK REF="REF-Haselkorn-2008" TYPE="REFERENCE">Haselkorn 2008</LINK>). The reasons for this are unclear, however contributing factors are arguably likely to include broad service delivery issues rather than a reflection of intrinsic asthma severity (<LINK REF="REF-Enarson-1999" TYPE="REFERENCE">Enarson 1999</LINK>; <LINK REF="REF-Chang-2002" TYPE="REFERENCE">Chang 2002</LINK>). Other cultural influences and barriers on the management of asthma include symptom perception, low literacy levels, and understanding of disease and self-management (<LINK REF="REF-Enarson-1999" TYPE="REFERENCE">Enarson 1999</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="REF-Stewart-2013" TYPE="REFERENCE">Stewart 2013</LINK>; <LINK REF="REF-Harrington-2015" TYPE="REFERENCE">Harrington 2015</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-08-04 01:01:02 +0100" MODIFIED_BY="[Empty name]">
<P>An appropriate model of care is important to successfully deliver services to improve outcomes for people with asthma (<LINK REF="STD-Partridge-2000" TYPE="STUDY">Partridge 2000</LINK>; <LINK REF="REF-Chang-2002" TYPE="REFERENCE">Chang 2002</LINK>; <LINK REF="REF-Mitchell-2016" TYPE="REFERENCE">Mitchell 2016</LINK>). The model of care should arguably be culturally appropriate (<LINK REF="REF-Enarson-1999" TYPE="REFERENCE">Enarson 1999</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Press-2012" TYPE="STUDY">Press 2012</LINK>) and modified to fit within the local context. As outlined by the World Health Organization's model of health care for chronic diseases in low-income settings, "health care should facilitate an ongoing relationship between provider and patient and help patients to make full use of their own and their community's resources for health" (<LINK REF="REF-Swartz-2002" TYPE="REFERENCE">Swartz 2002</LINK>). This is further supported by the implementation of chronic care models in low- to middle-income countries to facilitate chronic disease care (<LINK REF="REF-Beaglehole-2008" TYPE="REFERENCE">Beaglehole 2008</LINK>) and asthma guidelines (<LINK REF="REF-National-Asthma-Council-Australia-2015" TYPE="REFERENCE">National Asthma Council Australia 2015</LINK>; <LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>). Not surprisingly, in the health literature, the model of care for chronic diseases in Indigenous people includes the involvement of Indigenous healthcare workers (IHWs) (<LINK REF="REF-Hamdorf-1996" TYPE="REFERENCE">Hamdorf 1996</LINK>; <LINK REF="REF-Chino-2006" TYPE="REFERENCE">Chino 2006</LINK>; <LINK REF="REF-Abbott-2007" TYPE="REFERENCE">Abbott 2007</LINK>). Amongst other factors, involvement of IHWs in a supportive service delivery system would theoretically facilitate provider-patient relationships and could potentially reduce prejudices and inequities that exist in some areas of healthcare systems (<LINK REF="REF-Eades-2000" TYPE="REFERENCE">Eades 2000</LINK>; <LINK REF="REF-Schmidt-2016" TYPE="REFERENCE">Schmidt 2016</LINK>). The involvement of IHWs specifically as an inclusion factor has been addressed in another Cochrane review (<LINK REF="REF-Chang-2010" TYPE="REFERENCE">Chang 2010</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2017-08-04 01:01:02 +0100" MODIFIED_BY="[Empty name]">
<P>For a variety of reasons (e.g. availability) not all culture-specific asthma programmes involve intervention by IHWs (<LINK REF="STD-Anderson-2004" TYPE="STUDY">Anderson 2004</LINK>). Also, many minority groups are non-Indigenous to their country of residence (e.g. Latino groups in the United States of America). People from these groups have also been shown to have poorer asthma outcomes (<LINK REF="STD-Anderson-2004" TYPE="STUDY">Anderson 2004</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Alicea_x002d_Alvarez-2014" TYPE="STUDY">Alicea-Alvarez 2014</LINK>). Furthermore, there is a growing body of literature highlighting the need to tailor asthma education programs specifically for ethnic and cultural groups to improve asthma outcomes (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Press-2012" TYPE="STUDY">Press 2012</LINK>; <LINK REF="REF-Douglas-2013" TYPE="REFERENCE">Douglas 2013</LINK>; <LINK REF="REF-Stewart-2013" TYPE="REFERENCE">Stewart 2013</LINK>; <LINK REF="STD-Alicea_x002d_Alvarez-2014" TYPE="STUDY">Alicea-Alvarez 2014</LINK>; <LINK REF="REF-Speck-2014" TYPE="REFERENCE">Speck 2014</LINK>; <LINK REF="REF-National-Asthma-Council-Australia-2015" TYPE="REFERENCE">National Asthma Council Australia 2015</LINK>; <LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>). It is therefore not surprising that publications such as the Australian National Strategic Improvement Framework for Asthma makes special reference to disadvantaged/minority groups (<LINK REF="REF-NHPAC-2006" TYPE="REFERENCE">NHPAC 2006</LINK>). However, culture-specific programmes are likely more expensive than generic programmes as they involve specifically designed programmes to fit within the local context. It is therefore important that the efficacy of culture-specific education programmes for asthma is systematically examined.</P>
<P>There is no universally accepted definition of a culture appropriate program; however it usually refers to adapting the program to the culture-values, language, and/or using educators that come from the same culture, inclusion of beliefs and practices, culturally appropriate role models, involvement of local community health workers to support clinical teams, to that of the recipients (<LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>). Such adaptation impacts on the understanding and/or how well it is received and thus more likely to be effective (compared to non adapted programs).</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-08-04 01:01:08 +0100" MODIFIED_BY="[Empty name]">
<P>Arguably, the most important asthma education outcome is to improve self-management, so as to prevent morbidity and death from acute exacerbations. Other outcomes include reduction of day to day morbidity from asthma symptoms (e.g. improved asthma control scores and quality of life measures) and objective measurements of asthma severity (e.g. lung function data) (<LINK REF="REF-National-Asthma-Council-Australia-2015" TYPE="REFERENCE">National Asthma Council Australia 2015</LINK>; <LINK REF="REF-BTS-2016" TYPE="REFERENCE">BTS 2016</LINK>).</P>
<P>This systematic review update examines whether culture-specific asthma education programmes improve asthma-related outcomes in children and adults from minority groups who have asthma. This review update will provide much needed evidence to guide asthma specific clinical practice guidelines and health policy.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-08-04 02:49:27 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether culture-specific asthma education programmes in comparison to generic asthma education programmes or usual care, improve asthma-related outcomes in children and adults diagnosed with asthma who belong to minority groups.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-08-04 01:30:30 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs) with parallel group design, comparing specifically developed culture-orientated asthma education programmes in comparison to generic asthma education programmes or usual care for children and adults who belong to minority groups.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-07-26 16:46:40 +0100" MODIFIED_BY="Heather Maxwell">
<P>
<B>Inclusion criteria: </B>Children (&#8804; 18 years) and adults from minority groups with physician diagnosed asthma. Minority was defined by study authors according to their respective country's definition.</P>
<P>
<B>Exclusion criteria:</B> Eosinophilic bronchitis, asthma related to an underlying lung disease such as bronchiectasis and chronic obstructive airway disease, or diagnostic categories such as 'cough variant asthma' and 'wheezy bronchitis' where controversy exists.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>We included RCTs involving comparisons of specifically developed culture-orientated asthma programmes with their local generic asthma education programmes or usual care. We considered studies that involved the use of other education and other interventions for inclusion if all participants had equal access to such interventions. An education programme is defined as a programme which transfers information about asthma in any form, including but not limited to, adapting the program to the culture-values, language, and/or using educators who come from the same culture, inclusion of beliefs and practices, culturally appropriate role models, involvement of local community health workers to support clinical teams etc,</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>Attempts were made to obtain data on at least one of the following outcome measures. All analyses were planned separately for adults and children.<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-12-15 01:11:40 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Asthma exacerbations during follow-up defined as:</HEADING>
<OL>
<LI>Number of participants who had one or more exacerbation over the study period</LI>
<LI>Number of exacerbations over 52 weeks (exacerbation rate)</LI>
<LI>Severe exacerbations requiring oral corticosteroids over the study period</LI>
<LI>Severe exacerbations requiring hospitalisation over the study period</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Objective measurements of asthma control (FEV1, peak flow, airway hyper-responsiveness)</LI>
<LI>Asthma Control Score (score &#8804; 19 = uncontrolled asthma)</LI>
<LI>Asthma quality of life (QoL) score </LI>
<LI>Other asthma symptom scores (e.g. diary cards)</LI>
<LI>Adherence outcomes</LI>
<LI>Asthma knowledge factors</LI>
<LI>Economic data</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-08-04 01:23:35 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2017-08-04 01:23:35 +0100" MODIFIED_BY="[Empty name]">
<P>Studies were identified from the following sources.</P>
<OL>
<LI>The Cochrane Airways Group Specialised Trials Register (1950 to June 2016).</LI>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Library, 2016, Issue 6.</LI>
<LI>MEDLINE (1950 to June 2016). Topic search strategy combined with the RCT search filter as outlined in the Airways Group module.</LI>
<LI>Embase (1980 to June 2016).Topic search strategy combined with the RCT search filter as outlined in the Airways Group module.</LI>
<LI>Clinical trials registries: ClinicalTrials.gov and the WHO trials portal (all years to June 2016).</LI>
</OL>
<P>Conference abstracts and grey literature were searched for through the CENTRAL database. We did not impose any restrictions on language of publication. Full search strategies are listed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-12-15 01:03:36 +0000" MODIFIED_BY="[Empty name]">
<P>In addition to the electronic search, we checked reference lists of relevant publications for additional studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-08-04 01:30:30 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2017-08-04 01:01:25 +0100" MODIFIED_BY="[Empty name]">
<P>Retrieval of studies: Using article titles abstracts, or descriptors, two review authors (EJB and ABC in original and 2009 reviews; GBM and ABC in search from 2009 to 2016) independently reviewed literature searches to identify potentially relevant studies for full review. They conducted searches of bibliographies and texts to identify additional studies. From the full-text articles, the two review authors independently assessed studies for inclusion on the basis of specific criteria.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-08-04 01:01:25 +0100" MODIFIED_BY="[Empty name]">
<P>We had no disagreements but had planned to resolve disagreements through discussion with another review author (PSM). We extracted data using a standardised data collection form and entered the data in Review Manager 5.3 (<LINK REF="REF-Review-Manager-_x0028_RevMan_x0029_" TYPE="REFERENCE">Review Manager (RevMan)</LINK>), in accordance with recommendations provided in the <I>Cochrane Handbook for Systematic Review of Interventions (</I>
<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When required, we sought further information from study authors. We recorded the selection process in the PRISMA flow diagram (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (GBM and ABC) independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Review of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). It was planned that disagreements would be resolved by discussion or by third party adjudication. We assessed risk of bias according to the following domains.</P>
<OL>
<LI>Allocation sequence generation (selection bias)</LI>
<LI>Concealment of allocation (selection bias)</LI>
<LI>Blinding of participants (performance bias)</LI>
<LI>Outcome assessment (detection bias)</LI>
<LI>Incomplete outcome data (attrition bias)</LI>
<LI>Selective outcome reporting (reporting bias)</LI>
</OL>
<P>We graded each potential source of bias as low, unclear or high and provided a justification for our judgement in the "Risk of bias" tables (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-08-04 01:30:30 +0100" MODIFIED_BY="[Empty name]">
<P>We analysed dichotomous data as odds ratios (OR) and continuous data as mean difference (MD) and planned to use standardised mean difference (SMD) if necessary. We then entered data presented as a scale with a consistent direction of effect. We undertook meta-analyses only where it was meaningful. This took into account differences in study populations, inclusion/exclusion criteria, interventions, outcome assessment, and estimated effect size. We described skewed data which was reported as medians and interquartile ranges (IQR) in the text.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-06-09 03:25:47 +0100" MODIFIED_BY="[Empty name]">
<P>For dichotomous data, we reported the proportion of participants contributing to each outcome in comparison with the total number randomised. For rate ratios of common events whereby one participant may have more than one event, generic inverse variance (GIV) was used. The rate ratios were taken from the published papers and the standard errors calculated from confidence intervals or P values published in the papers. Cross-over trials are not appropriate for this intervention and therefore were not planned for inclusion in any meta-analysis performed.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-08-04 01:01:35 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to contact investigators or study sponsors to verify key study characteristics and to provide missing numerical outcome data when necessary. Three study authors (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) were contacted for further information, with responses from all three (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>).</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-08-04 01:01:35 +0100" MODIFIED_BY="[Empty name]">
<P>It was proposed that any heterogeneity between the study results would be described and tested to see if it reached statistical significance using a Chi<SUP>2</SUP>. The 95% confidence interval (CI), estimated using a random-effects model, would be included whenever there are concerns about statistical heterogeneity. Heterogeneity is considered significant when the P value is less than 0.10 (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2017-08-04 01:01:46 +0100" MODIFIED_BY="[Empty name]">
<P>If reporting bias was suspected (see '<LINK TAG="SELECTIVE_REPORTING" TYPE="SECTION">Selective reporting (reporting bias)</LINK>' in the '<LINK TAG="STUDY_QUALITY" TYPE="SECTION">Risk of bias in included studies</LINK>' table), we planned to contact the study authors to ask them to provide missing outcome data. We planned that if missing data were not provided, and if this was thought to introduce serious bias, the impact of including such studies in the overall assessment would be explored through a sensitivity analysis.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-08-04 01:01:54 +0100" MODIFIED_BY="[Empty name]">
<P>The results from studies that met the inclusion criteria and which reported any of the outcomes of interest (as defined above) were included in the subsequent meta-analyses. The summary weighted rate ratio and 95% CI (fixed-effect model) was calculated (<LINK REF="REF-Review-Manager-_x0028_RevMan_x0029_" TYPE="REFERENCE">Review Manager (RevMan)</LINK> using generic inverse ratio (GIV), whereby one participant may have more than one event. The risk ratios were taken from the published papers and the standard errors were calculated from CIs or P values in the published papers. The outcome indices would be assumed to be normally distributed continuous variables so theMD in outcomes could be estimated. If studies had reported outcomes using different measurement scales, we planned to estimate the SMD.</P>
<SUBSECTION>
<HEADING LEVEL="3">'Summary of findings' (SoF) tables</HEADING>
<P>We created 'Summary of findings' tables, using the primary outcomes (where able) (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>)</P>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-08-04 01:01:54 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to carry out the following a priori subgroup analysis.</P>
<OL>
<LI>Different settings (rural versus non-rural: as defined by study authors)</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-08-04 01:01:54 +0100" MODIFIED_BY="[Empty name]">
<P>Sensitivity analyses were planned to assess the impact of the potentially important factors on the overall outcomes.</P>
<OL>
<LI>Study quality (adequate allocation concealment and blinding)</LI>
<LI>Study size</LI>
<LI>Variation in the inclusion criteria</LI>
<LI>Differences in outcome measures</LI>
<LI>Analysis using random-effects model</LI>
<LI>Analysis by "treatment received"</LI>
</OL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-08-07 12:16:08 +0100" MODIFIED_BY="Emma J Dennett">
<STUDY_DESCRIPTION MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2017-08-07 11:51:59 +0100" MODIFIED_BY="Emma J Dennett">
<P>From the previous versions of this review (2007 and 2009), the Cochrane Airways Group Specialised Register (CAGR) identified 228 potentially relevant titles (29 abstracts with four studies satisfying the inclusion criteria for the reviews) (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). An additional 170 articles were identified from the updated search (up to June 2016), with a further four titles identified from reference lists. After duplicates were removed, 96 titles were considered for the review. After assessing abstracts, 20 studies were retrieved for full review, 15 studies were excluded, with three additional studies (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) fulfilling the eligibility criteria for this update (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Two other studies remain ongoing at the time of the review (<LINK REF="STD-Janevic-2012" TYPE="STUDY">Janevic 2012</LINK>; <LINK REF="STD-Patel-2014" TYPE="STUDY">Patel 2014</LINK>) (see<I> '</I>
<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>'). Another two studies are awaiting classification (<LINK REF="STD-Buist-2001" TYPE="STUDY">Buist 2001</LINK>; <LINK REF="STD-Butz-2004" TYPE="STUDY">Butz 2004</LINK>) (see '<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>'). An update search run in June 2017 returned three potentially relevant trials which have been added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="STD-Feldman-2016" TYPE="STUDY">Feldman 2016</LINK>; <LINK REF="STD-Griffiths-2016" TYPE="STUDY">Griffiths 2016</LINK>; <LINK REF="STD-Patel-2016" TYPE="STUDY">Patel 2016</LINK>) and have not been fully incorporated into the review. </P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-08-07 11:13:33 +0100" MODIFIED_BY="Emma J Dennett">
<P>For this review update seven studies were included (<I>see</I> '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'). A total of 837 participants with asthma from an ethnic minority group were included in this review. Two studies were multi-centre (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) and five were single-centre studies (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>). Two studies (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>) examined adults and four studies examined children (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>). The study by (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>) included both adults and children, however specific results for adults and children were not presented in the published paper. The study by (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>), reported outcomes from four treatment groups. For our analysis, we chose to report data from group three (intervention) and group four (control) as we believe group three was the true intervention (participants viewed both the community and knowledge video). The study duration varied ranging from six to 12 months. Exacerbations were defined differently in each study. Culture-specific programs and controls were defined differently for each study and are further described in (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>The seven studies used different inclusion and exclusion criteria for participation. All participants had 'doctor diagnosed asthma', but the definition varied across the studies.</P>
<SUBSECTION>
<HEADING LEVEL="5">Paediatric studies</HEADING>
<P>
<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> enrolled families (of African-American or Hispanic descent) with children aged one to 13 years with physician diagnosed asthma. <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> enrolled poor (defined by utilisation of the Peurto Rico Health Insurance Administration Agency Plan which required that the family be close to the poverty level) Peurto Rican families, with a child aged five to 12 years who had utilised health services for asthma within the previous 12 months. <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> enrolled Australian Indigenous children (Aboriginal or Torres Strait Islander) aged one to 17 years from Thursday Island and Horn Island with doctor diagnosed asthma. The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> enrolled Indian children aged seven to 12 years with asthma, who had at least two asthma-related visits to hospital in the previous 12 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adult studies</HEADING>
<P>
<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> enrolled participants (adults and children) with asthma aged 11 to 59 years from participating General Practices (GP) in the United Kingdom (UK). Specific data for children could not be obtained. Of the 689 participants, only 344 were from of an ethnic minority (i.e. Indian Sub-Continent (ISC)). The remainder (n = 345) were of White European descent. We included this study in the review but only examined data relevant to the ISC participants as published outcomes were stratified by ethnic descent as well as intervention group allocation. <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> enrolled African-American adults, aged 18 to 50 years who had been hospitalised for at least one night with a primary diagnosis of asthma. <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> enrolled adults aged &gt; 21 years with physician diagnosed asthma who had immigrated to Canada within the last 20 years, lived in the Greater Vancouver Area, and spoke Mandarin, Cantonese or Punjabi.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Paediatric studies</HEADING>
<P>Three studies (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) used asthma exacerbations as their primary outcome. The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> used paediatric asthma caregiver quality of life (QoL) as their primary outcome. For other primary outcomes, <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> was the only study to report the use of oral corticosteroids over the study period. Two studies (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) reported on severe asthma exacerbations requiring hospitalisation.</P>
<P>Secondary outcomes varied between studies. Two studies (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) used the change in Juniper Asthma QoL (<LINK REF="REF-Juniper-1992" TYPE="REFERENCE">Juniper 1992</LINK>; <LINK REF="REF-Juniper-1993" TYPE="REFERENCE">Juniper 1993</LINK>). <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> also reported on adherence outcomes using parents' descriptions of asthma action plan (AAP). Asthma knowledge factors were assessed differently between studies. <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> used the individualism-collectivism scale to measure asthma behavioural assessment for both career/parent and children; where <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> used change in carers knowledge on triggers and treatment. <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> used modified scores for asthma knowledge, asthma control and medication adherence.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adult studies</HEADING>
<P>Two studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) used asthma exacerbations as their primary outcome. <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> also reported other primary outcomes such as the use of oral corticosteroids over the study period and severe exacerbations requiring hospitalisation.</P>
<P>Secondary outcomes varied between studies. Objective measurements (FEV1) were used in the <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> study. Symptoms of asthma (QoL) were used in the <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> and <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> studies. Asthma knowledge factors were reported by a single study (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>). <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> reported on the proper use of inhaler technique and knowledge of asthma symptoms.</P>
<P>All study characteristics are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>The main reason that studies were excluded from the review related to non culture-specific interventions in minority groups, or non-randomised controlled studies (<I>see</I> '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>Risk of bias for included studies are summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2017-08-04 01:15:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> was the sole study assessed at low risk for both selection bias domains, as the authors adequately described the method of randomisation using computer-generated block randomisation sequencing with concealed allocation. <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> and <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> reported that randomisation was computer generated and randomly allocated, however did not describe the method of concealment allocation (unclear risk). The three remaining studies (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>) were assessed as an unclear risk; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> and <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> did not describe the method of randomisation or method of concealment allocation. <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> reported that randomisation was computer generated, yet did not describe method or how the allocation method was maintained. The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> reported that randomisation was generated randomly, however it was considered high risk, as the authors reported that allocation concealment was not implemented. There was an imbalance of allocation of treatment groups at baseline.</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-08-04 01:15:50 +0100" MODIFIED_BY="[Empty name]">
<P>One study (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>) was assessed as low risk for both blinding domains. The authors adequately described how outcome measures were assessed where blinding was not feasible. Two studies (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) were assessed as a high risk for both domains, as they did not describe how blinding was maintained for participants, study personal and did not describe if outcome assessors were blinded. The study by <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> was assessed as high risk for performance bias as participants and study personal were unblinded and unclear risk for detection bias,as it was not clear whether outcome assessors were blinded. The study by <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> was assessed as high risk for performance bias, as participants were unblinded, but low risk for detection bias as outcome assessors were blinded to groups. The remaining two studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>;) were assessed as an unclear risk as study authors did not describe how blinding was maintained or if outcome assessors were blinded to treatment allocation.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-08-04 01:15:50 +0100" MODIFIED_BY="[Empty name]">
<P>Three studies (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) were assessed as low risk, as &gt; 90% of participants were followed up. Three studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) were assessed as an unclear risk. In the <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> study, clinical data were only available in 86% of participants and 76% for asthma QoL at the 12-month follow-up. <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> did not describe if any participants withdrew or were lost to follow-up. The <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> study described that authors did not follow-up five children due to costs of travel. The study by <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> was assessed as high risk as only 46% of participants were able to be contacted for the six-month follow-up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-03-02 21:59:12 +0000" MODIFIED_BY="[Empty name]">
<P>Six studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) were assessed as low risk. They adequately described method of analysis (e.g. intention-to-treat or by per protocol analysis). <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> was assessed as an unclear risk, as they did not report complete baseline data (some variables presented as grouped data), thus it was difficult to determine differences between the four groups.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-08-04 01:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>Sources of bias were determined by the review authors and reported in each 'Risk of bias' table.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-08-07 12:16:08 +0100" MODIFIED_BY="Emma J Dennett">
<P>See 'Summary of findings' tables for the main comparisons (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>).</P>
<P>Three paediatric (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) and two adult (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) studies used asthma exacerbations as their primary outcome. The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> did not report any primary outcome data. Primary and secondary outcome data are reported below in accordance to the adult or paediatric studies.</P>
<SUBSECTION>
<HEADING LEVEL="3">Paediatric studies (Comparison 1)</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcome</HEADING>
<P>
<B>Asthma exacerbations during follow-up defined as:</B>
</P>
<SUBSECTION>
<HEADING LEVEL="5">Number of participants who had one or more exacerbations over the study period</HEADING>
<P>Three studies (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) reported exacerbation data, however we were only able to obtain data for one study (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>), thus meta-analysis was not possible. The study by <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> reported exacerbation data over a 12-month period in 88 children. There was no significant difference between groups for this outcome (odds ratio (OR) 1.55, 95% confidence interval (CI) 0.66 to 3.66) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Number of exacerbations over 52 weeks (exacerbation rate)</HEADING>
<P>Combined data from two studies in 110 children (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) did not show significant differences of the number of exacerbations over 52 weeks between groups (mean difference (MD 0).18, 95% CI -0.25 to 0.62) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> presented data on emergency department (ED) presentations post intervention (in the following six-month period), but these data could not be combined in the meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Severe exacerbations requiring oral corticosteroids over the study period</HEADING>
<P>
<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> reported this outcome over the 12-month study period. The number of events per group include 33 in the culture-specific group compared to 30 in the controls. We were, however unable to obtain further data from the study authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Severe exacerbations requiring hospitalisations</HEADING>
<P>Combined data from two studies in 305 children (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) showed significantly improved outcomes in the culture-specific group compared to the control group (Rate Ratio 0.48, 95% CI 0.24 to 0.95) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). It is important to note that <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> reported on hospitalisations for asthma in the six-month period, whilst <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> study reported on hospitalisations for asthma in the 12-month period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Objective measurements of asthma control (FEV1, peak flow, airway hyper-responsiveness)</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Asthma Control Score</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Asthma Control Score</HEADING>
<P>One study (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>) reported this outcome over the 12-month study period, with the outcome being the proportion of children (n=62) with good asthma control based on the score. They reported an OR 3.35, (95% CI 1.45 to 7.73), significantly favouring the group receiving the culture-specific intervention compared to the control group (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Asthma Control Questionnaire</HEADING>
<P>One study (<LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) reported this outcome in 40 children over the six-month study period. They used a validated modified Hindi/English version of the asthma control questionnaire and reported a significant improvement in the intervention group compared to controls (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Change in parent proxy asthma QoL score</HEADING>
<P>Three studies (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) reported this outcome. Data from <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> could not be combined.The follow-up period varied for each study; six months in <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> and 12 months in <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> and <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>. Additional data were obtained directly from the study authors (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>). The study by <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> measured the change in parent QoL at 12 months (88 parents), but there was no significant difference between the groups (MD -0.04; 95% CI -0.25 to 0.17). The studies by <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> and <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> reported an improvement favouring the culturally-specific group, but these were not significant. <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> in 109 parents (MD 3.15; 95% CI -0.13 to 6.43) and <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> in 16 parents (MD 0.70; 95% CI 0.26 to 1.14). The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> was a feasibility study and of low quality and thus the certainty of this outcome is poor. The clinically minimum important difference (MID) in the QOL scores differ in accordance to the type of QoLs. The most common asthma QoL used in studies is that of Junper where the MID is 0.5 points (<LINK REF="REF-Juniper-1996" TYPE="REFERENCE">Juniper 1996</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other asthma symptoms scores (e.g. diary cards)</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adherence outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Parent description of Asthma Action Plan (AAP)</HEADING>
<P>Two studies reported on use of AAP (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) but data were only available in the <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> study. <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> measured the change in 88 parents' description of AAP when the child was well. The outcome significantly favoured the group who received the culture-specific program (OR 2.82, 95% CI 1.17 to 6.83) (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> reported that none of the participants in either treatment group had a written AAP at baseline. All children in the intervention group were subsequently provided an AAP after baseline and education session. By six months, all participants in the intervention group reported they were confident in using their AAP. Children in the control group were provided a blank template in their information pack at baseline, however no additional data were provided if they were completed or used.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Self-reported medication adherence (using brief medication questionnaire)</HEADING>
<P>A single study (<LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>), measured adherence to medications in 40 participants using a validated medication adherence questionnaire (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables). Study authors reported an improvement in score from baseline in the culture-specific group compared to the controls.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Asthma knowledge factors</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Parent asthma knowledge scores</HEADING>
<P>One study <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> reported this outcome in 22 parents. They used a behavioural assessment score. There was an improvement in mean asthma knowledge scores favouring the culture-specific intervention, but the confidence interval includes no between-group difference (MD 1.90, 95% CI -0.04 to 3.84) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Child asthma knowledge scores</HEADING>
<P>Only one study <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> reported this outcome in 22 parents. The outcome significantly favoured the group who received the culture-specific programme; MD 3.30, (95% CI 1.04 to 5.56) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Asthma knowledge (change in parent knowledge on triggers and treatment)</HEADING>
<P>The <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK> study presented change from baseline for 218 parents asthma knowledge on asthma triggers and treatment. This outcome favoured the group receiving the culture-specific program (MD 0.94, 95% CI 0.31 to 1.57) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Change in asthma knowledge</HEADING>
<P>The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>, used a customised knowledge questionnaire and reported that participants in the intervention group had significantly higher knowledge at the six-month follow-up compared to those in the control group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Economic data</HEADING>
<P>The <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> study estimated that the economic savings made by using the culturally specific education programme, based on the reduction of ED presentations was $4675. The estimated total cost of the culturally specific programme for asthma education was $2295.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adult studies (Comparison 2)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Asthma exacerbations during follow-up defined as:</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Number of participants who had one or more exacerbations over the study period</HEADING>
<P>Two studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) reported exacerbations but numerical data were only provided by one paper (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>), therefore meta-analysis was not possible. <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> stated that there was no statistically significant differences between groups in asthma-related healthcare resource (defined as hospitalisations, ED visits and physician visits) but no figures were given. In the <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> study, we used the outcome of GP consultations for asthma exacerbations in 294 participants. There was no significant differences between groups (OR 0.80; 95% CI 0.50 to 1.26) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Number of exacerbations over 52 weeks (exacerbation rate)</HEADING>
<P>Two studies reported exacerbations over 52 weeks. <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> reported the number of events in each group (e.g. culture-specific n = 218 compared to controls n = 212), however we were unable to obtain or calculate the standard error. <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> stated that there was no statistically significant differences between groups but no figures were given. Thus meta-analysis was not possible for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Severe exacerbations requiring oral corticosteroids over the study period</HEADING>
<P>One study (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>) reported data for this outcome. There was no significant difference between groups for those participants (n=294) who required additional corticosteroids (OR 0.97; 95% CI 0.55 to 1.73) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Severe exacerbations requiring hospitalisations</HEADING>
<P>Two studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) reported this outcome, but numerical data could only be obtained from one study (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>). <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> stated that there was no statistically significant differences between groups. There was no significant difference between the groups for number of participants (n=294) who were hospitalised for asthma (OR 0.83; 95% CI 0.31 to 2.22) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Objective measurements of asthma control (FEV1, peak flow, airway hyper-responsiveness)</HEADING>
<P>One study (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>) reported there was no statistically significant differences between groups for lung function, however numerical data were not provided, therefore meta-analysis was not possible. We were unable to obtain any further details from study authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Asthma Control Score</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Change in asthma QoL score</HEADING>
<P>Two studies reported this outcome (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>). An improved asthma QoL score (the change in score <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) was seen in those who received the culture-specific education programme when compared to controls (MD 0.26, 95% CI 0.17 to 0.36) (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). For this outcome, the study authors (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>) report that 280 participants completed the end of study QoL, but the specific numbers for each group was not reported and we assumed that n = 140 was for each group. We could not obtain any further data from the primary author.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other asthma symptoms scores (e.g. diary cards)</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adherence outcomes</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Asthma knowledge factors</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Proper use of inhaler</HEADING>
<P>One study (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>) reported outcome data on improvement of the proper use of inhaler technique in 42 participants. There was no significant differences between groups (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Knowledge of asthma symptoms</HEADING>
<P>One study (<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>) reported improvement in knowledge of asthma symptoms in 42 participants. There was no significant difference between groups (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Economic data</HEADING>
<P>No studies reported this outcome.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Different settings (rural versus non-rural)</HEADING>
<P>We did not perform a separate subgroup analysis, as there was only one study in each subgroup (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The study by <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> was conducted in an urban setting in Boston, USA, whereas the study by <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> was conducted in two Indigenous communities in remote Australia.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>There were insufficient data to undertake any sensitivity analysis.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-08-04 01:40:31 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-08-04 01:19:03 +0100" MODIFIED_BY="[Empty name]">
<P>In this updated review, an additional three studies and 220 participants were added, with a total of seven randomised controlled trials (RCTs) with 837 participants with asthma from ethnic minority groups. Two were multi-centre and five single-centre with study durations ranging from six to 12 months. There were two adult-based studies and four paediatric-based studies, while one study included both adult and children. This updated review improves the evidence from the previous review supporting the use of culture-specific asthma education programmes for adults and children from minority groups with asthma. The benefit of culture-specific asthma education programmes (compared to generic or usual education programme) was stronger in children than in adults. In children, significant differences between groups were found for reducing hospitalisations and improving the outcomes of asthma control, asthma knowledge and adherence. In adults, asthma-related QoL was the only outcome where there was statistical significance between groups (although clinically the evidence was weak). In both children and adults, there was no difference between groups for the outcome of all exacerbations. A single study examined economic cost and described a significant benefit in cost saving when culture-specific asthma education programmes were used.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-08-04 01:20:40 +0100" MODIFIED_BY="[Empty name]">
<P>This systematic review is substantially limited by few studies and by a lack of available data preventing combining outcomes for meta-analysis. Statistical difference between the groups were not found in all outcomes, although this may be related to insufficient sample size (discussed below). While the studies shared some common themes, there were also differences among the studies; notably, the type of interventions used, ethnic groups being investigated and outcomes measured. Furthermore, several studies did not report follow-up data for clinical outcomes; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> did not report hospitalisations, emergency department (ED) visits etc, and <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> did not report objective measurements e.g. peak flow. Also, <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK> and colleagues' study was small, leading to baseline imbalances in the asthma knowledge scores. It was also unclear whether there were any participants lost to follow-up in the <LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK> study. The study by <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK> was a small feasibility RCT which had some baseline imbalances at randomisation.</P>
<P>The absence of a significant difference between groups for all-types of asthma exacerbations may be related to a type 1 error (inadequate sample size). Therefore, while both this review and the review from <LINK REF="REF-Tapp-2007" TYPE="REFERENCE">Tapp 2007</LINK> found no improvement in adult ED presentations or exacerbations over the study period, the type of educational intervention used can affect self-reported asthma-related QoL of participants. In this instance, we could theorise that the use of a culture-specific programme enables participants (adults) to more fully engage in the education being provided and in turn have a positive effect on QoL scores. These results however should be interpreted with caution due to the small number of included studies that measured asthma QoL (two studies) and the relatively small sample size (n = 308) in those studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>). Similar to previous updates, we were unable to include results from <LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>, which also included an asthma QoL outcome. In children however, a reduction with severe asthma exacerbations requiring hospitalisations was seen (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
<P>For the purpose of this review, it was assumed that 'usual care' for asthma presentations would include the provision of generic asthma education, in accordance with recommendations such as the 1997 National Asthma Education and Prevention Program Guidelines (<LINK REF="REF-Edmond-1998" TYPE="REFERENCE">Edmond 1998</LINK>). Therefore, while the studies by <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> and <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> do not specify the nature of the education that control group participants received, it has been assumed that through the provision of 'usual care', participants would have received some form of education during the clinical encounter.</P>
<P>Ideally, this review would have included RCTs in both adults and children with larger sample sizes and have presented more data regarding asthma exacerbation outcomes (e.g. hospitalisations, ED visits, use of rescue oral corticosteroids). This review is limited by the relatively small number of studies and sample sizes, and by the high rate of attrition of participants (clinical outcomes were measured for 329 participants from an original total sample size of 396). It should be noted that three of the studies (<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>; <LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) were pilot/feasibility studies. There were significant differences in several outcomes, however where outcomes did not reach statistical significance, the direction of results tended to favour the culture-specific programmes.</P>
<P>It has been recognized by Swartz and Dick that in models of care for chronic diseases, the focus must be on the person in his or her own context (<LINK REF="REF-Swartz-2002" TYPE="REFERENCE">Swartz 2002</LINK>). Certainly this ideal has been met with the intervention in the study by La Roche and colleagues, with one focus of the intervention being to locate the signs and symptoms of asthma within the cultural context of the participant and family (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>). La Roche and colleagues also trialled their culturally specific intervention against a generic education programme (<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>), whereas the control groups in the two other included studies (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>; <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>) received 'usual care' (standard asthma education) and participants were asked to continue with their usual follow-up routine. The interventions used by <LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK> and <LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK> could be argued to be culturally modified, rather than culturally specific, with both studies using interventions that have been used in populations understood to be white participants, and modified through the use of language, images and other additions. However, the decision was made to include these two studies as it was felt that the modifications and delivery of the intervention were specific to the ethnic groups to which the participants belonged. It should also be noted that while all the studies trialled interventions in minority groups, only two studies (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>; <LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>) involved a population who were Indigenous to the study setting.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-08-04 01:40:31 +0100" MODIFIED_BY="[Empty name]">
<P>The 'Summary of findings' tables report the available evidence for our primary outcomes related to asthma exacerbations and our justification for the quality of evidence (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>). Overall, the quality of evidence of the studies was very low to low, due to methodological differences, lack of objective measurements, reporting and imprecision of data. </P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-08-04 01:13:50 +0100" MODIFIED_BY="[Empty name]">
<P>One of the authors of this review is the senior author on the <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> paper. Additional data were obtained by direct contact with A/Prof Valery and data extraction was performed by another review author using data from another Cochrane review (<LINK REF="REF-Chang-2010" TYPE="REFERENCE">Chang 2010</LINK>).</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-08-04 01:13:46 +0100" MODIFIED_BY="[Empty name]">
<P>This review's findings are in agreement with the review examining the efficacy of involvement of an Indigenous healthcare worker (IHW) in comparison to absence of an IHW in asthma education programs in improving asthma-related outcomes in Indigenous children and adults with asthma (<LINK REF="REF-Chang-2010" TYPE="REFERENCE">Chang 2010</LINK>). Other systematic reviews on culture-specific interventions have like-wise found that culture-adapted programs were more efficacious than generic programs such as interventions that target smoking cessation, diet, and/or physical activity (<LINK REF="REF-Nierkens-2013" TYPE="REFERENCE">Nierkens 2013</LINK>). However, for health promotion interventions, other systematic reviews have also called for more evidence as there is yet insufficient evidence on the clinical effectiveness or cost-effectiveness of these adapted approaches although it has been shown that culturally adapting interventions increases salience, acceptability and uptake (<LINK REF="REF-Liu-2012" TYPE="REFERENCE">Liu 2012</LINK>; <LINK REF="REF-Davidson-2014" TYPE="REFERENCE">Davidson 2014</LINK>).</P>
<P>The results of another Cochrane review in adults found that asthma education interventions in the ED, while effective at reducing hospital admission, did not significantly reduce subsequent ED visits (<LINK REF="REF-Tapp-2007" TYPE="REFERENCE">Tapp 2007</LINK>). The review by Tapp and colleagues also found no significant difference in QoL scores between treatment and control groups (<LINK REF="REF-Tapp-2007" TYPE="REFERENCE">Tapp 2007</LINK>), whereas the review presented here found a significant improvement in asthma QoL scores for adult participants, although the difference between groups was lower then the minimum important difference for the QoL tool.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-08-04 01:13:40 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-08-04 01:13:40 +0100" MODIFIED_BY="[Empty name]">
<P>The evidence presented in this review suggests that culture-specific education programmes for adults and children from minority groups may be effective in improving asthma-related outcomes, but our confidence is limited by the small number of randomised controlled trials (RCTs) identified and difficulties encountered in performing meta-analysis. However, the benefits seen are in keeping with the wider body of evidence and current guidance and it is therefore justified that asthma education programmes for children and adults from minority groups should be culture-specific and considered for health service and policy (where able) to reduce ongoing disparities and poorer health outcomes faced by disadvantaged and minority groups.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-08-04 01:13:39 +0100" MODIFIED_BY="[Empty name]">
<P>Given the diversity of settings and complexities of health outcomes of people with asthma from minority groups, evidence from seven RCTs suggests that culture-specific education programmes are effective in improving some but not all asthma-related health outcomes.</P>
<P>Further high-quality parallel RCTs are needed to further assess the role of culturally specific education programmes for people with asthma from minority groups. Trials should include both adults and children (including families), and should compare the culture-specific programmes with generic education programmes (as opposed to usual care). Collection of clinical outcomes of asthma exacerbations and severity, as well as other asthma-related outcomes including QoL, knowledge, self-management behaviours, adherence outcomes and economic impact should be included in future trials to gain a better perspective on the efficacy of culture-specific programmes for people with asthma from minority groups. Trials involving minority groups indigenous to their country of residence should also be conducted. The type and extend of 'culture-specific' approaches should also be explicit. Given that there was only one study that reported economic data, economic data for the intervention are also required.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-02-06 21:54:58 +0000" MODIFIED_BY="[Empty name]">
<P>We also thank Elizabeth Stovold for performing the original and updated searchers and for obtaining the relevant papers. We further thank Dr Martin La Roche, Dr Fitzgerald, Dr Poureslami, Dr Canino, Dr Grover and A/Prof Patricia Valery for responding to our queries about their study. We are grateful to the Airways Group for their on-going support.</P>
<P>Christian Osadnik was the Editor for this review.</P>
<P>The Background and Methods sections of this review are based on a standard template used by Cochrane Airways.</P>
<P>This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.</P>
<P>We are very grateful to Dr Chris Cates for advice and help with extracting data and analysis.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-02-06 21:55:17 +0000" MODIFIED_BY="[Empty name]">
<P>GBM: none known.</P>
<P>PSM: none known.</P>
<P>NB: none known.</P>
<P>ABC: was an author in one of the included studies.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-02-06 21:55:02 +0000" MODIFIED_BY="[Empty name]">
<P>Previous version: ABC and EJB wrote protocol, selected studies, extracted data and drafted the review (2009). Other previous authors (NB, PM, SK) reviewed the manuscript.<BR/>Current review: GBM and ABC selected relevant papers from searches, extracted and analysed data and updated the review. PSM and NB contributed to writing the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-08-04 01:13:26 +0100" MODIFIED_BY="[Empty name]">
<P>The primary and secondary outcomes in this version were altered for clarity (compared to the previous version of the review) and to reflect current asthma-related outcomes. In the previous review (<LINK REF="REF-Bailey-2009b" TYPE="REFERENCE">Bailey 2009b</LINK>), we used a hierarchy of assessment which made it confusing. In this version, our primary and secondary outcomes are in line with other Cochrane reviews on asthma with exacerbation being the primary outcome and secondary outcomes reflecting other components of asthma morbidity (lung function, QoL, etc). </P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2017-08-04 01:13:20 +0100" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-08-14 09:31:57 +0100" MODIFIED_BY="Emma Dennett">
<STUDIES MODIFIED="2017-08-07 11:50:56 +0100" MODIFIED_BY="Emma J Dennett">
<INCLUDED_STUDIES MODIFIED="2017-07-25 13:33:30 +0100" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Blixen-2001" NAME="Blixen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blixen CE, Hammel JP, Murphy D, Ault V</AU>
<TI>Feasibility of a nurse-run asthma education program for urban African-Americans: a pilot study</TI>
<SO>Journal of Asthma</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>1</NO>
<PG>23-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195629"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195628"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canino-2008" MODIFIED="2016-08-17 17:44:33 +0100" MODIFIED_BY="[Empty name]" NAME="Canino 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-08-17 17:44:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canino G, Vila D, Norman S, Acosta-Perez E, Ramirez R, Garcia P, et al</AU>
<TI>Reducing asthma health disparities in poor Puerto Rican children: The effectiveness of a culturally tailored family intervention</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2008</YR>
<VL>121</VL>
<NO>3</NO>
<PG>665-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195631"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-06-17 04:53:54 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195630"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grover-2016" MODIFIED="2016-08-17 17:48:46 +0100" MODIFIED_BY="[Empty name]" NAME="Grover 2016" YEAR="2016">
<REFERENCE MODIFIED="2016-08-17 17:48:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grover C, Goel N, Armour C, van Asperen PP, Gaur SN, Moles RJ, et al</AU>
<TI>Medication education program for Indian children with asthma: A feasibility study</TI>
<SO>Nigerian Journal of Clinical Practice</SO>
<YR>2016</YR>
<VL>19</VL>
<NO>1</NO>
<PG>76-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6569825"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569824"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-La-Roche-2006" NAME="La Roche 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>La Roche M, Koinis-Mitchell D, Gualdron M</AU>
<TI>A culturally competent asthma management intervention: a randomized controlled pilot study</TI>
<SO>Annals of Allergy, Asthma and Immunology</SO>
<YR>2006</YR>
<VL>96</VL>
<PG>80-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195633"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195632"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moudgil-2000" MODIFIED="2016-08-17 17:49:04 +0100" MODIFIED_BY="[Empty name]" NAME="Moudgil 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-08-17 17:49:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moudgil H, Marshall T, Honeybourne D</AU>
<TI>Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and India subcontinent ethnic groups from socio-economically deprived areas in Birmingham, UK</TI>
<SO>Thorax</SO>
<YR>2000</YR>
<VL>55</VL>
<NO>3</NO>
<PG>177-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195635"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195634"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poureslami-2012" MODIFIED="2016-08-17 17:49:52 +0100" MODIFIED_BY="[Empty name]" NAME="Poureslami 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-17 17:49:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poureslami, I. Nimmon L, Doyle-Waters M, Rootman I, Schulzer M, Kuramoto L, et al</AU>
<TI>Effectiveness of educational interventions on asthma self-management in Punjabi and Chinese asthma patients: a randomized controlled trial</TI>
<SO>Journal of Asthma</SO>
<YR>2012</YR>
<VL>49</VL>
<NO>5</NO>
<PG>542-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195637"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195636"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valery-2010" MODIFIED="2017-07-25 13:33:30 +0100" MODIFIED_BY="Heather Maxwell" NAME="Valery 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-07-25 13:33:30 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valery PC, Masters IB, Taylor B, Laifoo Y, Chang AB</AU>
<TI>An education intervention for childhood asthma by Aboriginal and Torres Strait Islander health workers: a randomised controlled trial</TI>
<SO>Medical Journal of Australia</SO>
<YR>2010</YR>
<VL>192</VL>
<NO>10</NO>
<PG>574-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195639"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-02-15 06:15:32 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195638"/><IDENTIFIER MODIFIED="2016-02-15 06:15:32 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN012605000718640"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-08-04 01:37:34 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Alicea_x002d_Alvarez-2014" MODIFIED="2017-07-25 13:37:01 +0100" MODIFIED_BY="Heather Maxwell" NAME="Alicea-Alvarez 2014" YEAR="2013">
<REFERENCE MODIFIED="2016-08-17 17:51:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alicea-Alvarez N, Swanson-Biearman B, Kelsen SG</AU>
<TI>A review of barriers to effective asthma management in Puerto Ricans: cultural, healthcare system and pharmacogenomic issues. [Review]</TI>
<SO>Journal of Asthma</SO>
<YR>2014</YR>
<VL>51</VL>
<NO>1</NO>
<PG>97-105</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195641"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195640"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-2004" MODIFIED="2016-12-15 02:00:05 +0000" MODIFIED_BY="[Empty name]" NAME="Anderson 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-09-19 09:47:36 +0100" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson ME, Freas MR, Wallace AS, Kempre A, Glefand EW, Liu AH</AU>
<TI>Successful school based intervention for inner-city children with persistent asthma</TI>
<SO>Journal of Asthma</SO>
<YR>2004</YR>
<VL>41</VL>
<NO>4</NO>
<PG>445-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195643"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195642"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Apter-2003" MODIFIED="2016-08-18 16:12:35 +0100" MODIFIED_BY="[Empty name]" NAME="Apter 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-08-18 16:12:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Apter A, Boston R, George M, Norfleet A, Tenhave T, Coyne J, et al</AU>
<TI>Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2003</YR>
<VL>111</VL>
<PG>1219-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195645"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195644"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baren-2001" MODIFIED="2008-09-19 09:47:56 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Baren 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-09-19 09:47:56 +0100" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baren JM, Shofer FS, Ivey B, Reinhard S, Degeus J, Stahmer SA, et al</AU>
<TI>A randomized, controlled trial of a simple emergency department intervention to improve the rate of primary care follow-up for patients with acute asthma exacerbations</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>2</NO>
<PG>115-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195647"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195646"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruzzese-2011" MODIFIED="2016-08-17 17:52:27 +0100" MODIFIED_BY="[Empty name]" NAME="Bruzzese 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-08-17 17:52:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bruzzese JM, Kingston S, Sheares BJ, Cespedes A, Sadeghi H, Evans D</AU>
<TI>Feasibility and preliminary outcomes of a school-based intervention for inner-city, ethnic minority adolescents with undiagnosed asthma</TI>
<SO>Patient Education and Counseling</SO>
<YR>2011</YR>
<VL>85</VL>
<NO>2</NO>
<PG>290-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195649"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-02-15 00:03:08 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195648"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butz-2006" MODIFIED="2017-08-04 01:37:34 +0100" MODIFIED_BY="[Empty name]" NAME="Butz 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-08-04 01:37:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butz AM, Tsoukleris M, Donithan M, Van Doren H, Zuckerman I, Mudd K, at al</AU>
<TI>Effectiveness of nebulizer use-targeted asthma education on undeserved children with asthma</TI>
<SO>Archives of Pediatric and Adolescent Medicine</SO>
<YR>2006</YR>
<VL>160</VL>
<NO>6</NO>
<PG>622-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195651"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195650"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choy-1999" MODIFIED="2016-08-17 17:52:48 +0100" MODIFIED_BY="[Empty name]" NAME="Choy 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-08-17 17:52:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choy DK, Tong M, Ko F, Li ST, Ho A, Chan J, et al</AU>
<TI>Evaluation of the efficacy of a hospital-based asthma education programme in patients of low socio-economic status in Hong Kong</TI>
<SO>Clinical and Experimental Allergy</SO>
<YR>1999</YR>
<VL>29</VL>
<NO>1</NO>
<PG>84-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195653"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195652"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-2004" NAME="Clark 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark NM, Brown R, Joseph CL, Anderson EW, Liu M, Valerio MA</AU>
<TI>Effects of a comprehensive school-based asthma program on symptoms, parent management, grades and absenteeism</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>125</VL>
<PG>1674-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195655"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195654"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crowder-2012" MODIFIED="2016-08-17 17:53:31 +0100" MODIFIED_BY="[Empty name]" NAME="Crowder 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-17 17:53:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crowder S, Johnson B, Marion E</AU>
<TI>A framework to evaluate the cultural appropriateness of intervention research</TI>
<SO>Western Journal of Nursing Research</SO>
<YR>2012</YR>
<VL>34</VL>
<NO>8</NO>
<PG>1002-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195657"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195656"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DePue-2007" MODIFIED="2008-10-01 15:10:25 +0100" MODIFIED_BY="[Empty name]" NAME="DePue 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-10-01 15:10:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>DePue J, McQuaid E, Koinis-Mitchell D, Camillo C, Alario A, Klein R</AU>
<TI>Providence School Asthma Partnership: school-based asthma program for inner-city families</TI>
<SO>Journal of Asthma</SO>
<YR>2007</YR>
<VL>44</VL>
<NO>6</NO>
<PG>449-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195659"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195658"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-1997" NAME="Evans 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans D, Mellins R, Lobach K, Ramos-Bonoan C, Pinkett-Heller M, Weisemann S, et al</AU>
<TI>Improving care for minority children with asthma: professional education in public health clinics</TI>
<SO>Pediatrics</SO>
<YR>1997</YR>
<VL>99</VL>
<PG>157-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195661"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195660"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-1999" MODIFIED="2016-08-17 17:54:01 +0100" MODIFIED_BY="[Empty name]" NAME="Evans 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-08-17 17:54:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans R, Gergen P, Mitchell H, Kattan M, Kercsmar C, Crain E, et al</AU>
<TI>A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-city Asthma Study</TI>
<SO>Journal of Paediatrics</SO>
<YR>1999</YR>
<VL>135</VL>
<PG>332-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195663"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195662"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fisher-2009" MODIFIED="2016-08-18 16:13:04 +0100" MODIFIED_BY="[Empty name]" NAME="Fisher 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-08-18 16:13:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisher EB, Strunk RC, Highstein GR, Kelley-Sykes R, Tarr KL, Trinkaus K, et al</AU>
<TI>A randomized controlled evaluation of the effect of community health workers on hospitalization for asthma: The Asthma Coach</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2009</YR>
<VL>163</VL>
<NO>3</NO>
<PG>225-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195665"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195664"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ford-1997" NAME="Ford 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ford ME, Havstad SL, Tilley BC, Boulton MB</AU>
<TI>Health outcomes among African American and Caucasian adults following a randomized trial of an asthma education program</TI>
<SO>Ethnicity and Health</SO>
<YR>1997</YR>
<VL>2</VL>
<NO>4</NO>
<PG>329-39</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195667"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195666"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffiths-2005" MODIFIED="2016-08-18 16:13:54 +0100" MODIFIED_BY="[Empty name]" NAME="Griffiths 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-08-18 16:13:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffiths C, Motlib J, Azad A, Ramsay J, Eldridge S, Feder G, et al</AU>
<TI>Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease</TI>
<SO>British Journal of General Practice</SO>
<YR>2005</YR>
<VL>55</VL>
<NO>520</NO>
<PG>831-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195669"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195668"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gundelman-2004" MODIFIED="2016-08-18 16:14:05 +0100" MODIFIED_BY="[Empty name]" NAME="Gundelman 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-08-18 16:14:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gundelman S, Meade K, Chen YQ, Benson M</AU>
<TI>Asthma control and hospitalizations among inner-city children: Results of a randomized trial</TI>
<SO>Telemedicine Journal and E-Health</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>Suppl 2</NO>
<PG>S6-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195671"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195670"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kay-2006" MODIFIED="2008-09-19 09:47:46 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Kay 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-09-19 09:47:46 +0100" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kay Bartholemew L, Sockrider M, Abramson SL, Swank PR, Czyzewski DI, Tortolero SR, et al</AU>
<TI>Partners in school asthma management: evaluation of a self management program for children with asthma</TI>
<SO>Journal of School Health</SO>
<YR>2006</YR>
<VL>76</VL>
<NO>6</NO>
<PG>283-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195673"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195672"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelso-1995" MODIFIED="2008-09-19 09:47:52 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Kelso 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-09-19 09:47:52 +0100" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelso TM, Self TH, Rumbak MJ, Stephens MA, Garret W, Arheart KL</AU>
<TI>Educational and long-term therapeutic intervention in the ED: Effect on outcomes in adult indigent minority asthmatics</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>6</NO>
<PG>632-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195675"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195674"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mc-Manus-2010" MODIFIED="2016-08-18 16:14:51 +0100" MODIFIED_BY="[Empty name]" NAME="Mc Manus 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-08-18 16:14:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mc Manus V, Savage E</AU>
<TI>Cultural perspectives of interventions for managing diabetes and asthma in children and adolescents from ethnic minority groups. [Review]</TI>
<SO>Child</SO>
<YR>2010</YR>
<VL>36</VL>
<NO>5</NO>
<PG>612-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195677"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195676"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1986" NAME="Mitchell 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell EA, Ferguson V, Norwood M</AU>
<TI>Asthma education by community child health nurses</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1986</YR>
<VL>61</VL>
<NO>12</NO>
<PG>1184-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195679"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195678"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mosnaim-2013" MODIFIED="2016-08-18 16:16:22 +0100" MODIFIED_BY="[Empty name]" NAME="Mosnaim 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-18 16:16:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mosnaim G, Li H, Martin M, Richardson D, Belice PJ, Avery E, et al</AU>
<TI>The Iimpact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial</TI>
<SO>Journal of Allergy and Clinical Immunology: In practice</SO>
<YR>2013</YR>
<VL>1</VL>
<NO>5</NO>
<PG>485-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195681"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195680"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nelson-2011" MODIFIED="2016-08-18 16:17:16 +0100" MODIFIED_BY="[Empty name]" NAME="Nelson 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-08-18 16:17:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nelson KA, Highstein GR, Garbutt J, Trinkaus K, Fisher EB, Smith SR, et al</AU>
<TI>A randomized controlled trial of parental asthma coaching to improve outcomes among urban minority children</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2011</YR>
<VL>165</VL>
<NO>6</NO>
<PG>520-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195683"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195682"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Partridge-2000" NAME="Partridge 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Partridge M</AU>
<TI>In what way may race, ethnicity or culture influence asthma outcomes?</TI>
<SO>Thorax</SO>
<YR>2000</YR>
<VL>55</VL>
<PG>175-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195685"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195684"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez-1999" NAME="Perez 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez MG, Feldman L, Caballera F</AU>
<TI>Effects of a self-management educational program for the control of childhood asthma</TI>
<SO>Patient Education and Counselling</SO>
<YR>1999</YR>
<VL>36</VL>
<NO>1</NO>
<PG>47-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195687"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195686"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Persky-2007" MODIFIED="2008-10-01 15:14:13 +0100" MODIFIED_BY="[Empty name]" NAME="Persky 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-10-01 15:14:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persky V, Turyk M, Piorkowski J, Coover L, Knight J, Wagner C, et al</AU>
<TI>Inner-city asthma: the role of the community</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>132</VL>
<PG>831-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195689"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195688"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pilcher-2014" MODIFIED="2016-08-18 17:15:46 +0100" MODIFIED_BY="[Empty name]" NAME="Pilcher 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-08-18 17:15:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pilcher J, Patel M, Smith A, Davies C, Travers J, Weatherall M, et al</AU>
<TI>The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics [Conference abstract]</TI>
<SO>Respirology</SO>
<YR>2014</YR>
<VL>19</VL>
<PG>842-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195691"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195690"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poureslami-2011" MODIFIED="2017-08-04 01:33:41 +0100" MODIFIED_BY="[Empty name]" NAME="Poureslami 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-08-04 01:33:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poureslami I, Rootman I, Doyle-Waters MM, Nimmon L, FitzGerald JM</AU>
<TI>Health literacy, language, and ethnicity-related factors in immigrant asthma patients to Canada: a qualitative study</TI>
<SO>Journal of Immigrant and Minority Health</SO>
<YR>2011</YR>
<VL>13</VL>
<NO>2</NO>
<PG>315-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195693"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195692"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Press-2012" MODIFIED="2016-08-18 17:17:36 +0100" MODIFIED_BY="[Empty name]" NAME="Press 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-18 17:17:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Press VG, Pappalardo AA, Conwell WD, Pincavage AT, Prochaska MH, Arora VM</AU>
<TI>Interventions to improve outcomes for minority adults with asthma: a systematic review. [Review]</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>2012</YR>
<VL>27</VL>
<NO>8</NO>
<PG>1001-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195695"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195694"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sperber-1995" NAME="Sperber 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sperber K, Ibrahin H, Hoffman B, Eisenmesser B, Hsu H, Corn B</AU>
<TI>Effectiveness of a specialized asthma clinic in reducing asthma morbidity in an inner-city minority population</TI>
<SO>Journal of Asthma</SO>
<YR>1995</YR>
<VL>32</VL>
<NO>5</NO>
<PG>335-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195697"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195696"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sullivan-2002" MODIFIED="2016-08-18 17:17:51 +0100" MODIFIED_BY="[Empty name]" NAME="Sullivan 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-08-18 17:17:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sullivan SD, Weiss KB, Lynn H, Mitchell H, Kattan M, Gergen PJ, et al</AU>
<TI>The cost-effectiveness of an inner-city asthma intervention for children</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2002</YR>
<VL>110</VL>
<NO>4</NO>
<PG>576-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195699"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195698"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tatis-2005" NAME="Tatis 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tatis V, Remache D, DiMango E</AU>
<TI>Results of a culturally directed asthma intervention program in an inner-city latino community</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<PG>1163-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195701"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195700"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Velsor_x002d_Freidrich-2004" MODIFIED="2017-07-25 13:49:37 +0100" MODIFIED_BY="Heather Maxwell" NAME="Velsor-Freidrich 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-10-01 15:14:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Velsor-Freidrich B, Pigott TD, Louloudes A</AU>
<TI>The effects of a school based intervention on the self-care and health of African-American inner-city children with asthma</TI>
<SO>Journal of Pediatric Nursing</SO>
<YR>2004</YR>
<VL>19</VL>
<NO>4</NO>
<PG>247-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195703"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195702"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Velsor_x002d_Friedrich-2005" MODIFIED="2017-07-25 13:49:48 +0100" MODIFIED_BY="Heather Maxwell" NAME="Velsor-Friedrich 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Velsor-Friedrich B, Pigott T, Srof A</AU>
<TI>A practitioner-based asthma intervention program with African American inner-city school children</TI>
<SO>Journal of Pediatric Health Care</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>3</NO>
<PG>163-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195705"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195704"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wise-2010" MODIFIED="2016-08-18 17:18:31 +0100" MODIFIED_BY="[Empty name]" NAME="Wise 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-08-18 17:18:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wise M, Pulvermacher A, Shanovich KK, Gustafson DH, Sorkness C, Bhattacharya A</AU>
<TI>Using action research to implement an integrated pediatric asthma case management and eHealth intervention for low-income families</TI>
<SO>Health Promotion Practice</SO>
<YR>2010</YR>
<VL>11</VL>
<NO>6</NO>
<PG>798-806</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195707"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195706"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zar-2012" MODIFIED="2016-08-18 17:18:43 +0100" MODIFIED_BY="[Empty name]" NAME="Zar 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-18 17:18:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zar H, Levin M</AU>
<TI>Challenges in treating pediatric asthma in developing countries</TI>
<SO>Paediatric Drugs</SO>
<YR>2012</YR>
<VL>14</VL>
<NO>6</NO>
<PG>353-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195709"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195708"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zorc-2009" MODIFIED="2016-04-15 04:40:29 +0100" MODIFIED_BY="[Empty name]" NAME="Zorc 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-04-15 04:40:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zorc J, Chew A, Allen J, Shaw K</AU>
<TI>Beliefs and barriers to follow-up after an emergency department asthma visit: A randomized trial</TI>
<SO>Pediatrics</SO>
<YR>2009</YR>
<VL>124</VL>
<NO>4</NO>
<PG>1135-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3195711"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195710"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-08-07 11:50:56 +0100" MODIFIED_BY="Emma J Dennett">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Buist-2001" MODIFIED="2017-01-25 03:54:45 +0000" MODIFIED_BY="[Empty name]" NAME="Buist 2001" YEAR="2001">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569826"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Butz-2004" MODIFIED="2017-01-25 04:00:54 +0000" MODIFIED_BY="[Empty name]" NAME="Butz 2004" YEAR="2004">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569827"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feldman-2016" MODIFIED="2017-08-07 11:50:48 +0100" MODIFIED_BY="Emma J Dennett" NAME="Feldman 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-08-07 11:50:48 +0100" MODIFIED_BY="Emma J Dennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feldman JM, Matte L, Interian A, Lehrer PM, Lu SE, Scheckner B et al</AU>
<TI>Psychological treatment of comorbid asthma and panic disorder in Latino adults: Results from a randomized controlled trial</TI>
<SO>Behaviour Research and Therapy</SO>
<YR>2016</YR>
<VL>87</VL>
<PG>142-54</PG>
<IDENTIFIERS MODIFIED="2017-08-07 11:36:24 +0100" MODIFIED_BY="Emma J Dennett"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6569829"/><IDENTIFIER MODIFIED="2017-08-07 11:36:24 +0100" MODIFIED_BY="Emma J Dennett" TYPE="DOI" VALUE="10.1016/j.brat.2016.09.007"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569828"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffiths-2016" MODIFIED="2017-08-07 11:50:52 +0100" MODIFIED_BY="Emma J Dennett" NAME="Griffiths 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-08-07 11:50:52 +0100" MODIFIED_BY="Emma J Dennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffiths C, Bremner S, Islam K, Sohanpal R, Vidal DL, Dawson C et al</AU>
<TI>Effect of an Education Programme for South Asians with Asthma and Their Clinicians: A Cluster Randomised Controlled Trial (OEDIPUS)</TI>
<SO>PloS One</SO>
<YR>2016</YR>
<VL>11</VL>
<NO>12</NO>
<PG>e0158783</PG>
<IDENTIFIERS MODIFIED="2017-08-07 11:40:49 +0100" MODIFIED_BY="Emma J Dennett"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6569831"/><IDENTIFIER MODIFIED="2017-08-07 11:40:49 +0100" MODIFIED_BY="Emma J Dennett" TYPE="DOI" VALUE="10.1371/journal.pone.0158783"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569830"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2016" MODIFIED="2017-08-07 11:50:56 +0100" MODIFIED_BY="Emma J Dennett" NAME="Patel 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-08-07 11:50:56 +0100" MODIFIED_BY="Emma J Dennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel MR, Song PX, Sanders G, Nelson B, Kaltsas E, Thomas LJ et al</AU>
<TI>A randomized clinical trial of a culturally responsive intervention for African American women with asthma</TI>
<SO>Annals of Allergy, Asthma &amp; Immunology</SO>
<YR>2016</YR>
<VL>118</VL>
<NO>2</NO>
<PG>212-9</PG>
<IDENTIFIERS MODIFIED="2017-08-07 11:38:22 +0100" MODIFIED_BY="Emma J Dennett"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6569833"/><IDENTIFIER MODIFIED="2017-08-07 11:38:22 +0100" MODIFIED_BY="Emma J Dennett" TYPE="DOI" VALUE="10.1016/j.anai.2016.11.016"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6569832"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-01-25 03:54:15 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Janevic-2012" MODIFIED="2016-12-15 06:21:11 +0000" MODIFIED_BY="[Empty name]" NAME="Janevic 2012" YEAR="2012">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195716"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Patel-2014" MODIFIED="2016-12-15 06:21:18 +0000" MODIFIED_BY="[Empty name]" NAME="Patel 2014" YEAR="2014">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3195717"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-08-04 01:39:15 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-08-04 01:38:48 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abbott-2007" MODIFIED="2016-02-24 01:16:09 +0000" MODIFIED_BY="[Empty name]" NAME="Abbott 2007" TYPE="JOURNAL_ARTICLE">
<AU>Abbott P, Gordon E, Davison J</AU>
<TI>Expanding roles of Aboriginal health workers in the primary care setting: seeking recognition</TI>
<SO>Contemporary Nurse</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>1</NO>
<PG>66-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beaglehole-2008" MODIFIED="2016-08-18 17:20:32 +0100" MODIFIED_BY="[Empty name]" NAME="Beaglehole 2008" TYPE="JOURNAL_ARTICLE">
<AU>Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Shah E, Kidd M, et al</AU>
<TI>Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>372</VL>
<PG>940-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-BTS-2016" MODIFIED="2017-01-25 03:29:50 +0000" MODIFIED_BY="[Empty name]" NAME="BTS 2016" TYPE="OTHER">
<TI>SIGN 153. British guideline on the management of asthma</TI>
<SO>https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/</SO>
<YR>(accessed 25 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chang-2002" MODIFIED="2016-06-14 02:32:34 +0100" MODIFIED_BY="[Empty name]" NAME="Chang 2002" TYPE="JOURNAL_ARTICLE">
<AU>Chang AB, Grimwood K, Mulholland EK, Torzillo PJ</AU>
<TI>Bronchiectasis in Indigenous children in remote Australian communities</TI>
<SO>Medical Journal of Australia</SO>
<YR>2002</YR>
<VL>177</VL>
<NO>4</NO>
<PG>200-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chang-2010" MODIFIED="2016-04-14 02:42:41 +0100" MODIFIED_BY="[Empty name]" NAME="Chang 2010" TYPE="COCHRANE_REVIEW">
<AU>Chang AB, Taylor B, Masters IB, Laifoo Y, Brown ADH</AU>
<TI>Indigenous health worker involvement for Indigenous adults and children with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>5</NO>
<IDENTIFIERS MODIFIED="2008-10-01 15:21:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-10-01 15:21:56 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006344.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chino-2006" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Chino 2006" TYPE="JOURNAL_ARTICLE">
<AU>Chino M, DeBruyn L</AU>
<TI>Building true capacity: indigenous models for indigenous communities</TI>
<SO>American Journal of Public Health</SO>
<YR>2006</YR>
<VL>96</VL>
<NO>4</NO>
<PG>596-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coultas-1994" MODIFIED="2016-08-18 17:23:24 +0100" MODIFIED_BY="[Empty name]" NAME="Coultas 1994" TYPE="JOURNAL_ARTICLE">
<AU>Coultas DB, Gong H, Grad R, Handler A, McCurdy SA, Player R, et al</AU>
<TI>Respiratory diseases in minorities of the United States</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1994</YR>
<VL>149</VL>
<NO>3 Pt 2</NO>
<PG>S93-131</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davidson-2014" MODIFIED="2016-08-18 17:23:46 +0100" MODIFIED_BY="[Empty name]" NAME="Davidson 2014" TYPE="JOURNAL_ARTICLE">
<AU>Davidson EM, Liu JJ, Bhopal RS, White M, Johnson MR, Netto G, et al</AU>
<TI>Consideration of ethnicity in guidelines and systematic reviews promoting lifestyle interventions: a thematic analysis</TI>
<SO>European Journal of Public Health</SO>
<YR>2014</YR>
<VL>24</VL>
<NO>3</NO>
<PG>508-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Oliveira-1999" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="de Oliveira 1999" TYPE="JOURNAL_ARTICLE">
<AU>de Oliveira MA, Faresin SM, Bruno VF, de Bittencourt AR, Fernandes AL</AU>
<TI>Evaluation of an educational programme for socially deprived asthma patients</TI>
<SO>European Respiratory Journal</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>4</NO>
<PG>908-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Douglas-2013" MODIFIED="2016-08-18 17:23:58 +0100" MODIFIED_BY="[Empty name]" NAME="Douglas 2013" TYPE="JOURNAL_ARTICLE">
<AU>Douglas ML, McGhan SL, Tougas D, Fenton N, Sarin C, Latycheva O, et al</AU>
<TI>Asthma education program for First Nations children: an exemplar of the knowledge-to-action framework</TI>
<SO>Canadian Respiratory Journal</SO>
<YR>2013</YR>
<VL>20</VL>
<NO>4</NO>
<PG>295-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eades-2000" MODIFIED="2016-06-14 02:32:42 +0100" MODIFIED_BY="[Empty name]" NAME="Eades 2000" TYPE="JOURNAL_ARTICLE">
<AU>Eades SJ</AU>
<TI>Reconciliation, social equity and Indigenous health</TI>
<SO>Medical Journal of Australia</SO>
<YR>2000</YR>
<VL>172</VL>
<NO>10</NO>
<PG>468-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Edmond-1998" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Edmond 1998" TYPE="JOURNAL_ARTICLE">
<AU>Edmond SD, Camargo CA, Nowak RM</AU>
<TI>1997 National Asthma Education and Prevention Program Guidelines: A practical summary for emergency physicians</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>1998</YR>
<VL>31</VL>
<NO>5</NO>
<PG>579-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Enarson-1999" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Enarson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Enarson DA, Ait Khaled N</AU>
<TI>Cultural barriers to asthma management</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>4</NO>
<PG>297-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibson-2002a" MODIFIED="2016-02-19 01:50:35 +0000" MODIFIED_BY="[Empty name]" NAME="Gibson 2002a" TYPE="COCHRANE_REVIEW">
<AU>Gibson PG, Powell H, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, et al</AU>
<TI>Limited (information only) patient education programs for adults with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-10-01 15:32:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-10-01 15:32:48 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001005"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gibson-2002b" MODIFIED="2016-02-19 01:53:00 +0000" MODIFIED_BY="[Empty name]" NAME="Gibson 2002b" TYPE="COCHRANE_REVIEW">
<AU>Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al</AU>
<TI>Self-management education and regular practitioner review for adults with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-10-01 15:33:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-10-01 15:33:21 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001117"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT-2015" MODIFIED="2017-03-07 17:06:41 +0000" MODIFIED_BY="Rebecca Normansell" NAME="GRADEpro GDT 2015" TYPE="OTHER">
<AU>GRADEpro GDT</AU>
<TI>GRADEpro Guideline Development Tool [Software]</TI>
<SO>McMaster University, 2015 (developed by Evidence Prime, Inc.) Available from gradepro.org.</SO>
<YR>2015</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamdorf-1996" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Hamdorf 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hamdorf M, Wallace P, Gillam C, Stevenson M</AU>
<TI>Aboriginal health in the peel region of Western Australia</TI>
<SO>Australian Family Physician</SO>
<YR>1996</YR>
<VL>25</VL>
<NO>9 Suppl 2</NO>
<PG>S81-S85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harrington-2015" MODIFIED="2016-08-18 17:24:38 +0100" MODIFIED_BY="[Empty name]" NAME="Harrington 2015" TYPE="JOURNAL_ARTICLE">
<AU>Harrington KF, Zhang B, Magruder T, Bailey WC, Gerald LB</AU>
<TI>The impact of parents' health literacy on pediatric asthma outcomes</TI>
<SO>Pediatric Allergy, Immunology and Pulmonology</SO>
<YR>2015</YR>
<VL>28</VL>
<NO>128</NO>
<PG>20-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haselkorn-2008" MODIFIED="2017-08-04 01:37:49 +0100" MODIFIED_BY="[Empty name]" NAME="Haselkorn 2008" TYPE="JOURNAL_ARTICLE">
<AU>Haselkorn T, Lee JH, Mink DR, Weiss ST, TENOR Study Group</AU>
<TI>Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma</TI>
<SO>Annals of Allergy, Asthma &amp; Immunolgy</SO>
<YR>2008</YR>
<VL>101</VL>
<NO>3</NO>
<PG>256-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-03-31 06:11:00 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 1.0</SO>
<YR>Updated March 2011</YR>
<PB>The Cochrane Collaboration</PB>
<CY>Available from www.cochrane-handbook.org</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juniper-1992" MODIFIED="2017-08-04 01:37:56 +0100" MODIFIED_BY="[Empty name]" NAME="Juniper 1992" TYPE="JOURNAL_ARTICLE">
<AU>Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK</AU>
<TI>Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials</TI>
<SO>Thorax</SO>
<YR>1992</YR>
<VL>47</VL>
<NO>2</NO>
<PG>76-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juniper-1993" MODIFIED="2017-08-04 01:38:02 +0100" MODIFIED_BY="[Empty name]" NAME="Juniper 1993" TYPE="JOURNAL_ARTICLE">
<AU>Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE</AU>
<TI>Measuring quality of life in asthma</TI>
<SO>American Review of Respiratory Disease</SO>
<YR>1993</YR>
<VL>147</VL>
<NO>4</NO>
<PG>832-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juniper-1996" MODIFIED="2017-08-04 01:38:27 +0100" MODIFIED_BY="[Empty name]" NAME="Juniper 1996" TYPE="JOURNAL_ARTICLE">
<AU>Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M</AU>
<TI>Measuring quality of life in the parents of children with asthma.</TI>
<SO>Quality of Life Research</SO>
<YR>1996</YR>
<VL>5</VL>
<NO>1</NO>
<PG>27-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-2012" MODIFIED="2017-08-04 01:38:35 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2012" TYPE="JOURNAL_ARTICLE">
<AU>Liu J, Davidson E, Bhopal R, White M, Johnson M, Netto G, et al</AU>
<TI>Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis</TI>
<SO>Health Technology Assessment</SO>
<YR>2012</YR>
<VL>16</VL>
<NO>44</NO>
<PG>1-469</PG>
<IDENTIFIERS MODIFIED="2016-06-18 02:47:10 +0100" MODIFIED_BY="Anne Chang"><IDENTIFIER MODIFIED="2016-06-18 02:47:10 +0100" MODIFIED_BY="Anne Chang" TYPE="DOI" VALUE="10.3310/hta16440"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mitchell-2016" MODIFIED="2016-08-18 17:25:17 +0100" MODIFIED_BY="[Empty name]" NAME="Mitchell 2016" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell SJ, Bilderback AL, Okelo SO</AU>
<TI>Racial disparities in asthma morbidity among pediatric patients seeking asthma specialist care</TI>
<SO>Academic Pediatrics</SO>
<YR>2016</YR>
<VL>16</VL>
<NO>1</NO>
<PG>64-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-National-Asthma-Council-Australia-2015" MODIFIED="2016-08-18 17:26:59 +0100" MODIFIED_BY="[Empty name]" NAME="National Asthma Council Australia 2015" TYPE="OTHER">
<AU>National Asthma Council Australia</AU>
<TI>Australian Asthma Handbook, Version 1.1</TI>
<SO>http://www.asthmahandbook.org.au/download-order/complete-handbook</SO>
<YR>(accessed 18 August 2016)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NHPAC-2006" MODIFIED="2016-08-18 17:28:14 +0100" MODIFIED_BY="[Empty name]" NAME="NHPAC 2006" TYPE="OTHER">
<AU>National Health Priority Action Council (NHPAC)</AU>
<TI>National Service Improvement Framework for Asthma</TI>
<SO>http://www.healthinfonet.ecu.edu.au/key-resources/promotion-resources?lid=13452</SO>
<YR>(accessed 18 August 2016)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nierkens-2013" MODIFIED="2017-08-04 01:38:42 +0100" MODIFIED_BY="[Empty name]" NAME="Nierkens 2013" TYPE="JOURNAL_ARTICLE">
<AU>Nierkens V, Hartman MA, Nicolaou M, Vissenberg C, Beune EJAJ, Hosper K, et al</AU>
<TI>Effectiveness of cultural adaptations of interventions aimed at smoking cessation, diet, and/or physical activity in ethnic minorities. a systematic review</TI>
<SO>PLOS One</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>10</NO>
<PG>e73373</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Powell-2002" MODIFIED="2017-01-25 02:13:56 +0000" MODIFIED_BY="[Empty name]" NAME="Powell 2002" TYPE="COCHRANE_REVIEW">
<AU>Powell H, Gibson PG</AU>
<TI>Options for self-management education for adults with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2016-08-06 04:07:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-08-06 04:07:19 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004107"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Review-Manager-_x0028_RevMan_x0029_" MODIFIED="2016-03-31 06:11:12 +0100" MODIFIED_BY="[Empty name]" NAME="Review Manager (RevMan)" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-2016" MODIFIED="2017-07-25 14:22:07 +0100" MODIFIED_BY="Heather Maxwell" NAME="Schmidt 2016" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt B, Campbell S, McDermott R</AU>
<TI>Community health workers as chronic care coordinators: evaluation of an Australian Indigenous primary healthcare program</TI>
<SO>Australian and New Zealand Journal of Public Health</SO>
<YR>2016</YR>
<VL>40</VL>
<NO>Suppl 1</NO>
<PG>S107-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sin-2002" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Sin 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sin DD, Wells H, Svenson LW, Man SF</AU>
<TI>Asthma and COPD among aboriginals in Alberta, Canada</TI>
<SO>Chest</SO>
<YR>2002</YR>
<VL>121</VL>
<NO>6</NO>
<PG>1841-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Speck-2014" MODIFIED="2016-08-18 17:29:42 +0100" MODIFIED_BY="[Empty name]" NAME="Speck 2014" TYPE="JOURNAL_ARTICLE">
<AU>Speck AL, Nelson B, Jefferson SO, Baptist AP</AU>
<TI>Young, African American adults with asthma: what matters to them?</TI>
<SO>Annals of Allergy, Asthma and Immunology</SO>
<YR>2014</YR>
<VL>112</VL>
<NO>1</NO>
<PG>35-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stewart-2013" MODIFIED="2016-08-18 17:29:49 +0100" MODIFIED_BY="[Empty name]" NAME="Stewart 2013" TYPE="JOURNAL_ARTICLE">
<AU>Stewart M, King M, Blood R, Letourneau N, Masuda JR, Anderson S, Bearskin LB</AU>
<TI>Health inequities experienced by Aboriginal children with respiratory conditions and their parents</TI>
<SO>Canadian Journal of Nursing Research</SO>
<YR>2013</YR>
<VL>45</VL>
<NO>3</NO>
<PG>6-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Swartz-2002" MODIFIED="2017-08-04 01:38:48 +0100" MODIFIED_BY="[Empty name]" NAME="Swartz 2002" TYPE="JOURNAL_ARTICLE">
<AU>Swartz L, Dick J</AU>
<TI>Managing chronic diseases in less developed countries</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<NO>7370</NO>
<PG>914-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tapp-2007" MODIFIED="2016-08-17 17:28:45 +0100" MODIFIED_BY="[Empty name]" NAME="Tapp 2007" TYPE="COCHRANE_REVIEW">
<AU>Tapp S, Lasserson TJ, Rowe BH</AU>
<TI>Education interventions for adults who attend the emergency room for acute asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2016-08-17 17:28:45 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-08-17 17:28:45 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003000.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Toelle-2011" MODIFIED="2016-06-14 00:27:48 +0100" MODIFIED_BY="[Empty name]" NAME="Toelle 2011" TYPE="COCHRANE_REVIEW">
<AU>Toelle BG, Ram FSF</AU>
<TI>Written individualised management plans for asthma in children and adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2008-10-01 15:34:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-10-01 15:34:37 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002171.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wolf-2002" MODIFIED="2008-10-17 13:31:33 +0100" MODIFIED_BY="Toby J  Lasserson" NAME="Wolf 2002" TYPE="COCHRANE_REVIEW">
<AU>Wolf FM, Guevara JP, Grum CM, Clark NM, Cates CJ</AU>
<TI>Educational interventions for asthma in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-10-01 15:35:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-10-01 15:35:21 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000326"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-08-04 01:39:15 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bailey-2007" MODIFIED="2017-08-04 01:38:57 +0100" MODIFIED_BY="[Empty name]" NAME="Bailey 2007" TYPE="COCHRANE_PROTOCOL">
<AU>Bailey EJ, Chang AB</AU>
<TI>Culture-specific programs for children and adults from minority groups who have asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006580"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bailey-2008" MODIFIED="2017-08-04 01:39:02 +0100" MODIFIED_BY="[Empty name]" NAME="Bailey 2008" TYPE="COCHRANE_REVIEW">
<AU>Bailey EJ, Kruske SG, Morris PS, Cates CJ, Chang AB</AU>
<TI>Culture-specific programs for children and adults from minority groups who have asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2017-07-25 13:22:04 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER MODIFIED="2017-07-25 13:22:04 +0100" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD006580.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bailey-2009a" MODIFIED="2017-08-04 01:39:07 +0100" MODIFIED_BY="[Empty name]" NAME="Bailey 2009a" TYPE="COCHRANE_REVIEW">
<AU>Bailey EJ, Cates CJ, Kruske SG, Morris PS, Chang AB, Brown N</AU>
<TI>Culture-specific programs for children and adults from minority groups who have asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2017-07-25 13:25:59 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER MODIFIED="2017-07-25 13:25:59 +0100" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD006580.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bailey-2009b" MODIFIED="2017-08-04 01:39:15 +0100" MODIFIED_BY="[Empty name]" NAME="Bailey 2009b" TYPE="COCHRANE_REVIEW">
<AU>Bailey EJ, Cates CJ, Kruske SG, Morris PS, Brown N, Chang AB</AU>
<TI>Culture-specific programs for children and adults from minority groups who have asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2017-07-25 13:14:20 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER MODIFIED="2017-07-25 13:14:20 +0100" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD006580.pub4"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-08-14 09:28:48 +0100" MODIFIED_BY="Emma J Dennett">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-08-04 01:13:16 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-08-04 01:13:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Blixen-2001">
<CHAR_METHODS MODIFIED="2017-08-04 01:13:16 +0100" MODIFIED_BY="[Empty name]">
<P>An open, prospective, randomised controlled study evaluating the use of an asthma education program specifically targeted for African Americans compared with no education (control group).<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 01:13:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B> African-American adults aged between 18 to 50 years hospitalised overnight at a single hospital with a primary diagnosis of asthma</P>
<P>
<B>Exclusion criteria:</B> No information described</P>
<P>Participants were identified and approached whilst hospitalised with an asthma episode. Verbal consent was obtained from those who wished to participate. A face-to-face baseline interview was arranged (whilst still hospitalised). Following baseline interview, participants were randomly assigned to either the intervention or control group. Telephone interviews were conducted at 3 and 6 months consisting of the same questions asked at baseline plus additional information about any asthma events since the last interview.</P>
<P>
<B>Number approached:</B> n = 40</P>
<P>
<B>Number declined:</B> n = 12</P>
<P>
<B>Number consented and randomised</B>: n = 28 (n = 14 intervention group and n = 14 control group)</P>
<P>
<B>Baseline:</B> Intervention group n = 14, Control group n = 14</P>
<P>
<B>3 month follow-up:</B> Intervention group n = 10, Control group n = 11</P>
<P>
<B>6 month follow-up:</B> Intervention group n = 7, Control group n = 6</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:13:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Recruitment dates:</B> July to November 1997</P>
<P>
<B>Sample size:</B> n = 30 (15 per arm)</P>
<P>
<B>Intervention group:</B> received three one-hour individual asthma self-management educational sessions with a nurse educator while hospitalised with a primary diagnosis of asthma.</P>
<P>The aim of the sessions was to teach patients the rationale and skills required to manage asthma as a chronic inflammatory process rather than an episodic crisis-driven process. During these educational sessions, participants received a number of resources as outlined.</P>
<P>1. Workbook (Learn Asthma Control in Seven Days) which was modified to be culturally appropriate to African Americans. This included a discussion on handling the stressors common to many African Americans. The goals of the educational intervention were to;</P>
<UL>
<LI>optimise anti-inflammatory therapy by improving inhalation technique with metered dose inhalers (MDI's); and</LI>
<LI>have patients learn to monitor changes in airway obstruction through use of peak flow meters</LI>
</UL>
<P>To achieve these goals a video on MDI technique and peak flow monitoring was shown during the educational sessions. The video featured a well-known African-American asthma researcher (Dr Marvella Ford). Participants rehearsed the demonstration until appropriate technique was mastered, and which included:</P>
<OL>
<LI>illustrations of African Americans performing asthma management techniques</LI>
<LI>references to famous African Americans who have asthma and who could serve as role models</LI>
<LI>the addition of a discussion on handling the stresses common to many African Americans (such as looking for work)</LI>
<LI>substitution of lay language for medical terms wherever possible</LI>
<LI>addition of ideas for communicating with healthcare providers, such as taking a tape recorder to doctors visits and recording what the doctor says</LI>
<LI>the addition of toll-free telephone numbers for asthma organisations and local telephone numbers for the American Lung Association</LI>
</OL>
<P>2. Participants were shown a video on MDI-technique and peak flow monitoring. The video, "Managing Your Asthma: Understanding Proper Inhaler and Peak Flow Technique" was produced by Glaxo-Wellcome and featured an African-American asthma specialist showing African-American patients how to use MDIs and Peak flow meters. Participants then rehearsed the demonstration until the technique was mastered. Participants were given the video, a peak flowmeter and a spacer for an MDI to take home.</P>
<P>Written materials to reinforce the concepts and self-management techniques introduced in the educational sessions were mailed to the intervention group participants at 3 and 6 months.</P>
<P>
<B>Control group: </B>were asked to continue with their usual care and follow-up, which represented the 'generic' asthma programme.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-26 17:02:11 +0100" MODIFIED_BY="Heather Maxwell">
<P>
<B>Outcome measures</B>
</P>
<OL>
<LI>Symptom frequency (frequency of wheeze, shortness of breath and coughing in 2 weeks prior to hospitalisation) self-reported by participants, coded into categories of:</LI>
<OL>
<LI>mild intermittent (symptoms twice a week or less)</LI>
<LI>mild persistent (symptoms more than twice a week but less than once a day)</LI>
<LI>moderate persistent (daily symptoms)</LI>
<LI>severe persistent (continual symptoms)</LI>
</OL>
<LI>Asthma self management behaviours (participants recorded which medications they use, frequency of following physician instructions regarding these medications, use of a rescue plan for asthma, the use of a peak flow meter and whether they have a physician they see regularly for asthma).</LI>
<LI>Overall health status (participants asked to rate their health as excellent, very good, good, fair, or poor, using one question from Medical Outcomes Study 36-Item Short-Form-Health Survey).</LI>
<LI>Asthma QoL evaluating 4 domains: activity limitation, symptoms, emotional functioning and environmental stimuli.</LI>
<LI>Depression (participants asked to complete the Center for Epidemiological Studies Depression Scale)</LI>
<LI>Health Care Resource Use (survey addressing asthma-related inpatient hospital admissions and length of stay, number of office or clinic based physician visits, emergency department presentations for asthma and telephone contacts to nursing or medical personnel in 3 months prior to each interview).</LI>
</OL>
<P>Outcome assessments were performed by telephone interview at three and six months post intervention.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:13:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Lost to follow-up at final assessment:</B> n = 15</P>
<P>
<B>Funding: </B>The Nursing Research Program-Clinical Applications Research-GlaxoWellcome and The Agency for Health Care Policy and Research</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:12:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Canino-2008">
<CHAR_METHODS MODIFIED="2017-08-04 01:12:53 +0100" MODIFIED_BY="[Empty name]">
<P>Single-blinded randomised controlled trial comparing intervention "Take Control, Empower Yourself and Achieve Management of Asthma" (CALMA) program with control (usual care group).</P>
<P>All study participants completed a one hour in-home baseline interview and similar post-interview 4 months after randomisation.</P>
<P>Randomisation by computer algorithm based on mixed block design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 01:12:53 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were identified and screened for eligibility before invitation to participate.</P>
<P>
<B>Inclusion criteria:</B>
</P>
<OL>
<LI>families with a child aged between 5 and 12 years with poor asthma control, as defined by any of the following in the past 4 weeks:</LI>
<OL>
<LI>use of any asthma medication more than once a week</LI>
<LI>experiencing asthma symptoms such as wheezing, tightness of chest, problems coughing, or waking up at night because of asthma either daily or continuously</LI>
<LI>using the emergency department 2 or more times during the last 4 weeks; and</LI>
<LI>using oral steroids or having been hospitalised in the last year</LI>
</OL>
</OL>
<P>
<B>Exclusion criteria:</B>
</P>
<OL>
<LI>currently participating in another asthma study</LI>
<LI>being the sibling of a selected child</LI>
<LI>no appropriate address for follow-up</LI>
</OL>
<P>All study participants completed a one-hour in-home baseline interview and similar post-interview 4 months after randomisation.</P>
<P>Randomisation by computer algorithm based on mixed block design.</P>
<P>
<B>Number screened</B>: n = 332</P>
<P>
<B>Number eligible:</B> n = 256</P>
<P>
<B>Number randomised</B>: n = 221 (Intervention group n = 110 and Control group n = 111)</P>
<P>1 participant from control group and 2 participants from CALMA (intervention) group were lost to follow-up. All analyses were based on intention-to-treat.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:12:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Recruitment dates:</B> April 2006 to October 2006</P>
<P>
<B>Sample size: </B>Not stated</P>
<P>
<B>Intervention group: </B>CALMA is the abbreviation of the Spanish for "Take Control, Empower Yourself and Achieve Asthma Managment". The intervention was developed for reducing asthma morbidity in poor Puerto Rican children (aged 5 to 12 years) with asthma.</P>
<P>Children and families enrolled in the intervention group received 8 asthma education modules, delivered over the course of 2 home visits with telephone contact for follow-up and reinforcement of recommended plans and assignments. The modules aimed to help the patient/family with the following goals.</P>
<OL>
<LI>Understanding the chronic nature of asthma</LI>
<LI>Identifying and overcoming barriers to care and to appropriate medication use</LI>
<LI>Better understanding and use of the types of medications</LI>
<LI>Appropriately use the healthcare system and keep follow-up appointments</LI>
<LI>Enhance the use of action plans</LI>
<LI>Improve identification of asthma triggers and environmental avoidance techniques</LI>
<LI>Encourage identification of onset of symptoms and early management</LI>
<LI>Assume an active role in the communication with the provider</LI>
<LI>Identify the stressors that may affect the psychological well being of the parent and learn when and where to look for psychological and family therapy help, and</LI>
<LI>Provide a culturally competent environment in which the family feels understood and free to share cultural beliefs and practices.</LI>
</OL>
<P>The modules were culturally adapted with inclusions such as common practices and myths that Puerto Rican parents have about asthma, proper use of home remedies, culturally congruent pictures, and common asthma triggers in the island, such as Sahara dust and eruptions from Caribbean volcanoes. Educational material was developed relating to coping with marital and family stress resulting from the consequences of the child's asthma, increasing parental empowerment to deal with the Puerto Rican health system and educating parents how to teach their child and others how to manage asthma.</P>
<P>
<B>Control group: </B>received five flyers of educational materials that contained information about:</P>
<OL>
<LI>a description of control and rescue medications, when to use them and their benefit</LI>
<LI>information about what asthma is</LI>
<LI>common allergens and triggers and how to prevent episodes</LI>
<LI>how to take care of asthma equipment</LI>
<LI>common foods that may be allergenic.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:12:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<OL>
<LI>Number of symptom free days in the past month and past 2 weeks at follow-up</LI>
</OL>
<P>
<B>Secondary outcome</B>
</P>
<OL>
<LI>Childhood Asthma Control Test</LI>
<LI>Medication use in the last 12 months as per retrospective daily self-report</LI>
<LI>Pediatric Asthma QoL (caregivers QoL measured with Junipers Pediatric Asthma QoL scale)</LI>
<LI>Caregivers Asthma Knowledge Scale</LI>
<LI>Family Empowerment Scale</LI>
</OL>
<P>Assessments were performed at baseline and 4 months post randomisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:12:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Lost to follow-up at final assessment:</B> n = 3</P>
<P>
<B>Funding: </B>National Centre for Minority Health and Health Disparities and the National Institutes of Health</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:12:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grover-2016">
<CHAR_METHODS MODIFIED="2017-08-04 01:12:41 +0100" MODIFIED_BY="[Empty name]">
<P>A single-centre randomised controlled trial aiming to develop, implement and evaluate the efficacy of a culturally contextualised asthma education program for Indian parents and children with asthma</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-15 07:40:59 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria: </B>Indian children aged between 7 and 12 years; family spoke either English/Hindi; child diagnosed with asthma and child had at least 2 asthma-related visits to the hospital in the 12 months prior to study</P>
<P>
<B>Exclusion criteria: </B>Not stated</P>
<P>
<B>Clinical asthma: </B>Child needed to be diagnosed with asthma, however not defined as to who made diagnosis</P>
<P>
<B>Recruitment strategy:</B> Eligible participants were recruited and invited by their physician or by medical record review when attending asthma outpatient clinic in a Chest Diseases Hospital in New Dehli</P>
<P>
<B>Number approached:</B> Not stated</P>
<P>
<B>Number refused: </B>Not stated</P>
<P>
<B>Number randomised (parent-child pairs):</B> n = 24 (intervention group; n = 16 control group (usual care)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:12:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Education program development: </B>The overarching aim was to develop, implement and evaluate the efficacy of a culturally adapted asthma education program to parents and children with asthma. The asthma education program was designed based on key principles of health education and pedagogy and was split into three key components:</P>
<OL>
<LI>Power point presentation (covering asthma symptoms, triggers, medication, adherence, medication-related beliefs, inhaler techniques, written asthma action plans and setting health goals)</LI>
<LI>A child workbook (covering same topics as the power point presentation but with graphics, child friendly language and space for the child to write in)</LI>
<LI>Related activities interspersed at appropriate spots during power point presentation</LI>
</OL>
<P>The asthma education content was underpinned by international asthma guidelines (Global initiative for Asthma - GINA).</P>
<P>
<B>Participant recruitment dates: </B>July to December 2012</P>
<P>
<B>Sample size: </B>n = 20 per arm (total n = 40)</P>
<P>Parents and children were invited to participate in the RCT when attending asthma outpatient visit. It was not clear if the intervention was done at the time of the outpatient visit or arranged for another time convenient to families. While not reported, it was assumed that the intervention was individualised with parent-carer pairs.<BR/>
</P>
<P>Both the intervention and control group completed data collection at the baseline visit. This included asthma caregiver quality of life questionnaire, paediatric asthma control, asthma knowledge, asthma control, medication adherence, inhaler use competence and asthma action plan ownership.</P>
<P>
<B>Intervention group:</B> This was delivered by two allied health professionals (pharmacists) and asthma educators (researchers x 2) and included:</P>
<OL>
<LI>Delivery of the asthma education intervention (1 hour)</LI>
<LI>Working through power point/child workbook</LI>
<LI>Collaborative goal setting</LI>
<LI>All parent-child pairs sent to physician for asthma action plan</LI>
</OL>
<P>Further data collection was done at 3 months (phone call) and at 6 months (face to face follow-up) to collect primary and secondary outcome data.</P>
<P>
<B>Control group:</B> After baseline data were collected (identical to intervention group), parents and children were given a standard information pack for asthma in line with GINA guidelines. They were assessed at 6 months (face-to-face follow-up) to collect primary and secondary outcome data.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:12:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<OL>
<LI>Paediatric asthma caregiver quality of life</LI>
</OL>
<P>
<B>Secondary outcomes</B>
</P>
<OL>
<LI>Asthma knowledge (customised questionnaire - score ranging from 0 to 34. A high score indicated increased knowledge)</LI>
<LI>Asthma control (Juniper questionnaire - score is a mean of 7 items. 0 = poorly controlled, 7 = well controlled)</LI>
<LI>Medication adherence (validated beliefs questionnaire - 9 items. Score ranged between 0 (not hard at all) and 2 (very hard)</LI>
<LI>Inhaler technique</LI>
</OL>
<P>Outcomes were assessed at baseline, 3 and 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-15 07:35:11 +0000" MODIFIED_BY="[Empty name]">
<P>It was not clear how many people were screened or if written informed consent was provided.</P>
<P>Study reached sample size, however baseline imbalance between groups (n = 24 intervention group and n = 16 control group). Analysis of baseline characteristics was not clinically significant.</P>
<P>
<B>Funding: </B>Nil</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-La-Roche-2006">
<CHAR_METHODS MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised single-blind, parallel comparison of 2 types of interventions: Multifamily asthma group treatment (MFAGT) vs. Standard Psycho-educational Asthma Intervention (SPAI) in children with asthma.</P>
<P>These two interventions were also compared to controls (no additional education program provided) that were randomly selected from a pool of patients with asthma.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>Families with children with asthma were enrolled from Martha Eliot Health Centre, an inner-city community health centre which is part of the Boston's children Hospital.</P>
<P>
<B>Inclusion criteria:</B> African-American or Hispanic descent, aged 7-13 years with physician diagnosed asthma</P>
<P>
<B>Exclusion criteria:</B> Nil described</P>
<P>
<B>Number families screened:</B> n = 46</P>
<P>
<B>Number families randomised:</B> n = 24</P>
<P>
<B>Number families completed study:</B> n = 22</P>
<P>16 (73%) were Hispanic and 6 (27%) were African American. Mean age of children randomised was 10.2 years. 13 (59%) were male and 9 (41%) were female.</P>
<P>The control group had 11 families and were matched to the intervention group by ethnicity, age and sex. All children were from low socio-economic background. Participants competed 2 assessments (see outcome measures); one at enrolment and the second at one year following enrolment.</P>
<P>
<B>Lost to follow-up: </B>n = 2 participants at final assessment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Recruitment dates:</B> Not stated</P>
<P>
<B>Sample size:</B> Not stated</P>
<P>
<B>Intervention group</B>: MFAGT is based on allocentric self-orientation and socio-economic context of ethnic minorities. Program delivery included a Hispanic and African-American educator/psychologist. MFAGT also emphasised relational and collaborative asthma management among children, families, primary physician, and mental health specialist (as opposed to learning in isolation from others).</P>
<P>Families in the intervention group received three one-hour education sessions (on separate days) each covering one module of the education programme.</P>
<P>The content of each module consisted of:</P>
<OL>
<LI>Identifying and monitoring asthma symptoms and learning to effectively use medical/contextual resources (peak flow, medications) to control symptoms.</LI>
<LI>Identifying and preventing asthma triggers</LI>
<LI>Preventing and coping with an asthma attack (e.g. asthma action plans)</LI>
</OL>
<P>
<B>Control group</B>: SPAI has the same 3 education modules above but followed a structured teaching approach without locating asthma symptoms within the socio-economic or cultural context. This asthma education/management strategy did not include contingency plans that emphasised cultural resources and reflected a generic approach to asthma education.</P>
<P>Therefore, participants in the MFAGT arm of the study received the 'culturally specific' programme, whereas the SPAI participants served as a control group receiving the generic asthma education programme.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>1. Number of asthma-related Emergency Department visits</P>
<P>
<B>Secondary outcome</B>
</P>
<OL>
<LI>Individualism-Collectivism scale</LI>
<LI>Asthma Behavioural Assessment which consists of Asthma Knoweldge (AK) and Asthma skills (AS) in both parents and children. AK scores ranged from 0 to 12 and AS ranged from 17 to 85</LI>
</OL>
<P>Outcomes were assessed 12 months post intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>The paper provided data that compared MFAGT to SPAI and to controls. However, as the control group was not randomised, control group data were not included in the analysis.</P>
<P>
<B>Funding</B>: Office of Sponsored Projects of the Childrens Hospital Boston and Harvard Medical School, Center of Excellence in Minority Health and Health Disparities.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:12:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moudgil-2000">
<CHAR_METHODS MODIFIED="2017-08-04 01:12:03 +0100" MODIFIED_BY="[Empty name]">
<P>Open, prospective, randomised, controlled, parallel group study examining individually-based asthma education and structured follow-up for people with asthma.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-15 07:35:38 +0000" MODIFIED_BY="[Empty name]">
<P>Potential participants were identified through registration and diagnostic records inner city general practices in the Birmingham area. All eligible patients were requested to attend their general practice for review by the researcher. Participants were randomised to either the intervention or control group prior to initial appointments being sent.</P>
<P>
<B>Inclusion criteria</B>: All white European (WE) or Indian sub-continent (ISC) participants with asthma, from 12 participating general practices in the Birmingham area, aged 11 to 59 years</P>
<P>
<B>Exclusion criteria:</B> Minority groups (e.g. Afro-Caribbean and some mixed race) and a small number of Bangladeshi and/or only Bengali speaking patients who did not speak English, Punjabi, Urdu or Hindu</P>
<P>
<B>Number identified</B>: n = 1217</P>
<P>
<B>Number randomised:</B> n = 689 (Intervention group: n = 343 and Control group: n = 346)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:12:03 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Study dates:</B> August 1995 to 1996</P>
<P>
<B>Sample size:</B> n = 331 in each arm</P>
<P>
<B>Intervention group participants:</B> received individual asthma education session of 40 minutes duration with an asthma educator fluent in each participants own dialect (e.g. English, Punjabi, Hindi or Urdu). Emphasis during the session was on:</P>
<OL>
<LI>Advising GP regarding any necessary changes of treatment;</LI>
<LI>Optimising treatment including drug delivery technique and compliance;</LI>
<LI>Improving knowledge about disease severity and medication.</LI>
</OL>
<P>Participants were given peak flow meters free of charge and a booklet to record measurements during the 12-month intervention period, along with an individually-tailored asthma management plan and educational literature (in the appropriate dialect) describing aspects of asthma and asthma management. Plans were based on existing BTS guidelines.</P>
<P>Educational literature in the relevant ethnic dialect, describing aspects of asthma and its management, including triggers, medication, delivery devices etc were distributed to all participants in the intervention group (literature provided by Allen &amp; Hanburys). Educational intervention was reinforced at 4 and 8 months, although it is not stated how this was done.</P>
<P>
<B>Control group participants:</B> attended their GP at the start and end of the study for outcome assessment and were asked to continue their usual asthma follow-up and care for asthma (e.g. generic asthma programme).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:12:03 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Is this the right abbreviation Anne - I thought it was QoL&lt;/p&gt;" NOTES_MODIFIED="2017-08-04 01:12:03 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>
<B>Outcome measures</B>
</P>
<P>1. Number of asthma-related hospital admissions<BR/>2. Number of asthma-related presentations to the ED<BR/>3. Number of asthma-related home visits from GP<BR/>4. Number of asthma-related visits (during regular hours) to GP<BR/>5. Prescriptions of oral steroids<BR/>6. Prescriptions of antibiotic<BR/>7. Asthma QoL (Juniper - 32 questions about asthma events in the last 2 weeks and scores responses on 7-point scale (1 = severe limitation or most of the time; 7 = no limitation or none of the time))</P>
<P>Outcomes were performed 12 months post intervention<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-14 02:16:56 +0100" MODIFIED_BY="[Empty name]">
<P>Although the study included participants from the age of 11, data presented combines adult data, thus outcomes are not shown separately for the paediatric population. Study measured clinical outcomes for 294 (of 344) participants, and Asthma QoL outcomes for 280 (of 344) participants.</P>
<P>Domains for activity limitation, symptoms, emotional function and exposure to environmental stimuli. Some terms did not translate directly into the different dialects used and the terms used were agreed by two bilingual persons after a translation-back translation process.</P>
<P>
<B>Funding: </B>West Midlands Regional Health Authority and North Birmingham Health Authority</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:11:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poureslami-2012">
<CHAR_METHODS MODIFIED="2016-06-14 08:59:33 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised controlled trial to determine the effectiveness of different formats of culturally relevant asthma education on self-management in Punjabi and Chinese asthma patients in Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-26 17:02:55 +0100" MODIFIED_BY="Heather Maxwell">
<P>
<B>Inclusion criteria:</B> Adults with a physician diagnosis of asthma, used asthma medications daily, &gt; 21 years, immigrated to Canada within the last 20 years, lives in the Greater Vancouver Area, and spoke Mandarin, Cantonese or Punjabi.</P>
<P>
<B>Exclusion criteria:</B> Not stated</P>
<P>
<B>Number physician confirmed asthmatics</B>: n = 167</P>
<P>
<B>Number participated in development of educational intervention</B>: n = 35</P>
<P>Number participated in focus group session: n = 40</P>
<P>Number randomised in the educational intervention: n = 92 (n = 4 groups)</P>
<OL>
<LI>Group 1: Physician-led knowledge video n = 22</LI>
<LI>Group 2: Patient-generated community video n = 21</LI>
<LI>Group 3: Knowledge and Community video n = 20</LI>
<LI>Group 4: Pictorial pamphlet n = 22</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:11:51 +0100" MODIFIED_BY="[Empty name]">
<P>The overarching purpose of this study was to conduct a community-based research project to develop culturally and linguistically appropriate educational intervention to improve self-management of asthma among immigrants to Canada. 167 asthmatic adults were recruited at a University Pulmonary medical clinic in Vancouver using a convenience sampling method. This study was subsequently split into three parts.</P>
<P>Part 1 - Development of educational resources (two educational videos on knowledge and community views and educational pamphlet) (n = 35 participants)</P>
<P>Part 2 - Randomised controlled trial (n = 92 participants)</P>
<P>Part 3 - Focus group session (n = 40 participants)</P>
<P>
<B>Participants recruitment dates for RCT:</B> Not stated</P>
<P>
<B>Sample size: </B>n = 92</P>
<P>
<B>Intervention group: </B>Education interventions took place in a convenient place for participants (usually in their home or clinic). Participants were interviewed using bilingual and bicultural experienced moderators who were blinded to study groups and study hypothesis. Participants in the intervention group consisted of three groups.</P>
<OL>
<LI>Group 1: Physician-led knowledge video</LI>
<LI>Group 2: Patient-generated community video</LI>
<LI>Group 3: Knowledge and Community video</LI>
</OL>
<P>Participants undertook a pre-test assessment, followed by a 1-month education intervention based on their group allocation. This was followed by a 3-month follow-up post-test assessment. Immediately after receiving the education intervention, participants were asked a series of standardised qualitative questions. 6 months after the post-test assessment, participants were called to assess their self-management using a shorter version of the study questionnaire.</P>
<P>
<B>Control group: </B>Education interventions took place in a convenient place for participants (usually in their home or clinic). Participants were interviewed using bilingual and bicultural experienced moderators who were blinded to study groups and study hypothesis.</P>
<P>Control participants (group) four received a pictorial pamphlet for asthma. They followed the same process as the intervention group with respect to pre and post assessments.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-14 08:59:41 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Knowledge of asthma symptoms</LI>
<LI>Knowledge of asthma triggers</LI>
<LI>Self-reported medication adherence</LI>
<LI>Proper use of inhaler medication (self-reported)</LI>
</OL>
<P>Outcomes were assessed at baseline, 3 and 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:11:51 +0100" MODIFIED_BY="[Empty name]">
<P>It was not clear if any participants were lost to follow-up. We assumed all participants were included in the final analysis (n = 92).</P>
<P>
<B>Funding: </B>Canadian Institutes of Health Research and The Centre for Lung Health at the University of British Columbia, Vancouver.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-08-04 01:11:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Valery-2010">
<CHAR_METHODS MODIFIED="2016-06-14 09:00:16 +0100" MODIFIED_BY="[Empty name]">
<P>A multi-centre randomised controlled trial to assess the outcomes of an education intervention for childhood asthma conducted by Australian Indigenous Health Care Workers (ICHWs).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 01:11:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B> Indigenous children (Aboriginal or Torres Strait Islander) aged &lt; 18 years from Thursday Island and Horn Island with a provisional diagnosis of asthma or had been referred by Indigenous healthcare workers for assessment with respiratory specialist were eligible.</P>
<P>
<B>Exclusion criteria:</B> Not stated</P>
<P>
<B>Clinical asthma</B> was defined as repeated episodes of wheeze with dyspnoea that responded to bronchodilators (in children aged 3-6 years, 2 or more episodes of wheezy illness associated with cough and shortness of breath and documented amelioration of symptoms and clinical signs after administration of a bronchodilator).</P>
<P>
<B>Severity of asthma </B>was classified as persistent, frequent episodic, or infrequent episodic, based on the clinical pattern in the last 12 months.</P>
<P>
<B>Number screened for asthma:</B> n = 484</P>
<P>
<B>Number with physician confirmed asthma:</B> n = 117</P>
<P>
<B>Number refused:</B> n = 4</P>
<P>
<B>Number randomised:</B> Total n = 113 (Intervention group: n = 42 and Control group: n = 71)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:11:41 +0100" MODIFIED_BY="[Empty name]">
<P>Prior to the RCT, 67 ICHWs were trained in 7 separate 3-day asthma education workshops on Thursday Island during 2005 and 2008. ICHWs also attended respiratory specialist clinics where asthma management knowledge and skills were reinforced. Existing paediatric asthma and respiratory education resources were adapted to support Torres Strait culture, including child-friendly and age-specific asthma booklets.</P>
<P>
<B>Participant recruitment dates:</B> April 2005 to March 2007</P>
<P>
<B>Sample Size</B>: n = 54 children per arm</P>
<P>After children (n = 484) were screened by the respiratory physician, those with a confirmed diagnosis of asthma (n = 117) received an education session delivered by trained ICHWs, using existing paediatric asthma and respiratory education resources which were adapted to support Torres Strait culture. Training included using a child-friendly age-specific asthma booklet at enrolment (prior to randomisation).</P>
<P>Eligibility for the RCT was subsequently confirmed and consented children (n = 113) were then randomised to the intervention or control group.</P>
<P>
<B>Intervention group: </B>Children received additional education sessions delivered by ICHWs at 1, 3 and 6 months after the baseline visit (randomisation). Children were also clinically assessed by the ICHWs at baseline, 1,3, 6 and 12 months to collect primary and secondary outcome data.</P>
<P>
<B>Control group: </B>Control group children did not receive any further education sessions. Children were clinically assessed by ICHWs at the baseline visit (randomisation) and again 12 months later.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:11:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>:</P>
<OL>
<LI>Number of unscheduled visits to hospital or a doctor due to asthma exacerbation in 12 months after follow-up</LI>
</OL>
<P>
<B>Secondary outcomes:</B>
</P>
<OL>
<LI>QoL</LI>
<LI>Functional severity index for asthma</LI>
<LI>Asthma knowledge and use of AAP</LI>
<LI>School days missed because of wheezing</LI>
</OL>
<P>Data for primary outcome were collected 12 months prior and 12 months post intervention.</P>
<P>Data for secondary outcomes were collected as baseline (randomisation) 1, 3, 6 and 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:11:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Lost to follow-up at final assessment:</B> n = 19. A further five children who were infrequent episodic asthmatics were excluded as study investigators could not justify the cost of transport from a remote island for the clinical assessment at 12 months.</P>
<P>
<B>Funding: </B>National Health and Medical Research Council, Rural Health Suport, Education and Training grant, Telstra Foundation and Royal Children's Hospital Foundation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AAP: asthma action plan<BR/>RCT: randomised controlled trial:<BR/>QoL; quality of life</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-08-04 01:10:02 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:52:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alicea_x002d_Alvarez-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:52:58 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anderson-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:03 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Apter-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:04 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baren-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:10 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as the intervention was not culture-specific.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bruzzese-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:15 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:20 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Butz-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:20 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as the intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choy-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:22 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clark-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:27 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as the intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:53:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Crowder-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:53:49 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:48:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-DePue-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:48:02 +0000" MODIFIED_BY="[Empty name]">
<P>Non RCT and intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:50:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Evans-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:50:02 +0000" MODIFIED_BY="[Empty name]">
<P>Non RCT and participants were staff of the clinics rather than asthma patients. Intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Evans-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:28 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fisher-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:33 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:51:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ford-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:51:14 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as this re-analysis was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:51:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Griffiths-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:51:35 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as asthma management was nested within an RCT for chronic diseases.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gundelman-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:40 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kay-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:46 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kelso-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:57 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:54:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mc-Manus-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:54:58 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:55:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:55:16 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:55:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mosnaim-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:55:33 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:55:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nelson-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:55:39 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:55:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Partridge-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:55:47 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:55:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:55:54 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:56:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Persky-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:56:06 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:56:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pilcher-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:56:41 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:56:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poureslami-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:56:47 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:56:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Press-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:56:51 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:56:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sperber-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:56:54 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sullivan-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:00 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tatis-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:04 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Velsor_x002d_Freidrich-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:15 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Velsor_x002d_Friedrich-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:23 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wise-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:33 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific and was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:57:55 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zar-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:57:55 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-12-15 01:58:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zorc-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-12-15 01:58:02 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded as intervention was not culture-specific.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-08-14 09:28:48 +0100" MODIFIED_BY="Emma J Dennett" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-08-04 01:10:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buist-2001">
<CHAR_METHODS MODIFIED="2017-01-25 03:55:20 +0000" MODIFIED_BY="[Empty name]">
<P>Not available</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-25 03:55:34 +0000" MODIFIED_BY="[Empty name]">
<P>White, Asian (Hawaii), Hispanic and African-American persons with asthma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:10:00 +0100" MODIFIED_BY="[Empty name]">
<P>Does not use a culturally specific education intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-04 01:10:00 +0100" MODIFIED_BY="[Empty name]">
<P>No data available</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-04 01:10:00 +0100" MODIFIED_BY="[Empty name]">
<P>Start date in January 2001. Unable to establish if study is ongoing. Information from author in 2007 (Buist AS - Principal Investigator; buists@ohsu.edu).</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-08-04 01:35:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Butz-2004">
<CHAR_METHODS MODIFIED="2017-01-25 04:05:52 +0000" MODIFIED_BY="[Empty name]">
<P>Unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 01:09:56 +0100" MODIFIED_BY="[Empty name]">
<P>African American (93%)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:35:11 +0100" MODIFIED_BY="[Empty name]">
<P>Includes teaching children communication skills in order to communicate asthma health issues to their primary care provider. Parents completed a one-page cue card when talking with the child's physician, which included child's symptom frequency, number of emergency department visits or hospitalisations in the last 12 months, current medications and worries, health beliefs or expectations about their child's asthma.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-25 04:02:24 +0000" MODIFIED_BY="[Empty name]">
<P>No data available</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-25 04:02:54 +0000" MODIFIED_BY="[Empty name]">
<P>Study completed in July 2008, however no further data available on Clinical.Trials.Gov (last checked 25th January 2017)</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-08-14 09:28:31 +0100" MODIFIED_BY="Emma J Dennett" STUDY_ID="STD-Feldman-2016">
<CHAR_METHODS MODIFIED="2017-08-07 23:29:46 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-07 23:40:10 +0100" MODIFIED_BY="[Empty name]">
<P>Latino persons 18 years or older with asthma and panic disorder (PD)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-14 09:28:24 +0100" MODIFIED_BY="Emma J Dennett">
<P>Cognitivie behavior psychophysiological therapy (CBPT) culturally adapted for Latino people compared with music and relaxation therapy (MRT) for 8 weekly sessions to reduce PD severity, improve asthma control and inhaled corticosteroid adherence by 3 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-14 09:28:31 +0100" MODIFIED_BY="Emma J Dennett">
<P>
<B>Primary outcome</B>:</P>
<OL>
<LI>Reduce PD severity</LI>
</OL>
<P>
<B>Secondary outcomes:</B>
</P>
<OL>
<LI>Improvements in asthma control</LI>
<LI>Imptovements in inhaled corticosteroid adherence</LI>
</OL>
<P>Data for primary and secondary outcomes were collected at baseline and again at 3 months. Attrition was high (40%). Both groups showed improvements in PD severity, asthma control and several other anxiety and asthma outcome measures from baseline to 3 months. CBPT was more effective over MRT for improved adherence to inhaled corticosteroids.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-07 23:26:21 +0100" MODIFIED_BY="[Empty name]">
<P>Trial registered with ClinicalTrials.gov (NCT01583296)</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-08-14 09:28:39 +0100" MODIFIED_BY="Emma J Dennett" STUDY_ID="STD-Griffiths-2016">
<CHAR_METHODS MODIFIED="2017-08-07 23:48:34 +0100" MODIFIED_BY="[Empty name]">
<P>Cluster randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-07 23:49:11 +0100" MODIFIED_BY="[Empty name]">
<P>South Asians with asthma aged 3 year or older </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-14 09:28:34 +0100" MODIFIED_BY="Emma J Dennett">
<P>Culturally adapted Physician Asthma Care Education (PACE) programme and the Chronic Disease Self Management Programme (CDSMP), compared to usual practice. Participants in the intervention group received education on key messages about asthma with asthma specialist nurses using the PACE and CDSMP program, including self management plans and a follow up appointment either their general practitioner or practice nurses. Participants in the control group received standardised structured education from an asthma specialist.</P>
<P>Participants were interviewed in both groups by researchers (blinded to randomisation status) at baseline, 3 and 12 months. Medical records were reviewed at baseline and then again at 12 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-14 09:28:39 +0100" MODIFIED_BY="Emma J Dennett">
<P>
<B>Primary outcomes:</B>
</P>
<P>1. Time to first unscheduled contact with an asthma exacerbation.</P>
<P>2. Proportion of participants without unscheduled care</P>
<P>
<B>Secondary outcomes</B>
</P>
<P>1. Time to first asthma review in primary care</P>
<P>2. Asthma-specific and generic health related quality of life, using AQ20, North of England and EQ5D scales</P>
<P>3. Prescribing assessed from patient records and interviews</P>
<P>Data for primary and secondary outcomes were collected at baseline, 3 and 12 months. The intervention group did not have any effect on time to first unscheduled attendance for asthma, yet did improve follow-up in primary care, self-efficacy and quality of life.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-08 00:59:24 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear if trial was registered</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-08-14 09:28:48 +0100" MODIFIED_BY="Emma J Dennett" STUDY_ID="STD-Patel-2016">
<CHAR_METHODS MODIFIED="2017-08-08 01:02:13 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-08 01:02:27 +0100" MODIFIED_BY="[Empty name]">
<P>African American women with persistent asthma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-14 09:28:48 +0100" MODIFIED_BY="Emma J Dennett">
<P>To evaluate a telephone-based self-regulation intervention that emphasised African women's management of asthma compared to usual care in a series of six sessions.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-08-08 01:08:30 +0100" MODIFIED_BY="[Empty name]">
<P>Behavioral factors, symptoms and asthma control, asthma-related quality of life, and health care use were collected at baseline and 2 years later.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-08-08 01:07:15 +0100" MODIFIED_BY="[Empty name]">
<P>Trial registered with ClinicalTrials.gov (NCT01117805)</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-08-04 02:49:35 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-08-04 01:09:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Janevic-2012">
<CHAR_STUDY_NAME MODIFIED="2017-08-04 01:09:51 +0100" MODIFIED_BY="[Empty name]">
<P>Study protocol for women of color and asthma control: A randomised controlled trial of an asthma-managment intervention for African-American women</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-08-04 01:09:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-15 04:10:55 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion Criteria: African-American women &gt; 18 years with asthma who have access to a telephone or cell phone, not pregnant and willing to be involved in the study.</P>
<P>Exclusion Criteria: Patients with chronic respiratory conditions, including cystic fibrosis and chronic obstructive pulmonary disease (COPD)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 01:09:52 +0100" MODIFIED_BY="[Empty name]">
<P>African-American women comparing a five-session asthma-management intervention (over telephone by trained health care educator) compared with usual care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-15 00:39:31 +0000" MODIFIED_BY="[Empty name]">
<P>No data available</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-02-15 00:40:10 +0000" MODIFIED_BY="[Empty name]">
<P>May 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-02-15 00:41:42 +0000" MODIFIED_BY="[Empty name]">
<P>Mary R Janevic - Investigator</P>
<P>mjanevic@umich.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-06-14 02:28:14 +0100" MODIFIED_BY="[Empty name]">
<P>Last clinical trials registry update - June 2016 (recruitment completed)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-08-04 02:49:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patel-2014">
<CHAR_STUDY_NAME MODIFIED="2016-02-16 05:24:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study protocol for improving asthma outcomes through cross-cultural communication training for physicians: a randomised trial of physician training</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-02-16 05:24:14 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-08-04 02:49:32 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Primary healthcare physicians who treat African-American and Latino/Hisapanic children with asthma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-08-04 02:49:35 +0100" MODIFIED_BY="[Empty name]">
<P>Three-arm randomised controlled trial to compare effectiveness of Physician Asthma Care Education (PACE) with cross-cultural communication training on health outcomes of African-American and Latino/Hisapanic children with asthma</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-15 00:19:28 +0000" MODIFIED_BY="[Empty name]">
<P>No data available</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-02-15 00:30:41 +0000" MODIFIED_BY="[Empty name]">
<P>December 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-02-15 00:21:28 +0000" MODIFIED_BY="[Empty name]">
<P>Minal R Patel - Principal Investigator</P>
<P>minalrp@umich.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-06-14 02:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>Last clinical trials registry update - May 2016 (recruitment completed)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-08-04 01:11:57 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-07 22:12:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Method of randomisation was not described by authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-14 03:15:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Study authors state randomisation was done based on a mixed block randomisation scheme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-12 06:22:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Authors describe participants were recruited from asthma outpatient clinic and through note reviews. Generated using Microsoft Excel, using number sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-14 03:15:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Randomisation by computer, allocation method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-08-04 01:11:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Randomisation was computer-generated and randomly allocated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-14 03:19:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Authors describe participants were recruited from a convenience sample, however randomisation process not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:09:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>A randomly generated list (using a computer-generated permuted block design) stratified by age</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-08-04 01:11:45 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-07 22:13:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Study authors did not describe method of allocation concealment and how this was maintained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-14 03:15:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Randomisation by computerised algorithm based on mixed block randomisation scheme. No information provided on how allocation concealment was maintained </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-14 01:40:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Authors acknowledge in discussions that allocation concealment was not implemented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-12 13:53:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Study authors do not provide information on how allocation concealment was maintained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-14 03:18:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Participants were reviewed at local GP clinics by researcher. Study authors did not describe how allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-08-04 01:11:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Study authors did not describe how allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:09:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Allocation to intervention groups was revealed after enrolment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Blinding of participants was not possible after randomisation, given the nature of the intervention compared to the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-03-01 23:34:31 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Complete blinding was not possible after randomisation, given the nature of the intervention compared to the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-03-02 00:35:41 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>It was not clear when the intervention took place with the parent-child at the time of outpatient visit, or arranged for another time convenient for the family. It was not possible to keep participants blinded after randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-04-14 03:15:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Study authors do not describe how blinding was maintained throughout study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-03-01 23:35:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Unclear if outcome assessor was blinded to intervention groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-03-01 23:36:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Education intervention and assessments were done individually at participants home or in clinic. Personnel conducting assessments were blinded to study groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-30 04:39:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Study was unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-03-01 23:34:54 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-07 22:13:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>The randomisation status of participants at 3 and 6 months interviews were concealed by using a different trained interviewer who did not participate in the education program and was not aware of randomisation status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-01 23:34:41 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Study authors do not describe if outcome assessment was completed by study personnel who were blinded to treatment allocation, yet describe the strict training and certification of asthma counsellors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-01 23:34:54 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Outcome assessors were not blinded to treatment groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-30 04:39:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Study authors do not describe if outcome assessment was completed by study personnel who were blinded to treatment allocation. While treatment (exacerbations outcome) was given by health professionals unrelated to trial, for the outcome of asthma knowledge, risk is high as this was a single blind study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-04-14 03:18:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Study authors did not describe if outcomes assessor was blinded to intervention groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-03-31 06:09:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Personnel conducting assessments were blinded to study groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-30 04:40:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Unblinded study, but staff collecting data from medical records were blinded to intervention study allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Attrition was high, with only 13/28 (46%) participants able to be contacted for the 6-month post discharge follow-up interview due to disconnected phone or moving without a forwarding address</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-12-15 02:06:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Complete outcome data were measured in &gt; 95% of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-14 02:15:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Authors report all participants remained in study until end of study at 6 months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-12-15 02:07:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>All completed the trial, however two families did not complete 2nd evaluation (these families were omitted from analysis)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-08 01:07:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Clinical data was available for (86%) and 76% for Asthma QoL</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-08-04 01:11:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Authors do not describe if any participants withdrew or were lost to follow-up. Baseline characteristics were reported as one group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-08-04 01:11:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Five participants who had infrequent data were excluded from the 12 month follow-up, as investigators decided it was not cost-effective to fly participants in for this review</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-08-04 01:13:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Descriptive data reported. Intention-to-treat analysis not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:04:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Intention to treat analysis used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-12 06:28:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Authors report primary and secondary outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-12 13:53:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Paper provided data that compared MFAGT to SPAI and to controls. However, as the control group was not randomised, control group data was not included in analysis. Intention-to-treat analysis not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-08-04 01:11:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Intention-to-treat analysis not used. Per protocol analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-08-04 01:11:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Authors do not report descriptive data. Intention-to-treat analysis not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-15 07:36:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Progress of all randomly assignment participants was clearly described. Participants analysed using a per protocol analysis (n = 88)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-03-01 13:26:14 +0000" MODIFIED_BY="Rebecca Normansell" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-01 00:10:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Blixen-2001">
<DESCRIPTION>
<P>Education intervention aimed to optimise anti-inflammatory therapy by improving metered dose inhalation and peak flow - data not reported in paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:04:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Canino-2008">
<DESCRIPTION>
<P>Nil</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-12 06:28:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grover-2016">
<DESCRIPTION>
<P>Nil</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:06:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-La-Roche-2006">
<DESCRIPTION>
<P>Authors do not provide data for control children - not included in analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-01 13:26:14 +0000" MODIFIED_BY="Rebecca Normansell" RESULT="UNKNOWN" STUDY_ID="STD-Moudgil-2000">
<DESCRIPTION>
<P>Objective measurement of airflow obstruction (e.g. peak flow) recorded for 12 months - nil data reported in paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:09:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poureslami-2012">
<DESCRIPTION>
<P>Unclear whether the original 167 asthmatics participated in more than one step of the development phase (e.g. development of asthma education or focus group)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-31 06:10:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Valery-2010">
<DESCRIPTION>
<P>Nil</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-08-07 11:18:32 +0100" MODIFIED_BY="Emma J Dennett">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-08-04 01:09:01 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-02-02 02:24:33 +0000" MODIFIED_BY="[Empty name]">Summary of findings (paediatric studies)</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Culture-specific asthma education program compared to Generic asthma education (or usual care) for asthma in children</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>Children from minority groups with doctor diagnosed asthma</P>
<P>
<B>Settings: </B>Any</P>
<P>
<B>Intervention: </B>Culture-specific asthma education program</P>
<P>
<B>Comparison: </B>Generic asthma education program (or usual care)</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Risk with generic asthma education or usual care</P>
</TH>
<TH VALIGN="TOP">
<P>Risk with Culture-specific asthma education program</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Severe exacerbations requiring hospitalisation over the study period follow-up: 6-12 months</B>
<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>434 per 1,000</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>545 per 1000 </B>
</P>
<P>
<B>(336 to 737)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>OR 1.55</B> (0.6 to 3.66)</P>
</TD>
<TD VALIGN="TOP">
<P>88 (1 RCT)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW*</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Number of exacerbations over 52 weeks follow-up: 12 months</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>-</P>
</TD>
<TD VALIGN="TOP">
<P>Mean number of exacerbations over 52 weeks (exacerbation rate) in the intervention group was <B>0.18 MD higher (0.25 lower to 0.62 higher)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>-</P>
</TD>
<TD VALIGN="TOP">
<P>110<BR/>(2 RCTs)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>LOW<SUP>#</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Severe exacerbations requiring hospitalisation over the study period follow-up: 6-12 months</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>RR 0.48 (0.24 to 0.95)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>-</P>
</TD>
<TD VALIGN="TOP">
<P>305<BR/>(2 RCTs)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>LOW^</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> rate ratio; <B>OR:</B> Odds ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>This table was created using the GRADE Pro software (<LINK REF="REF-GRADEpro-GDT-2015" TYPE="REFERENCE">GRADEpro GDT 2015</LINK>)</P>
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
<P/>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Only one study with small number of participants was included in this analysis. This RCT was unblinded (downgrades for risk of bias and imprecision) (<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>)</P>
<P>
<SUP>#</SUP> One study by <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK> carried 85.4% of the weight of the results, which may have introduced bias. This RCT was also unblinded (downgrades for risk of bias and imprecision).</P>
<P>^ One study carried 75.1% of the analysis weight (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>). Both studies (<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>; <LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>) were unblinded which may have introduced bias (downgrades for risk of bias and inconsistency).</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-08-07 11:18:32 +0100" MODIFIED_BY="Emma J Dennett" NO="2" READONLY="YES">
<TITLE MODIFIED="2017-02-02 02:25:40 +0000" MODIFIED_BY="[Empty name]">Summary of Findings (adult studies)</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Culture-specific asthma education program compared to generic asthma education (or usual care) for asthma in adults</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Participant or population: </B>Adults from minority groups with doctor diagnosed asthma<BR/>
<B>Setting: </B>Any<BR/>
<B>Intervention: </B>Culture-specific asthma education program<BR/>
<B>Comparison: </B>Generic asthma education program (or usual care)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with generic asthma education or usual care</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Culture-specific asthma education program</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Number of participants who had one or more exacerbation of the study period follow-up: 12 months</B>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>559</B> <B>per 1,000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>504</B> <B>per 1000</B>
<BR/>(388 to 615)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.80</B>
<BR/>(0.50 to 1.26)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>294<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW*</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Number of participants requiring oral corticosteroids over the study period follow-up: 12 months</B>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>203</B> <B>per 1,000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>198</B> <B>per 1000</B>
<BR/>(123 to 306)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.97</B>
<BR/>(0.55 to 1.73)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>294<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW*</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Severe exacerbations requiring hospitalisation over the study period follow-up: 12 months </B>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>63</B> <B>per 1,000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>53</B> <B>per 1000</B>
<BR/>(20 to 130)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.83</B>
<BR/>(0.31 to 2.22)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>294<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW*</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>This table was created using the GRADE Pro software (<LINK REF="REF-GRADEpro-GDT-2015" TYPE="REFERENCE">GRADEpro GDT 2015</LINK>)</P>
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
<P/>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>*</SUP> The sole study (<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>) was of very low quality. There were many uncertainties in this study particularly with regard to outcomes reported (e.g. participants from the age of 11 were included, however the data presented combine adult data, thus outcomes are not shown separately for the paediatric population), allocation concealment, performance/detection bias, reporting bias and imprecision (3 downgrades for these items).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-08-07 11:53:05 +0100" MODIFIED_BY="Emma J Dennett">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2017-08-07 11:53:05 +0100" MODIFIED_BY="Emma J Dennett" NO="1">
<TITLE MODIFIED="2017-02-02 04:51:49 +0000" MODIFIED_BY="[Empty name]">Summary description of culture-specific programs vs control programs Study ID</TITLE>
<TABLE COLS="6" ROWS="10">
<TR>
<TH VALIGN="TOP">
<P>
<B>Study ID</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Setting</B>
</P>
</TH>
<TH>
<P>
<B>Definition of minority</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Participants</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Description of Culture-specific intervention</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Description of control</B>
</P>
</TH>
</TR>
<TR>
<TH COLSPAN="6" VALIGN="TOP">
<P>
<B>Paediatric studies</B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-La-Roche-2006" TYPE="STUDY">La Roche 2006</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Community Health Centre</P>
</TD>
<TD VALIGN="TOP">
<P>African-American and Hispanic people living in the USA</P>
</TD>
<TD VALIGN="TOP">
<P>African-American or Hispanic descent, children aged 7-13 years (n = 22)</P>
</TD>
<TD VALIGN="TOP">
<P>Multi-family asthma group treatment (MFAGT) was based on allocentric self-orientation and socio-economic context of ethnic minorities. Program delivery included a Hispanic and African-American educator/psychologist emphasising relational and collaborative asthma management among children, families, primary physician, and mental health specialist (as opposed to learning in isolation from others).</P>
<P/>
<P>Families received three one-hour education sessions (separate days) covering three modules</P>
<P>1. Identify and monitor asthma symptoms; effectively use medications/resources (e.g. peak flow, medications) to control symptoms.</P>
<P>2. Identifying and preventing asthma triggers</P>
<P>3. Preventing and coping with an asthma attack (e.g. asthma action plans)</P>
</TD>
<TD VALIGN="TOP">
<P>Standard Psycho-educational Asthma Intervention (SPAI). SPAI has the same 3 education modules as intervention group but followed a structured teaching approach without locating asthma symptoms within the socioeconomic or cultural context.</P>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Canino-2008" TYPE="STUDY">Canino 2008</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Home visits</P>
</TD>
<TD VALIGN="TOP">
<P>Socially disadvantaged (low-income and poor) Puerto Rican families living in the USA. They were identified from the national health plan insurance claims database</P>
</TD>
<TD VALIGN="TOP">
<P>Poor Puerto Rican children aged 5 to 12 years (n = 221)</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Eight asthma education modules, delivered at 2 home visits with telephone contact for follow-up and reinforcement of recommended plans and assignments. Modules were culturally adapted with inclusions such as common practices and myths that Puerto Rican parents have about asthma, home remedies, culturally congruent pictures, and common asthma triggers in the island, such as Sahara dust and eruptions from Caribbean volcanoes.</P>
</TD>
<TD VALIGN="TOP">
<P>Participants given 5 flyers that contained information on asthma (e.g. what is asthma, control and rescue medications, common allergens (including food) and triggers, how to take care of asthma equipment.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Valery-2010" TYPE="STUDY">Valery 2010</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Community Health Centre</P>
</TD>
<TD>
<P>First nations people of Australia who make up a minority of the whole Australian population. They are generally a socially disadvantaged group in a high-income country</P>
</TD>
<TD VALIGN="TOP">
<P>Aboriginal or Torres Strait Islander children aged &lt; 18 years (n = 113)</P>
</TD>
<TD VALIGN="TOP">
<P>Three additional education sessions delivered by trained Indigenous Health Care Workers, using existing paediatric asthma and respiratory education resources which were adapted to support Torres Strait culture at baseline, 1, 3 and 6 months</P>
</TD>
<TD VALIGN="TOP">
<P>Education session (identical to intervention group) delivered at baseline</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Grover-2016" TYPE="STUDY">Grover 2016</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Hospital (chest clinic)</P>
</TD>
<TD VALIGN="TOP">
<P>Indian residents whose first language was not English living in India</P>
</TD>
<TD VALIGN="TOP">
<P>Indian children aged between 7 and 12 years (n = 40)</P>
</TD>
<TD VALIGN="TOP">
<P>Culturally adapted asthma education program to Indian parents and children with asthma (underpinned by GINA guidelines) using age appropriate, graphically appealing and culturally relevant educational materials. The education program was designed based on key principles of health education and pedagogy and intervention delivered by 2 pharmacists. Asthma education was delivered over 1 hr with child/family, workbooks, goal setting and setting asthma action plan with physician.</P>
</TD>
<TD VALIGN="TOP">
<P>Parents and children were given a standard information pack for asthma in line with GINA guidelines.</P>
</TD>
</TR>
<TR>
<TH COLSPAN="6" VALIGN="TOP">
<P>
<B>Adult studies</B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Moudgil-2000" TYPE="STUDY">Moudgil 2000</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>General practitioners</P>
</TD>
<TD VALIGN="TOP">
<P>A sub group of Indian sub-continent people living in the UK whose first language was not English</P>
</TD>
<TD VALIGN="TOP">
<P>White European (WE) or Indian sub-continent (ISC) participants aged between 11 to 59 years (n = 689)</P>
</TD>
<TD VALIGN="TOP">
<P>Individual asthma education session of 40 minutes duration with an asthma educator fluent in each participants own dialect (e.g. English, Punjabi, Hindi or Urdu). Education sessions included; advising GP changes to treatment; optimising treatment, drug delivery, technique, improved knowledge of asthma, disease severity and medication.</P>
</TD>
<TD VALIGN="TOP">
<P>Usual care and follow-up; 'generic' asthma programme.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Blixen-2001" TYPE="STUDY">Blixen 2001</LINK>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Hospital</P>
</TD>
<TD>
<P>African-American people living in the USA. They are generally a socially disadvantaged group in a high-income country</P>
</TD>
<TD VALIGN="TOP">
<P>African-American adults aged between 18 to 50 years (n = 28)</P>
</TD>
<TD VALIGN="TOP">
<P>Three one-hour individual asthma self-management educational sessions; workbook modified to be culturally appropriate to African Americans; MDI technique and peak flow monitoring video featuring a well-known African-American asthma researcher.</P>
</TD>
<TD VALIGN="TOP">
<P>Usual care and follow-up; 'generic' asthma programme.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Poureslami-2012" TYPE="STUDY">Poureslami 2012</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Usually home or pulmonary clinic</P>
</TD>
<TD VALIGN="TOP">
<P>Immigrants to Canada whose first language was not English (e.g. non-Indigenous to Canada)</P>
</TD>
<TD VALIGN="TOP">
<P>Migrants in greater Vancouver Area, who spoke Mandarin, Cantonese or Punjabi with asthma aged &gt; 21 years (n = 92)</P>
</TD>
<TD VALIGN="TOP">
<P>Effectiveness of different formats of culturally and linguistically modified asthma education and their impact on self-management.Participants were allocated to one of three groups below.</P>
<P>1. Physician-led knowledge video</P>
<P>2. Patient-generated community video</P>
<P>3. Knowledge and community video</P>
</TD>
<TD VALIGN="TOP">
<P>Received a pictorial pamphlet on asthma.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-03-07 11:28:45 +0000" MODIFIED_BY="Emma J Dennett">
<COMPARISON ID="CMP-001" MODIFIED="2017-03-01 14:08:28 +0000" MODIFIED_BY="Rebecca Normansell" NO="1">
<NAME>Paediatric studies</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.6555242238133085" CI_START="0.6563030277923867" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.548913043478261" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" I2="0.0" I2_Q="100.0" ID="CMP-001.01" LOG_CI_END="0.5629496661595941" LOG_CI_START="-0.18289559216164658" LOG_EFFECT_SIZE="0.19002703699897378" METHOD="MH" MODIFIED="2016-12-14 08:49:10 +0000" MODIFIED_BY="Emma J Welsh" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.3179292447308062" Q="1.6054167806255687E-32" RANDOM="NO" SCALE="245.20894396900957" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="53" WEIGHT="100.0" Z="0.9987223072119709">
<NAME>Number of participants who had one or more exacerbation over the study period</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.6555242238133085" CI_START="0.6563030277923868" EFFECT_SIZE="1.548913043478261" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" LOG_CI_END="0.5629496661595941" LOG_CI_START="-0.18289559216164653" LOG_EFFECT_SIZE="0.19002703699897378" MODIFIED="2016-07-28 02:26:41 +0100" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.4381131967314691" STUDY_ID="STD-Valery-2010" TOTAL_1="35" TOTAL_2="53" VAR="0.19194317315026696" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.6249761340340525" CI_END="0.6175146296573291" CI_START="-0.2510574260377852" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1832286018097719" ESTIMABLE="YES" I2="38.460634648370515" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2016-12-19 15:51:25 +0000" MODIFIED_BY="Christopher J Cates" NO="2" NOTES="&lt;p&gt;Chris, not sure what happened but in the last published version, this outcome was a continuous variable. When you looked at it, it was GIV (which I didn't pick up previously). We obtained raw data from Patricia wrt calculating the mean and SD. we have now changed this back to a continuous variable.&lt;/p&gt;&lt;p&gt;Anne, the reason I changed this was to take advantage of the adjusted Mean difference reported in the Valery paper (MD 0.3, 95% CI 0.22 to 0.39). However this is similar to the raw data that you have used for the mean and SD, so I do not have a problem doing it this way. The data is skewed (SD larger than the mean) so the mean difference is not the same as the median difference. A rate ratio is the best way to compare the two groups, but this is not available to us.&lt;/p&gt;" NOTES_MODIFIED="2016-12-19 15:51:25 +0000" NOTES_MODIFIED_BY="Christopher J Cates" P_CHI2="0.202399389343911" P_Q="1.0" P_Z="0.4082802501084025" Q="0.0" RANDOM="NO" SCALE="3.500698644138009" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="64" UNITS="" WEIGHT="100.00000000000001" Z="0.8269238185365757">
<NAME>Mean number of exacerbations over 52 weeks (exacerbation rate)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6367176684954985" CI_START="-1.6367176684954985" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="1.2" MODIFIED="2016-07-28 02:10:39 +0100" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="0.9" SD_2="1.7" SE="0.5799686511904211" STUDY_ID="STD-La-Roche-2006" TOTAL_1="11" TOTAL_2="11" WEIGHT="14.596424773778518"/>
<CONT_DATA CI_END="0.7699350427130814" CI_START="-0.16993504271308135" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="0.7" MODIFIED="2016-07-28 02:10:45 +0100" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="1.19" SD_2="0.95" SE="0.23976718267267613" STUDY_ID="STD-Valery-2010" TOTAL_1="35" TOTAL_2="53" WEIGHT="85.40357522622149"/>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="3.5694768241408186" CI_END="0.9503962000501228" CI_START="0.23820697093954452" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="0.475805632592126" ESTIMABLE="YES" I2="71.98468993447793" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.022095308790241033" LOG_CI_START="-0.6230455333810347" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.3225704210856378" MODIFIED="2016-12-23 07:58:53 +0000" MODIFIED_BY="Christopher J Cates" NO="3" P_CHI2="0.05885100753634431" P_Q="1.0" P_Z="0.0353706757180181" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="143" TOTAL_2="162" WEIGHT="100.00000000000001" Z="2.104089097350028">
<NAME>Severe exacerbations requiring hospitalisation over the study period</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Rate Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="0.7199952438927397" CI_START="0.1458043933272389" EFFECT_SIZE="0.32400381129591416" ESTIMABLE="YES" ESTIMATE="-1.127" LOG_CI_END="-0.14267037239923253" LOG_CI_START="-0.8362293898106972" LOG_EFFECT_SIZE="-0.4894498811049648" MODIFIED="2016-12-19 16:11:01 +0000" MODIFIED_BY="Christopher J Cates" NOTES="&lt;p&gt;Rate ratio (Incidence Density Ratio) obtained from the logistic regression model in the paper&lt;/p&gt;" NOTES_MODIFIED="2016-12-19 16:11:01 +0000" NOTES_MODIFIED_BY="Christopher J Cates" ORDER="37" SE="0.4074" STUDY_ID="STD-Canino-2008" TOTAL_1="108" TOTAL_2="109" WEIGHT="75.07756148868867"/>
<IV_DATA CI_END="6.053826391136699" CI_START="0.3786698606959364" EFFECT_SIZE="1.5140678968293055" ESTIMABLE="YES" ESTIMATE="0.4148" LOG_CI_END="0.7820299623006934" LOG_CI_START="-0.42173926011375573" LOG_EFFECT_SIZE="0.18014535109346883" MODIFIED="2016-12-23 07:58:53 +0000" MODIFIED_BY="Christopher J Cates" NOTES="&lt;p&gt;Number of hosp exac was 4 in each group followed for 12 months (n in intervention=35, control=53). Thus RR= (4*53)/(4*35)&lt;/p&gt;" NOTES_MODIFIED="2016-12-23 07:58:53 +0000" NOTES_MODIFIED_BY="Christopher J Cates" ORDER="24" SE="0.7071" STUDY_ID="STD-Valery-2010" TOTAL_1="35" TOTAL_2="53" WEIGHT="24.922438511311338"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_DATA="YES" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2016-08-04 23:20:30 +0100" MODIFIED_BY="Anne Chang" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="68" TOTAL_2="62" WEIGHT="0.0" Z="0.0">
<NAME>Improved asthma control</NAME>
<GROUP_LABEL_1>Favours Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Culture-specific</GRAPH_LABEL_2>
<EFFECT_MEASURE>Odds Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="7.728421376733819" CI_START="1.449321301033227" EFFECT_SIZE="3.3467843857441526" ESTIMABLE="YES" ESTIMATE="1.208" LOG_CI_END="0.8880907930918717" LOG_CI_START="0.1611646751863847" LOG_EFFECT_SIZE="0.5246277341391282" MODIFIED="2016-07-27 03:45:51 +0100" MODIFIED_BY="[Empty name]" ORDER="46" SE="0.427" STUDY_ID="STD-Canino-2008" TOTAL_1="68" TOTAL_2="62" WEIGHT="0.0"/>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2016-08-04 15:38:19 +0100" MODIFIED_BY="Christopher J Cates" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="6.530797343076039" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="24" TOTAL_2="16" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Asthma control questionnaire</NAME>
<GROUP_LABEL_1>Culture-Specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.09192371002409105" CI_START="-2.311923710024091" EFFECT_SIZE="-1.1099999999999999" ESTIMABLE="YES" MEAN_1="0.08" MEAN_2="1.19" MODIFIED="2016-06-12 07:47:04 +0100" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="0.41" SD_2="2.43" SE="0.6132376510510967" STUDY_ID="STD-Grover-2016" TOTAL_1="24" TOTAL_2="16" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.1702984589084496" CI_START="-0.2502984589084497" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2016-12-19 16:11:29 +0000" MODIFIED_BY="Christopher J Cates" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.709299802780821" Q="0.0" RANDOM="NO" SCALE="0.5671751869058479" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="53" UNITS="" WEIGHT="100.0" Z="0.3727966423935228">
<NAME>Improvement in carer's asthma QoL scores (parent/carer PACQLQ)</NAME>
<GROUP_LABEL_1>Culture-Specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Culture-specific</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1702984589084496" CI_START="-0.2502984589084497" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="0.49" MEAN_2="0.53" MODIFIED="2016-07-28 22:51:07 +0100" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="0.55" SD_2="0.39" SE="0.10729710370560737" STUDY_ID="STD-Valery-2010" TOTAL_1="35" TOTAL_2="53" WEIGHT="100.0"/>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_DATA="NO" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-01 14:08:28 +0000" MODIFIED_BY="Rebecca Normansell" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="11.35" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="132" TOTAL_2="125" WEIGHT="0.0" Z="0.0">
<NAME>Change in Carers' Asthma QoL (PACQLQ)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Culture-specific</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_DATA CI_END="6.432939674104591" CI_START="-0.13293967410459118" EFFECT_SIZE="3.15" ESTIMABLE="YES" ESTIMATE="3.15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-01 14:08:12 +0000" MODIFIED_BY="Rebecca Normansell" ORDER="47" SE="1.675" STUDY_ID="STD-Canino-2008" TOTAL_1="108" TOTAL_2="109" WEIGHT="0.0"/>
<IV_DATA CI_END="1.1419718785137822" CI_START="0.25802812148621773" EFFECT_SIZE="0.7" ESTIMABLE="YES" ESTIMATE="0.7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-01 14:08:19 +0000" MODIFIED_BY="Rebecca Normansell" ORDER="97" SE="0.2255" STUDY_ID="STD-Grover-2016" TOTAL_1="24" TOTAL_2="16" WEIGHT="0.0"/>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.832169889368431" CI_START="1.1668794055467075" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.823529411764706" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.8345586570219763" LOG_CI_START="0.06702597497265049" LOG_EFFECT_SIZE="0.45079231599731334" METHOD="MH" MODIFIED="2016-07-31 08:39:52 +0100" MODIFIED_BY="Anne Chang" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.021319514391508275" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="53" WEIGHT="100.0" Z="2.3022777388529567">
<NAME>Parent description of AAP when child is well</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Culture-specific</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.832169889368431" CI_START="1.1668794055467075" EFFECT_SIZE="2.823529411764706" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.8345586570219763" LOG_CI_START="0.06702597497265049" LOG_EFFECT_SIZE="0.45079231599731334" MODIFIED="2016-04-14 04:21:39 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.4508524967838252" STUDY_ID="STD-Valery-2010" TOTAL_1="35" TOTAL_2="53" VAR="0.20326797385620915" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2016-07-31 08:39:52 +0100" MODIFIED_BY="Anne Chang" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.5088036692514395" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="24" TOTAL_2="16" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-reported medication adherence (brief medication questionnaire)</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7846410889099449" CI_START="-1.495358911090055" EFFECT_SIZE="-1.14" ESTIMABLE="YES" MEAN_1="0.26" MEAN_2="1.4" MODIFIED="2016-06-12 07:50:51 +0100" MODIFIED_BY="[Empty name]" ORDER="22" SD_1="0.44" SD_2="0.63" SE="0.18130889847623768" STUDY_ID="STD-Grover-2016" TOTAL_1="24" TOTAL_2="16" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2016-07-31 08:41:28 +0100" MODIFIED_BY="Anne Chang" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="130" TOTAL_2="132" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Asthma Knowledge Factors</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Culture-specific</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.01" MODIFIED="2016-05-20 02:36:30 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0" Z="0.0">
<NAME>Parent/carer Asthma Knowledge (behavioural assessment - score 0-12)</NAME>
<CONT_DATA CI_END="3.838464643396202" CI_START="-0.03846464339620126" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" MEAN_1="13.6" MEAN_2="11.7" MODIFIED="2016-04-14 04:28:59 +0100" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="2.6" SD_2="2.0" SE="0.9890307468333925" STUDY_ID="STD-La-Roche-2006" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.02" MODIFIED="2016-07-31 08:41:28 +0100" MODIFIED_BY="Anne Chang" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0" Z="0.0">
<NAME>Child Asthma Knowledge (behavioural assessment - score 0-12)</NAME>
<CONT_DATA CI_END="5.561885209754525" CI_START="1.0381147902454764" EFFECT_SIZE="3.3000000000000007" ESTIMABLE="YES" MEAN_1="13.3" MEAN_2="10.0" MODIFIED="2016-04-14 04:43:55 +0100" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="2.1" SD_2="3.2" SE="1.1540442720356017" STUDY_ID="STD-La-Roche-2006" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.03" MODIFIED="2016-07-26 14:37:24 +0100" MODIFIED_BY="Christopher J Cates" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="110" WEIGHT="0.0" Z="0.0">
<NAME>Parent/carer Asthma knowledge (triggers and treatment)</NAME>
<CONT_DATA CI_END="1.565262209550394" CI_START="0.31473779044960837" EFFECT_SIZE="0.9400000000000013" ESTIMABLE="YES" MEAN_1="12.64" MEAN_2="11.7" MODIFIED="2016-07-26 14:37:24 +0100" MODIFIED_BY="Christopher J Cates" NOTES="&lt;p&gt;Ok from raw data in Table II rather than the model which gives a mean difference of 1.10 (this does not make a material difference so not altered).&lt;/p&gt;" NOTES_MODIFIED="2016-07-26 14:37:24 +0100" NOTES_MODIFIED_BY="Christopher J Cates" ORDER="19" SD_1="2.31" SD_2="2.4" SE="0.3190171934190533" STUDY_ID="STD-Canino-2008" TOTAL_1="108" TOTAL_2="110" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-03-07 11:28:45 +0000" MODIFIED_BY="Emma J Dennett" NO="2">
<NAME>Adult studies</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="114" EVENTS_2="118" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2017-03-07 11:28:45 +0000" MODIFIED_BY="Emma J Dennett" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="96.86143302641057" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="453" TOTAL_2="429" WEIGHT="0.0" Z="0.0">
<NAME>Asthma exacerbations during follow-up</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="76" EVENTS_2="80" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-03-07 11:28:45 +0000" MODIFIED_BY="Emma J Dennett" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="151" TOTAL_2="143" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants who had one or more exacerbation over the study period</NAME>
<DICH_DATA CI_END="1.2629345084182821" CI_START="0.504225671050467" EFFECT_SIZE="0.798" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="80" LOG_CI_END="0.10138083007234691" LOG_CI_START="-0.29737504737088805" LOG_EFFECT_SIZE="-0.09799710864927055" MODIFIED="2017-03-07 11:28:45 +0000" MODIFIED_BY="Emma J Dennett" NOTES="&lt;p&gt;Footnoted added to explain definition that was used in the text. Data all look fine.&lt;/p&gt;" NOTES_MODIFIED="2017-03-07 11:28:45 +0000" NOTES_MODIFIED_BY="Emma J Dennett" ORDER="22" O_E="0.0" SE="0.2342311762835838" STUDY_ID="STD-Moudgil-2000" TOTAL_1="151" TOTAL_2="143" VAR="0.05486424394319131" WEIGHT="0.0">
<FOOTNOTE>Assessed by number who visited a GP for worsening asthma</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="30" EVENTS_2="29" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2016-06-09 22:06:54 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="151" TOTAL_2="143" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants requiring oral corticosteroids over the study period</NAME>
<DICH_DATA CI_END="1.7250157476721089" CI_START="0.5506712608919179" EFFECT_SIZE="0.9746366486178398" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="29" LOG_CI_END="0.2367930641025581" LOG_CI_START="-0.2591075884211004" LOG_EFFECT_SIZE="-0.011157262159271143" MODIFIED="2016-06-09 05:04:25 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.2912944980402166" STUDY_ID="STD-Moudgil-2000" TOTAL_1="151" TOTAL_2="143" VAR="0.08485248458850175" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="9" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2016-06-09 22:07:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="151" TOTAL_2="143" WEIGHT="0.0" Z="0.0">
<NAME>Severe exacerbations requiring hospitalisation over the study period</NAME>
<DICH_DATA CI_END="2.221770530065034" CI_START="0.3122721655279078" EFFECT_SIZE="0.8329448329448329" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.34669920191682957" LOG_CI_START="-0.5054667250121004" LOG_EFFECT_SIZE="-0.07938376154763549" MODIFIED="2016-06-09 05:14:40 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.5005664837674235" STUDY_ID="STD-Moudgil-2000" TOTAL_1="151" TOTAL_2="143" VAR="0.2505668046712823" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<IV_OUTCOME CHI2="0.115020774160231" CI_END="0.36113248314700913" CI_START="0.1674152035270126" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="0.26427384333701087" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.4423334458932445" LOG_CI_START="-0.7762051048369847" LOG_DATA="NO" LOG_EFFECT_SIZE="-0.5779458192994245" MODIFIED="2016-07-28 06:21:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7344989451034709" P_Q="1.0" P_Z="8.90979197591106E-8" Q="0.0" RANDOM="NO" SCALE="1.33" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="152" TOTAL_2="141" WEIGHT="100.0" Z="5.347661458106235">
<NAME>Change in AQLQ</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours culture-specific</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_DATA CI_END="0.7219927969080109" CI_START="-0.06199279690801085" EFFECT_SIZE="0.33" ESTIMABLE="YES" ESTIMATE="0.33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-07-28 06:21:21 +0100" MODIFIED_BY="[Empty name]" ORDER="447" SE="0.2" STUDY_ID="STD-Blixen-2001" TOTAL_1="7" TOTAL_2="6" WEIGHT="6.105490481444096">
<FOOTNOTE>13 participants</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.3599581632115428" CI_START="0.16004183678845724" EFFECT_SIZE="0.26" ESTIMABLE="YES" ESTIMATE="0.26" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-07-28 06:21:26 +0100" MODIFIED_BY="[Empty name]" ORDER="448" SE="0.051" STUDY_ID="STD-Moudgil-2000" TOTAL_1="145" TOTAL_2="135" WEIGHT="93.8945095185559">
<FOOTNOTE>280 participants</FOOTNOTE>
</IV_DATA>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2016-08-23 13:02:26 +0100" MODIFIED_BY="Christopher J Cates" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.7509644757108361" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="44" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Asthma Knowledge Factors</NAME>
<GROUP_LABEL_1>Culture-specific</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Culture-specific</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" MODIFIED="2016-07-26 13:07:32 +0100" MODIFIED_BY="Christopher J Cates" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Proper use of inhaler technique</NAME>
<CONT_DATA CI_END="1.1132063225907822" CI_START="-0.7132063225907819" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="6.6" MODIFIED="2016-07-26 13:07:32 +0100" MODIFIED_BY="Christopher J Cates" NOTES="&lt;p&gt;CJC matches Table 2 for Group 3 v Group 4&lt;/p&gt;" NOTES_MODIFIED="2016-07-26 13:07:32 +0100" NOTES_MODIFIED_BY="Christopher J Cates" ORDER="23" SD_1="1.6" SD_2="1.4" SE="0.46593015473449356" STUDY_ID="STD-Poureslami-2012" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.02" MODIFIED="2016-07-26 13:07:45 +0100" MODIFIED_BY="Christopher J Cates" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Knowledge of asthma symptoms</NAME>
<CONT_DATA CI_END="1.0268041233079206" CI_START="-0.6268041233079185" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="8.2" MODIFIED="2016-07-26 13:07:45 +0100" MODIFIED_BY="Christopher J Cates" NOTES="&lt;p&gt;Where does this come from please?&lt;/p&gt;" NOTES_MODIFIED="2016-07-26 13:07:45 +0100" NOTES_MODIFIED_BY="Christopher J Cates" ORDER="19" SD_1="1.5" SD_2="1.2" SE="0.4218465899524914" STUDY_ID="STD-Poureslami-2012" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-12-15 03:45:36 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAloAAAHyCAYAAAAz/GD0AABIC0lEQVR42u2dD4RV2//3vyRJksjI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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUoAAAInCAIAAABxyYdLAAAbAElEQVR42u3dv44cxdfG8ZGQEMEG
DnwFXMNGaEUEEfeEww0s4dB3gbgEhCE0jsgQsIvwBg7WkPHH6nf23Z/Qstvd093T9edUfx6NkBnb
z7ar61vnVHV1nd2OiBpWR0TNCd5E8CYieBMRvIkI3kQEbyKCNxG8iQjeRARvCt5RbHOEN7XXRaZ8
SfCmYP1j8e8SvIkI3lRHGNdh4E3Nsi0thzfBm+BN8CZ4Uw0dBdvwJiJ4ExG8qZaOYl8qvKm9XnL3
FzoMvKlZvBEOb4I3wZuiEa7DwJuI4E1E8KZSObm6dPAmIngTEbypuo4iM4c3NTkDH/+G4E3wJnhT
xYTrMPCmBqfcpt/wJiJ4ExG8iQjeRARvIngT/aejOIwJ3tReLxn6BcGb4E3wJngTvKnU3FuHgTcR
wZuI4E2VTL9NvOFNzbKNcHgTvAneFKujWDmHNxHBm4jgTZUl5/oMvKmdXqIR4E3wPjYv0NrwphYI
7+17OiS8qfDE+/g+M+6gT8KbiOBNEdJ+XRHeVEt+vjrb0nJ4U+EAuy6B8IY31YX3ihDCG97ULN73
pty6IrypMOE6DLyJCN6kC9qXCm9qD8J0a/IEb5oHYdIpfeqfBW8qEAnhDW94t9PcU77cJuG6Irzb
THErvwsWwOBN5t4Eb7SESkcTneXQpXmTnOBdBduBYqNOAm9qE28xFt7UcvTONnboIfBuodFl5p3q
ZfCmhgmHN7yp5bm3yuHwbpwWjWD6De+mslzvSBG8G8e7i7O6JsDCmxrE2wIYvGkJ4UEfjOkz8KbW
xiN4w5va7SgJ5t5WzuHdTgyM9Sgo9bXpe/Cm8kMSvOFN7aflSXetEbzNY9tJ0e1ag3eD6W6s8KWH
wJuaxRvh8KYlqETckbr63FtmDu/Wptz6dGfDDLwJ3gRvypF6rEsgvOFNtcTYFG+5mafAm5rFm+BN
8CZ4h5rHxtq4tu4FK0IE75YjIRG84b2t1tA+8EZ4C8m5TT7wbn/iveWjFPU9eJMUmuBNWQhf/aw1
owa8m83Pg04oVrl4eQG8JbpaYxPDKLx16MJXu/qVp4Cw12qDXR3e4lVrqGQYkuBNTUEo0YU3iVfL
B44u2Zq8uTdRyYFp9XfRvOUG7wJdOU9JgHAnqMMb3tRah4Y3vBufJ2+8Q6euPbpZtuFdsh+nWDxf
HW/vdcGbjoreW45X9vDBm+Qy6/wIeFPWkBWl8bOdc766c+oS5fCmTOlooFl9tna2cg7vFvBOF6/y
lDEIdM3wpqkxtv4OHfTptE2p8G4wLwhUKkiMhTc1G6/gDe9mk3O9uVP/BN5S6Nog1GfgTZnwTh2v
9BB4U7PRO8UV5t+1Bm8KOdsMSvhD56T74cy9ycAxNdJWDiG84d1m2h+oQ6feorvx5QN4FwutgSJh
rIzDO+rwbj+Apzj5xIMxeFP7eUFqT30S3uFp7MKeqbJiO0z5kuAdLH+OfmpStXPviOsF8IZ3Xcn/
luNhlIwD3vDe0JLE1tYL4C21a3wY1dM0hHjV2pCU+sDpytNyeItXy51DbMVJt+AfZXoF78LT71iH
Cq/4szI8q3duLLxLsh0uXmWI3hu/g/CGd+541VkO7GuN+kcod8vYX0cXNCTB29jf6mAXaEIBb6oi
EiZKOja7HJgh44B3m5EqxZ6qWLVEouAdqDghvIul5eNfbgTviMuBVs6pZLeLFb3jZmHwpnbm3thO
vRIBb2p2SFpr4FCECN50VNq/wUQX3lQSv9TLVLHwTrRPPlZeAG+aPaWv/PUMByHDuy5aqo1X+Vuj
/gkFvClrtxOv2hiS4A3vMvEq0OHN+cshm3tT4Lwx9abUWBkHvGleIp2i54XYhhk3lwkxWMO75aQg
xJ7zQFlSuDUOeMN7Sc+uP8xaaIR3Ffl5COecsxU9BN5ibJutoZ3hDe9GMg67AOAN79k9u0t8oErE
01ok59RCJAzxesZIpI14zSqEUqa8IPWJaPXvWktNYG9rqBBKIfGOOJvNv2gHb/ipJTI2KgWtPQpv
ogITipzDKLzJ89h8E4rKQyu8W2zrBMl53Ce92fDubGuhItFbgyRd6t/yS6zwpjbzgi5gXTR4t8nM
6s6r98JAz73lX/CuZba58V1rKWJs6lKNgQiHd2G8u5iHLlR+zalLNZp7Uzt4dzGrbXqNHN6FCd/4
cQ4eX8Gb2u+CIdhWhIhmz2MjxQFHJoneVIpwT3qL3D7RmwbDoOOKA9U/cRAyFY4qqY9zCHTNec6B
kZxTYLxDZxwZTp6DN+VIRwOtQmfGe5uEw7upFLqBxYgt5zLwhvfsYJJoJ2asprZrjQJH79S7rBPN
Ywne0tFmE90u47P6De5mhzcVnsemmKokfTptWwu1THjQd9RD5AXwbi05d1JqF+o5ArypQFQJPdil
aBzlIuDdDt5OUB/JCzwYo6iEq2jdRtoP7wYn3ht81WGIQ8c8wZtAWMU11z+wwrvx1KByCK2cw7tZ
CLsgrzHBe6SpJeeUFZVA19wleDCWYddalIVMeLeDd2rCwy1BK5wE76aitwdjEWfI8G5z7h3uxekU
qER88SPK8Y/wpsLz2Lu/8HosvCl3VAm6aOea4V1LPISKa4Z3I4SP9JU6u13St6/u/girJ/BuhO11
p51Bq5QQvOFdMqroIUFbA961pHYhat8GbecuwZo8vKnN8ShEn7F9CN7tcyiFdpwDvM0JW0uhg1aD
gTcV6F7h3iTv0iw0Jq0GA28qQHiGYrrh3vf23JuypqOd01oI3pUEWMc5pI6EFhrhDe/Zlx30JVbR
mwLjrU9rCnhXNPdOWhknUJi1lxbe1OaQFG7gCFQQBt60BMKIZXoTmde85g/vwrREOfo3HTypn9Vn
G+zgTVFP8Ex3qHC4uTe8qSm802UHqQ9mz1nfG9402Dkqj4QRZ8gE7wbzglgF63U/eNNsvLv1XoHM
XK9LlgTvdpJzr2fEWuNw1hqV6RwRDxWGN7zhXdFlxyoVlOKyHaVI7RCeMxLWP/d2lCKV6RzZaoyF
wJvg3WBSEOjQBXjDm8rjnS2dqXm9IPVjQng3lZ93jiUMuF4gelMjKXS4eGW9AN5S6Eo5rPyRW+oX
b+ENb5GwutaQnFPCqJIuEsY9KMKuNXg3m+UG6tARU2i71gjebabQ5t5UpnPkSftDDEkE75aDTOVD
UoZZvSJE8Eb4Jv7tId5yg7cuPi9kad4MKxHm3pScwGYqfsAb3pQP72yHNIZIZOBNTRGec6fdxt9y
g3dryXnStWh462watFiMDXcaeeqDjTYYY+Hdcv6s/cO1s+ScdLs229nSGhWAMOjAEa414E3iVeND
Uoi5FbzhLRIeNWrUPBuCd8n+0cXZC50oXllohHebMTbWYUzp4pXlQHjDmzaRf8Eb3rlTaAo6QMO7
fK5rHhsrxsKbSkaVFfGOu7c8HYTwpkbygnTTy2zvlgYqqAjv1iZvcZfNa3buLGHCuzjbUbpd0BQ9
6Kk4Kw798IY31UL46n0D3vAuPNuM+EpJlAkFvIuhEovtdKis7hyujie8aWHP3iDeoac86w798DYh
bBNvgje8m517d3F2hsObWs5IQ8xjI06v4N3yxFv1si7xrrUu5W52c+9GONQmgfAO5Kx7yZ+3Moxu
cOCAd1N4SwoaSPvv3krJOcIHbZPu06r/rRLDKLzbmXunPlR4JHxV5Rx31xq8he4y0bv3mxTHRUQ5
wCzFvVt9SIK3uTe8j2pq0ZvyEZ5z4Eh3EHKgI5ZrJgje5Sfe2j/WVCVp9E5S8l1vaKArGziyrURE
efYBb1qYdIRwjjUhgneDqISIV+GWIVI8HsuQJa07JMG7haQx9ZPeuKedx02OPBiDdz5UEJ7hDqYa
NVCnc8yNLZU7p5jVh9sPB+925t6dV02lG/BuvkNv+fghs3p4bwLvbr1NoynS0cyr0OnGjpovGN6F
Z7CqauVs8PpXT5JM1rBXKm9c/Xbeva8aOY9ztQuN8C7f7QKcB5AmOQ/6rL5znAO1gXfOjCOp86an
J6grGBLrRyVoEaKIjwnXPWIZ3vKCNp0DQdi7dLJKa8Ab3uUzjnABdl0I4d1ych4CQpMgeNOSGEtB
pypJyxs5rQXeDWYcUTafeDBGuQkPvbsz0EpEsEEZcgXDYMT17RC5TMSVCLvWqEw6arYSbqcdvOFd
OOPwjjq8G8/Pt5yO5qElUHIO7xb6nEMXQk9V1t215ijFNvHuqn9jrIt5nEPQ596Sc3hnGvsbmwTV
P0ArY9Aa4RrfAC05pyoC4JYPFc6ZF0jOSXI+u1k22gIIydzhko7Z1DVURB3e8Trc3XXjpH1l3SEp
0Z6WLkG57HQ1eu8tndS81A/vYngn7X8p+tzqxSsTOSedymZojRX/CfAuGb0TUZ2hHm39eKd7Vg9v
yop3usl86Oid7Q7Cm0RveJt7N413hsdXGd7oqvy5d9J2vmdV+RtB8G58NNEO+oBOQARvIoI3EcGb
iOBNRPAu35pEeQXvTHhz5lyPM7x1Ds7wJt2OM7zhzZkzvOHNmTO84c2ZM7zrx/vdu+u3b8+vrs4u
Lx/98svu4uLk9evT6+sn7969qdb57+vri/PzV2dn3z569PVu9+Lk5OXp6c9Pnvz15ljn67+vzy/O
z16dPfr20e7r3cmLk9OXp09+fvLmry1ec4o7CO98eP/xx/PLy8f7O/fws7+jv//+rELn354//+7x
4z0hDz97cn59ttz5+W/PH3/3eNdnvSfn2a/buuZEdxDemfDeD8O9N+/uZ/9nqnLeh7teSO5+9n9m
gfM+3O0OWe//zEauOd0dhHcOvPdj88H7d/sZGqfzO+9j4EFObj9D8XDIeR8Dd9Osh+JhS9ec7g5W
gffQ9rpE9dmGThqf+OXB1uydU93Nu775Zvfxx7sPPrj5fPbZ7vvv72di//xzVdx5P3cdym97M94/
r6Y67+euQ/ltb8Z79WfL15zuDlaEd+//priqg8PH+JfdoSNQen/r7dvzuzfpww9vHL76avfllze/
+OijSWlYZueL8/OJnIyku73O5xfnuznWveluM9ec7g6Gwfvh8YAj58hPLw+wAO+DBxX2/tbV1Vlv
rvXjjzcX+f77979//fq0uPOrs7NZqLw8nep89uqs5+/fqs/69GXL15zuDgbD+yFdI8BPif/LovcC
vG+fc9z7/PDD7pNPbi71iy/u/9bFxUlx59vnSdM/L06mOt8+T5qOysmLlq853R2MN/eeiPdcDlPj
3Ts8f/rpzT/288/7F1GKOz/stI//e5se/oGJzv2QjFo3fM3p7mC86N07DX54MG1tePeO0O+9d3PN
P/3Uc/+OjN6rOIveBaP3KncwZHJ+kN4peI/gmgLvofnV0Of4uffxzubeZefex9/BZufe0/nPg/e9
1dHbz62mb2DI7GzlvMjK+Yp3MNjce9bK+QjJQz8r23Pv8Vt4zHPvFZ099y7y3HvFO1gL3i3JrrUp
znat5bmD8M6Ed2fP+X9lz3meOwjvTHh3/3sr6NHwW0FPK3Tex8OhFen995dPlzvv42H/ivT/57dP
L7d1zYnuILzz4d0Nv9PbO6eqxHno3eneuess56F3p3vnrs1fc4o7CO+seHPmnNMZ3joHZ3iTbscZ
3vDmzBne8ObMGd7w5swZ3jXgTaRCqOjNmbPoDW/OnOENb86c4Q1vzvAm3Y4zvEm34wxveAerL3mr
dNU2I9bxVCEU3v0KV1+yS1ltM2IdTxVC4d2viGd9pDv5JOKZKk5rgXc7J3WlO7cs4olozlqbwcAx
P/TIqz2yQuj4xTdTXzLdqaMRzzNVIXQJnPmzhiMrhC44RL2LWV8y3ZnhEU8jVyF0YeAdP2y8t9zn
w/PPZwXY/HhHrC+ZruJHxFoiKoQem1dPL/c58Xe7BBVCl+Edsb5kunpdESuBqRC65rR5ImNFKoQu
mHtHrC+ZrtpmxDqeKoSugPfEcp8F8Q4RvSuvECp657mDdc29FzC2GO/FFUKjzL1rrhBq7p3nDta1
cj4+o14R72MqhFa+ch6iQqiV8zx3sLrn3v9+eQze49Pj4yuE1vzcO0SFUM+989zBYng3LLvWyjrb
tQbvMmuH9pzncbbnHN5lHg2Eqy/Zpay2GbGOpwqh8B5TrPqS/86WE1XbjFjHU4VQeHPmXIUzvHUO
zvAm3Y4zvOHNmTO84c2ZM7zhzZkzvGvAm0iFUNGbM2fRG96cOcMb3pw5wxvenOFNuh1neJNuxxne
8E5YXzJiHU8VQlM7wzsf3unqS0as46lCaAZneGfCO91ZHxHPVHFaSx5neOfAO91JXRFPRHPWWh7n
8ngfWS10rZ84cnjrrAvOfM5mxPNMnZSax7k83vmrhS6oNzTrgjOfkh3xNHLnnOdxLoz3wYol9wob
HDz8fKi66MELGC8/OmvxM3ONi4i1RFQpyeNcHd69YXOc2KFvemPvLLxH/nducp6uQlXESmBqjOVx
rgjvKfF5PLyPQzt9XnAQ73H/zPUlI9bxVCE0j3PtyfksvMeri66I94K5t+gtem86eh+P99x/80Ro
V8Hb3Nvce3Nz74khdPGvp0+PU+Nt5dzK+eZWzsefQh//Z46vEOq5t+fennvT4Ya2ay2Ps11r8C7z
tM+e8zzO9pzDuwDeXcr6khHreKoQmsEZ3vnw7lLWl4xYx1OF0NTO8M6KN2fOOZ3hrXNwhjfpdpzh
DW/OnOENb86c4Q1vzpzhXQPeRCqEit6cOYve8ObMGd7w5swZ3vDmDG/S7TjDm3Q7zvCGd/fu3fXb
t+dXV2eXl49++WV3cXHy+vXp9fWTd+/ecF7ROWKF0BStAe98eP/xx/PLy8f7O/fws7+jv//+jPMq
zhErhCZqDXhnwns/DPfevLuf/Z/hfKRzxDNV0rUGvHPgvR+bD96/28/QOM15inPEE9HStcZqeC9w
mL6xbt21iukVQmfVEh25pP2c6m7e9c03u48/3n3wwc3ns892339/PxP7558rzgucI55nmq41yuN9
pMmRP3R6DaMp1chGvnz79vzuTfrww5sG/+qr3Zdf3vzio48mpWGcDzpHPI08XWvkwHsk1h0sJzAU
Oe/9+bkBdi28p7fD1dVZb6714483F/n++/e/f/36lPMC54i1RNK1RnK8x2Pd3CJEvb8Y+d1ucpmx
uXjPTc5vn3Pc+/zww+6TT258vvji/m9dXJxwXuAcsRJYutbImpyPlPsYLzAyEjmX5c/jf2xKFfG5
yXnv8PzppzdWn3/ev4jCeYFzxDqe6Voja3K+uLLXArwnvge71oR82Qj93ns3l/fTTz3378hIuFnn
ZqL3Kq1RV3KeInpPvNrUeA/Nr4Y+x89jt+nc0tz7+NbIh/eU6nzT8V6dwMwr57efW03fwMB5Cyvn
K7bGynj3ZsX//nrW0tqslfOJf3c8dc/53Hv8Fh7zDHnjzg08916xNdbEm8Yb2t6yPM52rcG7AN6d
neG5nO05h3cBvLv/vRX0aPitoKecV3GOWCE0UWvAOx/e3fA7vb1zKs6LnSNWCE3RGvDOijdnzjmd
4a1zcIY36Xac4Q1vzpzhDW/OnOENb86c4V0D3kQqhIrenDmL3vDmzBne8ObMGd7w5gxv0u04w5t0
O87whnew+pKco99BeOfDO1x9Sc7R7yC8M+Ed8awPztHvILxz4B3xpC7O0e9gJryPrxY4668fLCSS
uUJoxPqSnKPfwax4Pzx1OMMi5OpHmi875zxifUnO0e9gLXhPrDHWDZya/vDLiRVLsuEdsb4k5+h3
MHdy/vC/y9AaKgxaLd4R60tyjn4Ho+LdzS8VPN4iqfGOWF+Sc/Q7CO+uyeit9mig2qMxKoTGwjtz
hdCI9SU5R7+DBR6Mza3yOWuaPRHv/BVCI9aX5Bz9DlaBd3eoGOi6K+dFKoRGrC/JOfodzId3HtXw
r7BrrVVnu9bK4HTwNLlKhhh7zqM723O+dTVWX5Jz9DsI76wThFj1JTlHv4PwjjH/58wZ3vDmzBne
OgdneJNuxxnepNtxhje8OXOGd1C8iVQIFb05cxa94c2ZM7zhzZkzvOHNGd6k23GGN+l2nOENbzUx
Mzmragrv3HiriZnHWVVTeOfG2/kkeZydMAPv3Hg7XSyPs/PhluA9cQdcbasRR1YI7UbPWp3+E9XE
zOOsqulyvPOsAaZebJx1ennvKHBw7Hj4pZqYeZxVNV0f74n1PR8eRT4lhE75QfcKGBwkcCLeDw9U
n5gaPPxSTcw8zqqaroz3rPoea5UTGvJct0LolIab+KWamHmcVTVdee59fPmeuQWDjvec+HfHHWZ9
ryZmHmdVTdeJ3sfjPbES0NDfioW3mpgFo/dmq5qWxHvij0uREXTTKoTOzSkWzK+2WRNTvdQ8zsnx
XhxpxyuKrp7wz8J74nx+ZHV04zUx1UvN47wC3t3k+p7Lim9OrAQ6He9ZFUJHLnuo0dTErOe598ar
ms7Am458UG/XWh5nu9bgXQDvzp7zXM72nMO7AN6dmpi5nFU1hXcBvDs1MXM5q2oK7wJ4c+ac0xne
OgdneJNuxxne8ObMGd7w5swZ3vDmzBneNeBNpEKo6M2Zs+gNb86c4Q1vzpzhDW/O8CbdjjO8Sbfj
DG94h6y2+ff19cX5+auzs28fPfp6t3txcvLy9PTnJ0/+erPFOp6xqprCOx/eEatt/vb8+XePH/ce
uLCn/ddn26rjGa6qKbwz4R3x5JN9iD54YtL+zyxwdnZNnmuGdw68I55bto/bE48zHYrhTp4re83l
8Z510vAq15m/QmjEU0f38+2hnLw3S//zquVqmxGrmm4R7yIVQiOeGX5xfj7HuD9FVy+14DXXkpzP
LQk6/rvTi4QuqBC6DO+IFT9enZ3NwvvlacvVNiNWNa0a72MKhq6C98H/nY53xHpdt8/Apn9enLRc
bTNiVdPao/cCvB9G8gUpw+p4R6y2+bDTPj5g3HK1zYhVTStaOR/KhIdKgva+7Fot3qL3wXi12Xqp
VVQIzY/39OR85K+sXiHU3Dvd3Hub9VKrqBCafwl9vCTolIKB059dpcbbyvnIWvHG66VWUSG01BOy
8ZKg44vkQ/gdUyHUc+/Vn3tvvF6qCqGrjRcFf6hda3dl11qea24W71L/InvOJzrbc57nmu05zzes
RKy2uY/hQ6vo++8vn26rjme4qqbwzpo1RKy2OfS+d+98e5azeqmprxneMSYFnDnDG96cOcNb5+AM
b9LtOMObdDvO8IY3Z87wDoo3kQqhRJQr3mgIIngTEbyJCN5EBG8igjcRwZtoE3gTUZP6P+eyANtx
Ha3tAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Paediatric studies, outcome: 1.1 Number of participants who had one or more exacerbation over the study period.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAysAAACQCAMAAAA/bARFAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Paediatric studies, outcome: 1.2 Mean number of exacerbations over 52 weeks (exacerbation rate).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0IAAACQCAMAAAASniv/AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Paediatric studies, outcome: 1.3 Severe exacerbations requiring hospitalisation over the study period.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA34AAACQCAMAAABgUUlJAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.04" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Paediatric studies, outcome: 1.4 Improved asthma control.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3kAAABgCAMAAACXH0spAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.08" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Paediatric studies, outcome: 1.8 Parent description of AAP when child is well.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAysAAACQCAMAAAA/bARFAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-002.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Adult studies, outcome: 2.1 Asthma exacerbations during follow-up.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAz4AAAEQCAMAAABGLFGFAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2017-08-04 01:13:01 +0100" MODIFIED_BY="[Empty name]" NO="9" REF_ID="CMP-002.02" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Adult studies, outcome: 2.2 Change in AQLQ.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAucAAADQCAMAAACTOT/GAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-08-23 11:55:16 +0100" MODIFIED_BY="Elizabeth M Stovold">
<APPENDIX ID="APP-01" MODIFIED="2016-08-23 11:54:16 +0100" MODIFIED_BY="Elizabeth M Stovold" NO="1">
<TITLE MODIFIED="2008-10-01 15:07:31 +0100" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2016-08-23 11:54:16 +0100" MODIFIED_BY="Elizabeth M Stovold">
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Airways Register of trials</HEADING>
<P>#1 AST:MISC1<BR/>#2 MeSH DESCRIPTOR Asthma Explode All<BR/>#3 asthma*:ti,ab<BR/>#4 #1 or #2 or #3<BR/>#5 MeSH DESCRIPTOR Oceanic Ancestry Group<BR/>#6 aboriginal* or aborigine*<BR/>#7 indigenous*<BR/>#8 MeSH DESCRIPTOR Minority Groups<BR/>#9 MeSH DESCRIPTOR Culture Explode All<BR/>#10 MeSH DESCRIPTOR Ethnology<BR/>#11 culture* NEAR3 (specific* OR appropriate* or tailored*)<BR/>#12 cultural*<BR/>#13 MeSH DESCRIPTOR Cultural Diversity<BR/>#14 MeSH DESCRIPTOR Cultural Deprivation<BR/>#15 MeSH DESCRIPTOR Cultural Characteristics<BR/>#16 MeSH DESCRIPTOR Anthropology, Cultural Explode All<BR/>#17 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16<BR/>#18 MeSH DESCRIPTOR Self Care<BR/>#19 MeSH DESCRIPTOR Self Administration<BR/>#20 MeSH DESCRIPTOR Self Medication<BR/>#21 MeSH DESCRIPTOR Self Efficacy<BR/>#22 self* NEXT manage*<BR/>#23 MeSH DESCRIPTOR Patient Acceptance of Health Care Explode All<BR/>#24 MeSH DESCRIPTOR Patient Education as Topic<BR/>#25 MeSH DESCRIPTOR Patient Care Planning Explode All<BR/>#26 MeSH DESCRIPTOR Patient-Centered Care<BR/>#27 MeSH DESCRIPTOR Health Services, Indigenous<BR/>#28 indigenous* NEAR3 health*<BR/>#29 aboriginal* NEAR3 health*<BR/>#30 (educat*) or (program*) or (learn*) or (specific*)<BR/>#31 #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30<BR/>#32 #4 AND #17 AND #31</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL (Cochrane Library)</HEADING>
<P>#1 MeSH descriptor Asthma explode all trees</P>
<P>#2 MeSH descriptor Bronchial Spasm explode all trees</P>
<P>#3 asthma*</P>
<P>#4 wheez*</P>
<P>#5 bronchospas*</P>
<P>#6 bronch* near spas*</P>
<P>#7 bronchoconstrict*</P>
<P>#8 bronch* near constrict*</P>
<P>#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)</P>
<P>#10 MeSH descriptor Oceanic Ancestry Group, this term only</P>
<P>#11 (aboriginal* or aborigine*)</P>
<P>#12 indigenous</P>
<P>#13 MeSH descriptor Minority Groups, this term only</P>
<P>#14MeSH descriptor Culture, this term only</P>
<P>#15 MeSH descriptor Ethnology, this term only</P>
<P>#16 culture-specific</P>
<P>#17 cultural</P>
<P>#18 MeSH descriptor Cultural Diversity, this term only</P>
<P>#19MeSH descriptor Cultural Deprivation, this term only</P>
<P>#20 MeSH descriptor Cultural Characteristics, this term only</P>
<P>#21 MeSH descriptor Anthropology, Cultural, this term only</P>
<P>#22 (#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21)</P>
<P>#23 MeSH descriptor Self Care, this term only</P>
<P>#24 MeSH descriptor Self Administration, this term only</P>
<P>#25 MeSH descriptor Self Medication, this term only</P>
<P>#26 MeSH descriptor Self Efficacy, this term only</P>
<P>#27 self manage*</P>
<P>#28 MeSH descriptor Patient Acceptance of Health Care explode all trees</P>
<P>#29 MeSH descriptor Patient Education explode all trees</P>
<P>#30 MeSH descriptor Patient Care Planning explode all trees</P>
<P>#31 MeSH descriptor Patient-Centered Care explode all trees</P>
<P>#32 MeSH descriptor Health Services, Indigenous, this term only</P>
<P>#33 indigenous health*</P>
<P>#34 aboriginal* health*</P>
<P>#35 (educat*) or (program*) or (learn*) or (specific)</P>
<P>#36 (#23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35</P>
<P>#37 (#9 AND #22 AND #36)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (Ovid)</HEADING>
<P>1. exp asthma/<BR/>2. exp Bronchial Spasm/<BR/>3. asthma$.tw.<BR/>4. wheez$.tw.<BR/>5. bronchospas$.tw.<BR/>6. (bronch$ adj3 spas$).tw.<BR/>7. bronchoconstrict$.tw.<BR/>8. (bronch$ adj3 constrict$).tw.<BR/>9. or/1-8<BR/>10. oceanic ancestry group/ or (aboriginal$ or aborigine$).tw.<BR/>11. minority groups/ or indigenous.tw.<BR/>12. culture/ or ethnology/ or culture specific.tw. or cultural.tw.<BR/>13. or/10-12<BR/>14. self care/ or self administration/ or self medication/ or self efficacy/ or self manage$.tw.<BR/>15. "patient acceptance of health care"/ or patient compliance/ or patient participation/ or patient satisfaction/ or treatment refusal/<BR/>16. patient education/ or patient care planning/ or patient-centered care/<BR/>17. health services indigenous/ or indigenous health$.tw.<BR/>18. (educat$ or program$ or learn$ or specific).tw.<BR/>19. or/14-18<BR/>20. 9 and 13 and 19<BR/>21. (controlled clinical trial or randomized controlled trial).pt.<BR/>22. (randomized or randomised).ab,ti.<BR/>23. placebo.ab,ti.<BR/>24. dt.fs.<BR/>25. randomly.ab,ti.<BR/>26. trial.ab,ti.<BR/>27. groups.ab,ti.<BR/>28. or/21-27<BR/>29. Animals/<BR/>30. Humans/<BR/>31. 29 not (29 and 30)<BR/>32. 28 not 31</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Embase (Ovid)</HEADING>
<P>1. exp asthma/<BR/>2. Bronchospasm/<BR/>3. asthma$.tw.<BR/>4. wheez$.tw.<BR/>5. bronchospas$.tw.<BR/>6. (bronch$ adj3 spas$).tw.<BR/>7. bronchoconstrict$.tw.<BR/>8. (bronch$ adj3 constrict$).tw.<BR/>9. or/1-8<BR/>10. (aboriginal$ or aborigine$ or indigenous).tw. or exp minority group/<BR/>11. culture/ or ethnology/ or culture specific.tw. or cultural.tw.<BR/>12. 10 or 11<BR/>13. self care/ or self administration/ or self medication/ or self efficacy/ or self manage$.tw.<BR/>14. patient attitude/ or patient compliance/ or patient participation/ or patient satisfaction/ or refusal to participate/ or treatment refusal/<BR/>15. health education/ or health promotion/ or nutrition education/ or patient education/<BR/>16. exp patient care/ or health care planning/ or patient care planning/<BR/>17. health services indigenous/ or indigenous health$.tw. or aboriginal$ health$.tw. or aborigine$ health$.tw.<BR/>18. (educat$ or program$ or learn$ or specific).tw.<BR/>19. or/13-18<BR/>20. 9 and 12 and 19<BR/>21. Randomized Controlled Trial/<BR/>22. randomization/<BR/>23. controlled clinical trial/<BR/>24. Double Blind Procedure/<BR/>25. Single Blind Procedure/<BR/>26. Crossover Procedure/<BR/>27. (clinica$ adj3 trial$).tw.<BR/>28. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (mask$ or blind$ or method$)).tw.<BR/>29. exp Placebo/<BR/>30. placebo$.ti,ab.<BR/>31. random$.ti,ab.<BR/>32. ((control$ or prospectiv$) adj3 (trial$ or method$ or stud$)).tw.<BR/>33. (crossover$ or cross-over$).ti,ab.<BR/>34. or/21-33<BR/>35. exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/<BR/>36. human/ or normal human/ or human cell/<BR/>37. 35 and 36<BR/>38. 35 not 37<BR/>39. 34 not 38</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>

<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;3 additional studies included in quantitative synthesis&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;5 full-text articles assessed for eligibility&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;20 records screened&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;96 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;228 total records identified for 2007 &amp;amp; 2009 review publications&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;170 additional records identified from updated search (June 2016)&lt;/p&gt;&lt;p&gt;4 additional records identified from reference list&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;15 records excluded&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;2 records excluded (studies ongoing and were protocols)&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_12396_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="12396"><ADDRESS><DEPARTMENT>Institute of Health and Biomedical Innovation</DEPARTMENT><ORGANISATION>Queensland University of Technology</ORGANISATION><CITY>Brisbane</CITY><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>